Category: GlobeNewswire

  • MIL-OSI: Spryker Wins 2025 Silver Stevie® Award for Technology Excellence in E-Commerce

    Source: GlobeNewswire (MIL-OSI)

    BERLIN and NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) — Spryker, the leading composable commerce platform for global enterprises, today announced it has been named the winner of the Silver Stevie® Award in the 2025 Stevie Awards for Technology Excellence. This recognition highlights Spryker’s continued achievements in the commerce industry transforming the enterprise landscape from rigid legacy platforms to agile ecosystems. With its composable architecture, Spryker empowers businesses to adapt faster, build smarter and stay ahead of evolving buyer expectations.

    Spryker has become the trusted commerce engine of choice for global innovators, supporting advanced digital transformation across sectors like healthcare, manufacturing, automotive and distribution. Its composable approach allows enterprises to build custom commerce ecosystems tailored to their unique business needs.

    “From the beginning, Spryker set out to redefine how enterprises approach digital commerce by introducing a truly composable platform,” said Boris Lokschin, Co-founder and CEO at Spryker. “As businesses face growing pressure to innovate faster and meet ever-changing customer demands, this recognition affirms our commitment to building flexible, future-proof solutions. We’re proud to earn this validation of our technology and our team’s hard work.”

    The Stevie Awards are the world’s premier business awards and honor global excellence in business. The Stevie Awards for Technology Excellence recognize the remarkable achievements of individuals, teams, and organizations that are shaping the future of technology across all industry sectors.

    This is the latest in a series of recognitions that Spryker and its customers have received from industry analysts and awards including the Paradigm B2B Enterprise CombineB2B E-Commerce Association Awards, and RetailTech Breakthrough.

    About Spryker
    Spryker is the leading global composable commerce platform for enterprises with complex use cases to enable growth, innovation, and differentiation. Designed specifically for sophisticated transactional businesses, Spryker’s easy-to-use, headless, API-first model enables businesses to adapt, scale, and quickly go to market while facilitating faster time-to-value throughout their digital transformation journey. As a global platform leader for B2B and B2C Enterprise Marketplaces, IoT Commerce, and Unified Commerce, Spryker has empowered 150+ global enterprise customers worldwide and is trusted by brands such as ALDI, Siemens, ZF Friedrichshafen, and Ricoh. Spryker is a privately held technology company headquartered in Berlin and New York backed by world class investors such as TCV, One Peak, Project A, Cherry Ventures, and Maverick Capital. Learn more at spryker.com and follow Spryker on LinkedIn and X.

    The MIL Network

  • MIL-OSI: Standard Premium Expands Stock Repurchase Program Following Strong Q2 Results

    Source: GlobeNewswire (MIL-OSI)

    MIAMI, July 31, 2025 (GLOBE NEWSWIRE) — Standard Premium Finance Holdings, Inc. (OTCQX: SPFX), a leading specialty finance company, today announced that its board of directors has authorized an expansion of the Company’s previously announced $250,000 stock repurchase program which follows the Company’s strong second quarter performance, including $3.1 million in revenue, income before taxes of $345,000 and a return-on-equity of 15%. The board approved the ability for repurchases to be effectuated in the open market in accordance with applicable SEC regulations and safe harbor provisions, in addition to privately negotiated transactions directly with stockholders.

    “The expanded repurchase program reinforces our continued confidence in the Company’s strategic direction and long-term vision, and our ability to execute on a compelling growth trajectory,” says William Koppelmann, CEO, Standard Premium. “It provides us with another flexible mechanism to return value to shareholders while maintaining a disciplined, balanced and methodical capital allocation approach.”

    The Company noted that repurchases under the program remain subject to a number of factors, including market conditions, stock price, regulatory requirements and limitations and corporate liquidity needs and priorities. The program does not obligate the Company to repurchase any specific number of shares and repurchases may be suspended or discontinued at any time. The program remains in effect through November 2, 2025.

    “As we continue to scale our business and deliver consistent, solid financial performance, we remain focused on sustainably enhancing shareholder value through prudent capital deployment and strategic execution,” adds Koppelmann.

    About Standard Premium Finance Holdings, Inc. 
    Standard Premium Finance Holdings, Inc. (OTCQX: SPFX), is a specialty finance company which has financed premiums on over $2 Billion of property and casualty insurance policies since 1991. We currently operate in 38 states and are seeking M&A opportunities of synergistic businesses to leverage economies of scale. https://www.standardpremium.com/ 

    Cautionary Statement Regarding Forward-Looking Statements
    This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 and within the meaning of Section 27a of the Securities Act of 1933, as amended, and Section 21e of the Securities Exchange Act of 1934, as amended with regard to our anticipated future growth and outlook, including the Company’s current plans concerning the stock repurchase plan. Our actual results may differ from expectations presented or implied herein and, consequently, you should not rely on these forward-looking statements as predictions of future events. We do not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statement to reflect any change in our expectations or any change in events, conditions or results.

    Additional information concerning risk factors relating to our business is contained in Item 1A Risk Factors of our Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 10, 2025 which is available on the SEC’s website at www.sec.gov or on the Investor Relations section of our website, standardpremium.com.

    Media:
    Nicholas Turchiano
    CPR Marketing
    nturchiano@cpronline.com  
    201-641-1911×35

    The MIL Network

  • MIL-OSI: imPAC Labs and BigID Join Forces to Bring Data-Centric Cloud Security to Enterprises

    Source: GlobeNewswire (MIL-OSI)

    Atlanta, GA , July 31, 2025 (GLOBE NEWSWIRE) — imPAC Labs, the cloud-control plane for security and compliance, today announced a strategic integration with BigID, the leading platform for data security, privacy, compliance, and AI governance, giving security and DevOps teams unified, real-time insight and control from sensitive data all the way to the cloud infrastructure that stores and processes it.

    Data-Centric Cloud Security by imPAC x BigID

    Reimagining Proactive, Data-Centric Cloud Security

    Traditional cloud security tools flag surface-level misconfigurations but lack the context to highlight what really matters: the data at risk. By combining BigID’s deep data discovery and classification with imPAC’s policy automation engine, joint customers can now:

    • Unify Data Intelligence & Cloud Controls – BigID continuously discovers and classifies regulated and high-value data; imPAC ingests that context to enrich cloud configurations and surface previously hidden exposures.
    • Prioritize & Remediate by Actual Risk – BigID’s data signals (PII, PHI, financial data, IP) feed imPAC’s High-Fidelity Risk Scoring, so teams focus on the misconfigurations that endanger the most critical data.
    • Automate Data-Aware Guardrails – Using imPAC Compose and Playbooks, security teams can trigger actions like encryption, revoking access, or quarantining based on BigID’s sensitivity tags the moment risky conditions appear.
    • Continuous Compliance & Audit-Ready Evidence – BigID maps data to GDPR, HIPAA, PCI DSS and more, while imPAC’s Time Machine captures every configuration change, producing end-to-end proof without manual effort.
    • Cut Noise, Respond Faster – Data context slashes alert fatigue; imPAC automatically raises or lowers severity so responders spend time on the incidents that matter most.

    Availability

    The integrated imPAC + BigID solution is available today.

    About imPAC Labs

    imPAC Labs is the only cloud control plane allowing Security, DevOps, and Compliance teams to move fast while reducing security risk by gaining continuous control over all cloud assets, configurations, and hidden relationships. Teams can now track all configuration changes over time with evidence, build automated no-code guardrails, and ingest contextual DSPM signals for proactive cloud control.

    Enterprises trust imPAC to protect their multi-cloud environments, streamline their audit and compliance burden, safeguard their deployments and unify internal teams with a common goal of strengthening security.

    One unified, self-service hub for proactive cloud control. Learn more at www.impac.io.

    About BigID

    BigID helps organizations connect the dots in data & AI: for security, privacy, compliance, and AI data management.  BigID enables customers to find, understand, manage, protect, and take action on high-risk & high-value data, wherever it lives.

    Customers use BigID to reduce their AI & data risk, automate security and privacy controls, achieve compliance, and understand their data throughout their entire data landscape: from the cloud, on-prem, and everywhere in between.

    BigID has been recognized for innovation as a World Economic Forum Technology Pioneer; named to the Forbes Cloud 100; the Inc 5000 for 4 consecutive years; the Deloitte 500 for 4 consecutive years; Market Leader in Data Security Posture Management (DSPM); Leader in Privacy Management in the Forrester Wave; and an RSA Innovation Sandbox winner.

    Media Contacts

    imPAC Labs – pr@impac.io
    BigID – comms@bigid.com

    The MIL Network

  • MIL-OSI: FirstBank’s Strategy Delivers in Q2 2025 with Financial and Customer Wins

    Source: GlobeNewswire (MIL-OSI)

    LAKEWOOD, Colo., July 31, 2025 (GLOBE NEWSWIRE) — FirstBank, one of the nation’s largest privately held banks with a focus on “banking for good,” announced its 2025 second-quarter summary of the company’s holdings and activities. The bank reported the following quarter-end results:

    • Net income was $151.7 million
    • Total deposits were $23.4 billion
    • Net loans were $15.8 billion
    • Total assets were $26.8 billion

    During the second quarter, FirstBank earned the No. 1 ranking in customer satisfaction in the Southwest region for the fifth consecutive year, according to a national retail banking study. The study evaluated customer satisfaction across several key categories, account offerings, digital channels, and overall experience.

    “We’re honored to once again be recognized as a leader in customer satisfaction, which is a direct reflection of the trust our customers place in us,” said Kevin Classen, CEO of FirstBank.  “We also experienced a sizable year-over-year increase in net income from $96.5 million in Q2 2024 to $151.7 million in Q2 2025, demonstrating our commitment to long-term sustainable growth. As we look ahead, we’re focused on deepening our community impact, expanding support for local businesses, and driving innovation that helps customers and local economies thrive.”

    To promote its small business customers and give back to communities, FirstBank launched its “Our Cube Means Business” campaign. From July 11 to September 5, the bank’s signature orange cube will pop up at select businesses and storefronts throughout Colorado every Friday, providing exclusive giveaways. 

    In addition, FirstBank announced its continued partnership with the Colorado Chamber of Commerce on the Coolest Thing Made in Colorado contest, which works to celebrate and strengthen local manufacturers. 

    About FirstBank

    FirstBank began providing banking services in 1963. Today, it’s known as an industry leader in digital banking. It has grown to be one of the top-performing and largest privately held banks in the United States. FirstBank offers a variety of consumer deposit accounts, home equity loans, mortgages, rental property loans, and a full range of commercial banking services, including business financing, commercial real estate loans, treasury management, and more. Since 2000, FirstBank has been recognized as a top corporate philanthropist, contributing more than $90 million and thousands of volunteer hours to charitable organizations. The company is also unique in that a large portion of its stock is owned by management and employees, giving employees a financial stake in the bank’s success through its Employee Stock Ownership Program. For more information, visit www.efirstbank.com. Member FDIC.

    Media Contact
    Cody Wheeler
    (303) 228-6986 
    1stbank@wearecsg.com

    The MIL Network

  • MIL-OSI: EarthOptics™ Surpasses 5 Million Acres Mapped, Solidifies Position as Global Leader In Soil Measurement

    Source: GlobeNewswire (MIL-OSI)

    MINNEAPOLIS, July 31, 2025 (GLOBE NEWSWIRE) — EarthOptics, the leading soil data and measurement platform, has now mapped over five million acres of farmland and rangeland across its agronomic and sustainability business lines. This milestone further cements EarthOptics position as the world’s most comprehensive soil intelligence company—and the unrivaled leader in below-ground data.

    EarthOptics rapid scaling is driving a seismic shift in agriculture, from input efficiency to sustainability measurement, spanning the continental U.S. states and multiple continents. The company’s robust footprint now fuels the largest soil metagenomic dataset ever assembled, unlocking unprecedented insights into the biological, chemical, and physical properties of soil.

    “Our vision is to transform how the world understands and manages soil,” said Lars Dyrud, CEO of EarthOptics. “Surpassing 5 million acres isn’t just a milestone in growth—it’s a signal that the future of agriculture depends on deeper, smarter, and scalable soil insights. No one is doing this at the scale, speed, or accuracy that we are.”

    EarthOptics integrated platform combines ground-truth physical samples with its GroundOwl™ multimodal sensor and artificial intelligence (AI) models. This next-generation approach generates the highest-resolution, actionable insights for growers, agronomists, carbon market operators, and input providers alike. With thousands of soil samples collected weekly, EarthOptics enables data-driven decisions for fertility planning, tillage, crop planning, carbon credits, and biological interventions. The company’s technologies are reducing customer costs by minimizing required sampling and unlocking new value from the soil, be it improved yields or verified carbon sequestration.

    Their unmatched scale has created the world’s most expansive biological soil database, positioning the company at the forefront of predictive agronomy, input optimization, and sustainable land management. This biological dataset is already being utilized to facilitate the early detection of pests, pathogens, and nutrient deficiencies through AI-based modeling.

    Partnering with carbon registries, food brands, ranchers, farmers, agronomists, and input companies, EarthOptics is emerging as the leader in scalable soil analytics. With an expanding customer base and increasing demand for trusted data to back sustainability claims, the company’s reach is accelerating. For more information, go to www.earthoptics.com.

    About EarthOptics

    Headquartered in Minneapolis, Minnesota, EarthOptics harnesses advances in soil-sensing technologies, genomics, and data science to provide farmers and ranchers with deep, actionable insights into their soil’s chemical, physical, and biological properties. By blending cutting-edge laboratory analysis with industry-leading field-based sensors, we deliver powerful predictive insights that enable producers to optimize input use, improve soil health, increase yields, and unlock new opportunities in sustainable agriculture. EarthOptics is also the leading carbon measurement company in the U.S., supporting the growth of carbon markets with accurate, verifiable soil data. The company has offices in Raleigh, North Carolina; Emeryville, California; Blacksburg, Virginia; and Fayetteville, Arkansas, with laboratories in Emeryville, California, and Memphis, Tennessee. Learn more at www.EarthOptics.com.

    For media interviews or to request investor materials, please contact:
    Natalie McCracken
    Director of Marketing
    708-220-4342
    natalie.mccracken@earthoptics.com

    For media interviews, contact:
    Jill Means
    Mod Op Vice President, Account Director
    515-710-2667
    jill.means@modop.com

    The MIL Network

  • MIL-OSI: TAB Bank Q2 Loans Fund Growth for 218 Companies Totaling $66 Million

    Source: GlobeNewswire (MIL-OSI)

    OGDEN, Utah, July 31, 2025 (GLOBE NEWSWIRE) — TAB Bank funded growth for 218 companies in Q2 2025 with loans totaling $66 million. Companies signed with TAB Bank for working capital, cash flow management through factoring, equipment purchases and small business lines of credit. Businesses in the manufacturing, transportation, healthcare, food, fintech and toy/game industries selected TAB Bank as their financial partner.

    Highlights of some of the largest Q2 2025 deals include:

    • $8 million—A leader in global sourcing, supply chain management, manufacturing and nearshoring solutions in Ohio.
    • $5 million—Package Steel Systems, of Massachusetts, the premier builder of metal buildings in the Northeast.
    • $5 million—An exotic and collector car financing dealer in Utah.
    • $5 million—A toy, puzzle and gaming company based in California.
    • $2.5 million— Ryan Transportation, Inc., a Michigan-based truckload transportation provider.

    Additionally, in Q2, TAB Bank provided equipment financing to 140 companies, with a combined value of $15.2 million. Nine companies in the transportation sector—the core industry of the bank’s beginnings—received term loans and accounts receivable lines of credit ranging from $40,000 to $300,000. TAB also funded 55 small- to medium-sized businesses.

    “TAB Bank is a key financial partner, whether a company is looking for creative ways to manage cash flow or to leverage cash or assets to maximize growth,” said Justin Hatch, Chief Lending Officer at TAB Bank. “Our expertise in financing, along with our experience in many industries, allows us to take a comprehensive, creative and strategic view of the business goals and then structure the deal that best meets those needs. We are with our companies every step of the journey, even in some of their most difficult times.”

    The bank’s services include working capital, equipment financing, term loans, lines of credit and commercial real estate loans. TAB Bank’s specialists ensure each client is matched with the right financial product for their industry and growth stage. The bank supports businesses with stellar credit and those without, requiring alternative assessments. To determine creditworthiness, the bank considers various factors, such as income and operational history.

    For more information on TAB Bank’s capital financing and credit solutions, visit TABBank.com.

    About TAB Bank
    At TAB Bank, our mission is to unlock dreams with bold financial solutions that empower individuals and businesses nationwide. We are committed to building value in all we do through our innovative banking products.   Our dedication drives us to continuously improve, ensuring that we meet the evolving needs of our clients with excellence and agility. For over 25 years, we have remained steadfast in offering tailored, technology-enabled solutions designed to simplify and enhance the banking experience. 

    For more information about how we can help you achieve your financial dreams, visit www.TABBank.com.

    Contact Information:
    Trevor Morris
    Director of Marketing
    801-710-6318
    trevor.morris@tabbank.com

    The MIL Network

  • MIL-OSI: Latest Release of Quark Publishing Platform® Delivers Accelerated AI- Powered Content Automation at Scale for Highly Regulated Industries

    Source: GlobeNewswire (MIL-OSI)

    GRAND RAPIDS, Mich., July 31, 2025 (GLOBE NEWSWIRE) — Quark Software, the global provider of content automation, intelligence and design software, today announced the July 2025 release of Quark Publishing Platform® (QPP), its enterprise content lifecycle management platform designed to revolutionize how highly regulated industries manage, author, and deliver complex content.

    Built to address the documentation challenges of sectors such as financial services, life sciences, manufacturing, and public sector organizations, the SaaS platform offers unparalleled levels of automation, compliance, and personalization — specifically for use cases like client investment reports, drug safety reports, SOPs, technical data sheets, policy documents, and legislative reports.

    Next-Level Automation with Strict Regulatory Guardrails and Governance

    The July 2025 release introduces powerful new capabilities that enable enterprise content teams to:

    • Achieve 80–100% batch automation of recurring content through data-driven personalization powered by Content Variables
    • Convert unstructured content into structured, reusable, tagged components for compliant output, reducing onboarding costs by 50–80%
    • Leverage AI-powered Repeatable Accelerator Packs (RAPs) for sector-specific use cases, cutting onboarding cycles by 25–30%
    • Seamlessly reuse brand-compliant, design-rich content in Microsoft PowerPoint, drastically improving presentation workflows
    • Gain access to workflow enhancements including agile content strategy, smarter authoring workflows, enhanced usability, and enhanced Microsoft 365 Office desktop app integration

    The result is a smarter, faster, and more scalable way to manage regulated content across global teams — without compromising on compliance, accuracy, or brand consistency.

    Executive Insight
    “This release is a game-changer for content teams facing complex, regulatory data integration and workflow demands,” said Amit Sood, SVP Enterprise Products at Quark. “By combining powerful AI with structured content models, we’ve created a platform that accelerates use case deployment and transforms unstructured content into reusable, audit-ready components to drive enterprise-grade AI. It’s about faster outcomes, better compliance, and enabling teams to do more with less.”

    Built for the Industries That Can’t Afford to Get Content Wrong
    From automating client-facing investment communications to streamlining drug safety reporting, policy documentation, and manufacturing SOPs, QPP is built to support high-stakes content processes where speed and accuracy are critical.

    Use cases include:

    • Financial Services: Fund factsheets, ESG disclosures, regulatory filings
    • Life Sciences: PSURs, CSRs, PADERs, and labeling updates
    • Manufacturing: Technical guides, data sheets, SOPs
    • Public Sector: Legislative documents, policy updates, legal frameworks

    Enterprise-Grade Integration and Security
    The new platform is powered by Microsoft Azure Cloud Services and integrates directly with Microsoft 365 desktop applications — ensuring security, scalability, and accessibility across regulated ecosystems. Advanced permissions, traceable workflows, and Automated Content Validations features ensure trust and accountability across every step of the content lifecycle.

    About Quark
    Quark is a leading provider of AI-powered content automation solutions for highly regulated industries. QPP enables organizations to transform how they create, manage, and distribute content by combining intelligent automation, data integration, and compliance frameworks. With customers worldwide, Quark empowers teams to accelerate enterprise content lifecycle management while ensuring accuracy and regulatory readiness. Visit quark.com for more information.

    Media Contacts:
    Emerson Welch
    Quark
    ewelch@quark.com

    https://www.linkedin.com/in/emerson-welch/

    The MIL Network

  • MIL-OSI: The Payden Securitized Income Fund Offers Timely Strategy for Today’s Income Investors

    Source: GlobeNewswire (MIL-OSI)

    LOS ANGELES, July 31, 2025 (GLOBE NEWSWIRE) — With investors increasingly seeking income and diversification amid shifting monetary policy and market volatility, the Payden Securitized Income Fund (PYSFX) offers a compelling approach. The Fund provides access to a wide range of securitized assets—including agency and non-agency residential mortgage-backed securities (RMBS), asset-backed securities (ABS), commercial mortgage-backed securities (CMBS), and collateralized loan obligations (CLOs).

    Designed to offer attractive yield potential while seeking limited interest rate sensitivity, the Payden Securitized Income Fund navigates changing market conditions through active management. The Fund seeks to capitalize on market inefficiencies and spread opportunities while maintaining a high degree of liquidity and risk awareness.

    “The Payden Securitized Income Fund is designed with an aim to help investors earn more income, enhance diversification beyond traditional bonds, and maintain flexibility in a changing interest rate environment,” said Gary Greenberg, CFA, Director and Co-Manager.

    Recent market dynamics have favored securitized credit, with CMBS and residential credit offering strong relative value. A resilient U.S. economy and a Federal Reserve nearing the end of its tightening cycle create favorable conditions for active managers seeking differentiated sources of income.

    The Fund’s diversified structure and risk-conscious portfolio management strategy make it a timely solution for investors looking to complement traditional fixed income holdings.

    PAYDEN & RYGEL

    With $160 billion under management, Payden & Rygel is one of the largest privately-owned global investment advisers focused on the active management of fixed income and equity portfolios. Payden & Rygel provides a full range of investment strategies and solutions to investors around the globe, including Central Banks, Pension Funds, London, and Milan. Visit www.payden.com for more information about Payden’s investment offerings, including US mutual funds and Irish-domiciled funds (subject to investor eligibility).

    Past performance does not guarantee future results. Investment returns and principal value will fluctuate, so investors’ shares, when sold, may be worth more or less than their original cost. For the most recent month-end performance, which may be higher or lower than that quoted, visit our website at payden.com or call 800 572-9336.

    For more information and to obtain a prospectus or summary prospectus, visit payden.com or call 800 572-9336. Before investing, investors should carefully read and consider investment objectives, risks, charges, expenses and other important information about the Fund, which is contained in these documents. Interest Rate Risk: As with most funds that invest in debt securities, the income on and value of your shares in the Fund will fluctuate along with interest rates. When interest rates rise, the market prices of the debt securities the Fund owns usually decline. When interest rates fall, the prices of these securities usually increase. Extension Risk: Rising interest rates can cause the average maturity of the Fund’s holdings of mortgage-backed securities to lengthen unexpectedly due to a drop in prepayments. This would increase the sensitivity of the Fund to rising rates, and could cause certain of the Fund’s investments to decline in value more than they would have declined due to the rise in interest rates alone. The Payden Funds are distributed through Payden & Rygel Distributors, member FINRA.

    This material reflects the firm’s current opinion and is subject to change without notice. Sources for the material contained herein are deemed reliable but cannot be guaranteed. This material is for illustrative purposes only and does not constitute investment advice or an offer to sell or buy any security. Past performance is no guarantee of future results.

    CONTACT

    Kate Ennis
    ennis@daipartnerspr.com
    (301) 580-6726

    This press release was published by a CLEAR® Verified individual.

    The MIL Network

  • MIL-OSI: Coface SA: Coface confirms its good start to the year and continues its strategic investments. Annualised return on tangible equity at 12.6%

    Source: GlobeNewswire (MIL-OSI)

    Coface confirms its good start to the year and continues its strategic investments. Annualised return on tangible equity at 12.6%

    Paris, 31 July 2025 – 5.35 p.m.

    • Turnover: €937m, up +2.3% at constant FX and perimeter
      • Trade Credit Insurance revenue up +1.7%; client activity up +1.8%
      • Client retention back up at near-record (94.0% vs. 92.8% in H1-24); pricing remained negative
        (-1.6%), in line with historical trends
      • Business Information growing again double-digit (+14.7% at constant FX); Debt Collection up +35.0%; Factoring down slightly by -1.5% due to lower interest rates
    • Net loss ratio at 40.1%, up 5.1 ppts; net combined ratio at 71.3%, up 7.9 ppts
      • Gross loss ratio at 37.8%, up 5.3 ppts year-on-year but improving slightly in Q2-25 relative to the previous quarter, showing good risk control
      • Net cost ratio up 2.8 ppts at 31.2%, reflecting past inflation as well as continued investments
    • Coface continues to strengthen its credit insurance business and is rolling out its data strategy:
      • Strengthening governance with the appointment of Joerg Diewald as Director of Information Services and Partnerships and Thibault Surer as head of a new technology division focused on data, connectivity and product innovation
      • Creation of a new Lloyd’s syndicate allowing Coface to offer AA solutions to its clients
      • Acquisition of Cedar Rose and Novertur International
    • Net income (Group share) at €124.2m, down 12.7% compared with the record set in H1-24. Annualised RoATE1at 12.6%
    • Estimated solvency ratio of 195%2, above the target range (155% – 175%)

    Unless otherwise indicated, changes are expressed by comparison with the results as at 30 June 2024.

    Commenting, Xavier Durand, CEO of Coface, said:
    Coface generated net income of €62m in Q2-25, down from a record Q2-24. The number of bankruptcies worldwide has continued to rise steadily and is now well above pre-COVID levels. Through constant vigilance and flawless execution, we have contained the increase in the loss experience, with the uncertainties created by the increase in tariffs in the United States having probably yet to fully materialise.
    However, our revenues are growing, both in credit insurance and services. This growth is being driven by our investments, which have brought new business to a record level in insurance and services.
    These deliberate investments strengthen our distribution capabilities, the range of products and services available to our clients, and our risk analysis tools. Since the beginning of the year, we have made two acquisitions in information services, Cedar Rose and Novertur. We have also announced the launch of a Lloyd’s syndicate to offer AA solutions to some of our clients.
    Lastly, our solvency ratio remains high, at 195%.”  

    Key figures at 30 June 2025

    The Board of Directors of COFACE SA examined the consolidated financial statements at 30 June 2025 at its meeting of 31 July 2025. These statements were also previously reviewed by the Audit Committee at its meeting of 30 July 2025. These interim consolidated financial statements have been subject to limited review by the Statutory Auditors. The limited review report is being issued.

    Income statement items in €m H1-24 H1-25 Variation % ex FX*
    Insurance revenue 754.3 760.0 +0.8% +1.7%
    Other revenues 168.5 176.6 +4.9% +4.8%
    REVENUE 922.7 936.6 +1.5% +2.3%
    UNDERWRITING INCOME (LOSS) NET OF REINSURANCE 195.0 153.6 (21.2)% (20.3)%
    Investment income, net of management expenses,excluding finance costs 40.8 26.3 (35.4)% (36.0)%
    Insurance finance expenses (18.1) 6.7 (137.1)% (130.8)%
    CURRENT OPERATING INCOME 217.7 186.6 (14.3)% (14.1)%
    Other operating income and expenses (0.5) (0.6) +21.8% +12.2%
    OPERATING INCOME 217.2 186.0 (14.4)% (14.2)%
    NET INCOME (GROUP SHARE) 142.3 124.2 (12.7)% (12.7)%
             
    Key ratios H1-24 H1-25 Variation
    Loss ratio after reinsurance 35.0% 40.1% 5.1 ppts
    Cost ratio after reinsurance 28.4% 31.2% 2.8 ppts
    COMBINED RATIO AFTER REINSURANCE 63.4% 71.3% 7.9 ppts
             
    Balance sheet items in €m 2024 H1-25 Variation
    Total equity (Group share) 2,193.6 2,098,0 (4.4)%
      H1-24 H1-25    
    Solvency ratio 195%1 195%1 0 ppt

    * Excluding scope effect.
    1This estimated solvency ratio is a preliminary calculation made according to Coface’s interpretation of Solvency II regulations and using the Partial Internal Model. The final calculation may differ from this preliminary calculation. The estimated solvency ratio is not audited.

    1.   Revenue

    Coface posted consolidated turnover of €937m in the first half of 2025, up +2.3% at constant FX and perimeter compared with H1-24. On a reported basis (at current FX and perimeter), turnover was up +1.5%.

    Revenues from insurance activities (including Bonding and Single Risk) increased +1.7% at constant FX and perimeter, benefiting from a slight increase in client activity and the return to a record retention level at 94.0%. New business reached €76m, the highest since H1-20, driven by an increase in demand and benefiting from growth investments made by Coface.

    Growth in client activity had a positive impact of +1.8% in H1-25 against a backdrop of extreme political uncertainty, particularly in terms of tariffs, and modest economic growth. The price effect remained negative at -1.6% in H1-25, in line with long-term trends. This decrease is largely explained by a very low past loss experience, offset by today’s return to normal.

    Turnover from non-insurance activities was up +8.2% compared with H1-24. Factoring turnover fell -1.5% in H1-25 and -2.2% in Q2 25 on lower interest rates and weak client activity in Germany and Poland. Information services turnover continued to post double-digit growth, at +14.7%. Debt Collection commissions increased, from a still modest base, by +35% due to the increase in claims to be collected. Fee and commission were up +2.3%.

    Total revenue in €m
    (by invoicing region)
    H1-24 H1-25 Variation % ex FX3
    Northern Europe 185.0 185.2 +0.1% +0.1%
    Western Europe 187.6 191.6 +2.1% +1.0%
    Central and Eastern Europe 87.0 83.9 (3.5)% (3.8)%
    Mediterranean & Africa 276.0 280.2 +1.5% +3.0%
    North America 88.7 87.7 (1.2)% +2.0%
    Latin America 38.2 41.5 +8.6% +17.5%
    Asia-Pacific 60.2 66.5 +10.5% +9.5%
    Total Group 922.7 936.6 +1.5% +2.3%

    In the Northern Europe region, turnover was up +0.1% at constant and current FX. The credit insurance business benefited from robust new business and a high retention rate. Factoring turnover was down -1.6%.

    In Western Europe, turnover rose +1.0% at constant FX (2.1% at current FX) on solid sales performances in services (+27%) and credit insurance, offsetting the loss of a contract with a financial institution.

    In Central and Eastern Europe, turnover was down -3.8% at constant FX (-3.5% at current FX) but improved significantly compared with the previous quarter (-6.9%). Credit insurance was negatively impacted by a non-recurring effect recorded in 2024, as well as the transfer of a major contract to the Asia-Pacific region.

    In the Mediterranean & Africa region, which is driven by Italy and Spain, turnover increased +3.0% at constant FX and +1.5% at current FX, the result of a high retention rate and a more dynamic economy overall.

    In North America, turnover rose +2.0% at constant FX (-1.2% on a reported basis). The region is benefiting from an improvement in new business. Reported figures have been adversely affected by the sharp fall in the US dollar since the beginning of the year.

    In Latin America, turnover was up +17.5% at constant FX and +8.6% at current FX. The region is benefiting from the persistently high level of local inflation, which is benefiting client activity.

    Turnover in the Asia-Pacific region was up +9.5% at constant FX and +10.5% at current FX, driven by a high retention rate, a rebound in client activity, and the transfer of a client from another region.

    2.   Result

    • Combined ratio

    The combined ratio after reinsurance stood at 71.3% in H1-25 (up 7.9 ppts year on year) and 74.0% in Q2-25, reaching a level close to the cycle average.

    (i)  Loss ratio

    The gross loss ratio stood at 37.8%, up 5.3 ppts year-on-year. This increase reflects the return to normal of the loss experience, offset by the reserve releases, which remain at a high level. The number of mid-sized claims increased but remains below long-term trends.

    The Group’s reserving policy remained unchanged. The amount of provisions related to the underwriting year, although discounted, remained in line with the historical average. The rigorous management of past claims enabled the Group to record 41.0 ppts of recoveries.

    The net loss ratio increased to 40.1%, up 5.1 ppts compared with H1-24, but close to the level reached in H1-23 (40.3%), in today’s more difficult economic environment.

    (ii)  Cost ratio

    Coface is pursuing its strict cost management policy while maintaining its investments, in accordance with the Power the Core strategic plan. Costs were up +7.0% in H1-25 at constant FX and perimeter and +6.3% at current FX.

    The cost ratio before reinsurance stood at 34.6% in H1-25, up 2.0 ppts year on year. This increase mainly resulted from cost inflation (0.6 ppt) as well as continued investments (2.3 ppts). Conversely, the improved product mix (information services, debt collection and fee and commission income) had a positive effect of -0.9 ppt. The trend in reinsurance commissions explains the remainder of the variation.

    • Financial income

    Income from financial investments was +€26.3m in the first half of the year. The total includes an FX effect of -€17.0m on financial assets, owing to the sharp fall in the dollar against the euro, as well as a negative impact of the application of IAS 29 (hyperinflation) in Turkey of -€6.7m.

    The portfolio’s current income (i.e. excluding capital gains, depreciation and FX) was €52.1m. The accounting yield4, excluding capital gains and fair value effect, was 1.6% in H1-25. The yield on new investments was 3.7%.

    Insurance finance expenses (IFE) were positive at €6.7m in H1-25. They include a significant FX gain (+€23.1m) on technical liabilities, which reflects the expense recorded on assets and partially on net loss.

    • Operating income and net income

    Operating income totalled €186.0m in H1-25, down 14.4%, approaching the level reached in H1-23.

    The effective tax rate in H1-25 was 25% (vs. 27% in H1-24).

    Overall, net income (Group share) was €124.2m, down 12.7% compared with H1-24, slightly below the result in H1-23 (€128.8m) in a more difficult economic environment.

    3.   Shareholders’ equity

    At 30 June 2025, Group shareholders’ equity was €2,098.0m, down €95.6m or -4.4% (€2,193.6m at 31 December 2024).

    The change is mainly due to positive net income of €124.2m, the dividend payment of -€209m, and the increase in unrealised capital gains (€21.9m).

    The annualised return on average tangible equity (RoATE) was 12.6% at 30 June 2025, down compared with the previous year, in line with the decline in net income.

    The solvency ratio stood at 195%5, stable compared with H1-24. It remains well above the Group’s target range (155%-175%).

    4.   Outlook

    The second quarter of 2025 was marked by the continued increase in tariffs announced by the United States. The US administration’s announcements of sharp increases alternated with deferments of varying duration and the signing of a few bilateral agreements. As things stand today, tariffs on imports from Europe should reach 15%.

    Some tariffs (automotive, metals) have already come into force and have had direct negative consequences on the trade flows of the goods concerned. Conversely, announcements of deferred tariffs triggered advance purchases, bolstering economic activity. Lastly, extreme uncertainty as to the final outcome of the tariff issue have led to a postponement of investments as well as the redirection of Chinese exports, particularly towards markets deemed more stable.

    This highly uncertain environment is impacting global trade and the health of companies in markedly different ways. During the second quarter, Coface downgraded the ratings of 23 sectors and 4 countries. Persistent inflationary pressures are preventing central banks from cutting rates for now. Demand is being supported solely by the maintenance of high public deficits and the continuation of an extremely strong investment cycle to foster the development of AI technology.

    Business failures have increased in 80% of advanced economies and are now at a decade high, 20% to 25% higher than in 2019.

    Coface’s expertise in risk management and services (information services, debt collection) is more relevant than ever in this context of rapid change. The company is resolutely pursuing its investments while they weigh on the cost ratio in the short term. Since the beginning of the year, Coface has announced two acquisitions (Cedar Rose and Novertur) as well as the creation of a Lloyd’s syndicate and a technology division.

    Conference call for financial analysts

    Coface’s H1-2025 results will be discussed with financial analysts during the conference call that will take place on Thursday 31 July at 6.00 p.m. (Paris time). It will be accessible:

    The presentation will be available (in English only) at the following address:
    http://www.coface.com/fr/Investisseurs/Résultats-et-rapports-financiers

    Appendices

    Quarterly results

    Income statement items in €m
    Quarterly figures
    Q1-24 Q2-24 Q3-24 Q4-24 Q1-25 Q2-25   % % ex. FX*
    Insurance revenue 378.6 375.6 375.9 382.7 382.9 377.1   +0.4% +2.3%
    Other revenues 85.0 83.4 78.0 85.5 90.3 86.3   +3.5% +4.2%
    REVENUE 463.7 459.1 453.8 468.3 473.2 463.4   +0.9% +2.6%
    UNDERWRITING INCOME (LOSS)
    AFTER REINSURANCE
    100.3 94.7 88.8 84.9 85.4 68.2   (27.9)% (25.5)%
    Investment income, net of management expenses, excluding finance costs 17.9 22.8 19.0 31.9 10.4 15.9   (30.3)% (29.5)%
    Insurance finance expenses (11.4) (6.7) (7.3) (17.1) (4.1) 10.8   (262.8)% (249.1)%
    CURRENT OPERATING INCOME 106.8 110.9 100.5 99.7 91.6 95.0   (14.3)% (12.9)%
    Other operating income and expenses (0.1) (0.5) (2.6) (5.5) (0.4) (0.3)   (43.9)% (48.0)%
    OPERATING INCOME 106.8 110.4 97.9 94.2 91.2 94.7   (14.2)% (12.7)%
    NET INCOME (GROUP SHARE) 68.4 73.8 65.4 53.4 62.1 62.1   (15.9)% (14.7)%
    Income tax rate 27.2% 26.8% 25.5% 36.2% 23.0% 26.3%   (0,5) ppt

    Cumulated results

    Income statement items in €m
    Cumulated figures
    Q1-24 H1-24 9M-24 FY-24 Q1-25 H1-25   % % ex. FX*  
    Insurance revenue 378.6 754.3 1,130.2 1,512.9 382.9 760.0   +0.8% +1.7%  
    Other revenues 85.0 168.5 246.4 331.9 90.3 176.6   +4.9% +4.8%  
    TURNOVER 463.7 922.7 1,376.6 1,844.8 473.2 936.6   +1.5% +2.3%  
    UNDERWRITING INCOME (LOSS)
    AFTER REINSURANCE
    100.3 195.0 283.8 368.7 85.4 153.6   (21.2)% (20.3)%  
    Investment income, net of management expenses, excluding finance costs 17.9 40.8 59.8 91.7 10.4 26.3   (35.4)% (36.0)%  
    Insurance finance expenses (11.4) (18.1) (25.4) (42.5) (4.1) 6.7   (137.1)% (130.8)%  
    CURRENT OPERATING INCOME 106.8 217.7 318.2 417.9 91.6 186.6   (14.3)% (14.1)%  
    Other operating income and expenses (0.1) (0.5) (3.1) (8.6) (0.4) (0.6)   +21.8% +12.2%  
    OPERATING INCOME 106.8 217.2 315.1 409.2 91.2 186.0   (14.4)% (14.2)%  
    NET INCOME (GROUP SHARE) 68.4 142.3 207.7 261.1 62.1 124.2   (12.7)% (12.7)%  
    Income tax rate 27.2% 27.0% 26.5% 28.7% 23.0% 24.7%   (2,3) ppt

    * Excluding scope effect.

    CONTACTS

    INVESTOR/ANALYST RELATIONS
    Thomas Jacquet: +33 1 49 02 12 58 – thomas.jacquet@coface.com
    Rina Andriamiadantsoa: +33 1 49 02 15 85 – rina.andriamiadantsoa@coface.com

    MEDIA RELATIONS
    Saphia Gaouaoui: +33 1 49 02 14 91 – saphia.gaouaoui@coface.com
    Adrien Billet: +33 1 49 02 23 63 – adrien.billet@coface.com

    FINANCIAL CALENDAR 2025
    (subject to change)
    9M-2025 results: 3 November 2025, after market close

    FINANCIAL INFORMATION
    This press release, as well as all of COFACE SA’s regulated information, can be found on the Group’s website: https://www.coface.com/investors

    For regulated information on Alternative Performance Indicators (APMs), please refer to our Interim Financial Report for H1-2025 and our 2024 Universal Registration Document (see 3.7 “Key financial performance indicators”).

      Regulated documents posted by COFACE SA have been secured and authenticated with the blockchain technology by Wiztrust.
    You can check the authenticity on the website www.wiztrust.com.
     

    COFACE: FOR TRADE
    As a global leading player in trade credit risk management for almost 80 years, Coface helps companies grow and navigate in an uncertain and volatile environment.
    Whatever their size, location or sector, Coface provides 100,000 clients across some 200 markets. with a full range of solutions: Trade Credit Insurance, Business Information, Debt Collection, Single Risk insurance, Surety Bonds, Factoring.
    Every day, Coface leverages its unique expertise and cutting-edge technology to make trade happen, in both domestic and export markets.
    In 2024, Coface employed +5,200 people and recorded a turnover of ~€1.845 billion.

    www.coface.com

    COFACE SA is listed on Compartment A of Euronext Paris
    ISIN: FR0010667147 / Ticker: COFA

    DISCLAIMER – Certain statements in this press release may contain forecasts that notably relate to future events, trends, projects or targets. By nature, these forecasts include identified or unidentified risks and uncertainties, and they may be affected by many factors likely to give rise to a significant discrepancy between the real results and those stated in these statements. Please refer to chapter 5 “Main risk factors and their management within the Group” of the Coface Group’s 2024 Universal Registration Document filed with AMF on 3 April 2025 under the number D.25-0227 to obtain a description of certain major factors, risks and uncertainties likely to influence the Coface Group’s businesses. The Coface Group disclaims any intention or obligation to publish an update of these forecasts or to provide new information on future events or any other circumstance.


    1 RoATE = Return on average tangible equity.
    2 This estimated solvency ratio is a preliminary calculation made according to Coface’s interpretation of Solvency II regulations and using the Partial Internal Model. The final calculation may differ from this preliminary calculation. The estimated solvency ratio is not audited.
    3 Excluding scope effect.
    4 Book yield calculated on the average of the investment portfolio excluding non-consolidated investments.
    5 This estimated solvency ratio is a preliminary calculation made according to Coface’s interpretation of Solvency II regulations and using the Partial Internal Model. The final calculation may differ from this preliminary calculation. The estimated solvency ratio is not audited.

    Attachment

    The MIL Network

  • MIL-OSI: Coface SA: 2025 half-year financial report available

    Source: GlobeNewswire (MIL-OSI)

    2025 half-year financial report available

    Paris, 31 July 2025 – 17.35

    Coface announces today that its half-year financial report for 2025 is now available and was filed with the French financial market authority (Autorité des marchés financiers – AMF).

    This report is also on Coface website in “Investor Relations” section (Investor Resources – Coface Group Financial Reports | Coface).

    Copies are available, free of charge and on request by writing to the Company at 1 place Costes et Bellonte, 92270 Bois-Colombes, France.

    The present press release and the full regulated information concerning COFACE SA are available on the Group’s website Financial press releases & Publication announcements | Coface.

    CONTACTS

    ANALYSTS / INVESTORS
    Thomas JACQUET: +33 1 49 02 12 58 – thomas.jacquet@coface.com
    Rina ANDRIAMIADANTSOA: +33 1 49 02 15 85 – rina.andriamiadantsoa@coface.com

    MEDIA RELATIONS
    Saphia GAOUAOUI: +33 1 49 02 14 91 – saphia.gaouaoui@coface.com
    Adrien BILLET: +33 1 49 02 23 63 – adrien.billet@coface.com

    FINANCIAL CALENDAR 2025
    (subject to change)
    9M-2025 results: 3 November 2025 (after market close)

    FINANCIAL INFORMATION
    This press release, as well as COFACE SA’s integral regulatory information, can be found on the Group’s website: http://www.coface.com/Investors

    For regulated information on Alternative Performance Measures (APM), please refer to our Interim Financial Report for H1-2025 and our 2024 Universal Registration Document (see part 3.7 “Key financial performance indicators”).

      Regulated documents posted by COFACE SA have been secured and authenticated with the blockchain technology by Wiztrust.
    You can check the authenticity on the website www.wiztrust.com.
     

    COFACE: FOR TRADE
    As a global leading player in trade credit risk management for almost 80 years, Coface helps companies grow and navigate in an uncertain and volatile environment.
    Whatever their size, location or sector, Coface provides 100,000 clients across some 200 markets. with a full range of solutions: Trade Credit Insurance, Business Information, Debt Collection, Single Risk insurance, Surety Bonds, Factoring.
    Every day, Coface leverages its unique expertise and cutting-edge technology to make trade happen, in both domestic and export markets.
    In 2024, Coface employed +5,200 people and recorded a turnover of ~€1.845 billion.

    www.coface.com

    COFACE SA is listed in Compartment A of Euronext Paris
    ISIN: FR0010667147 / Ticker: COFA

    DISCLAIMER – Certain declarations featured in this press release may contain forecasts that notably relate to future events, trends, projects or targets. By nature, these forecasts include identified or unidentified risks and uncertainties, and may be affected by many factors likely to give rise to a significant discrepancy between the real results and those stated in these declarations. Please refer to chapter 5 “Main risk factors and their management within the Group” of the Coface Group’s 2024 Universal Registration Document filed with AMF on 5 April 2025 under the number D.25-0227 in order to obtain a description of certain major factors, risks and uncertainties likely to influence the Coface Group’s businesses. The Coface Group disclaims any intention or obligation to publish an update of these forecasts, or provide new information on future events or any other circumstance.

    Attachment

    The MIL Network

  • MIL-OSI: 2025 second-quarter results Solid performance amid a volatile environment Annual Net Cash Flow objective reaffirmed

    Source: GlobeNewswire (MIL-OSI)

    Paris (France), July 31, 2025

    2025 second-quarter results
    Solid performance amid a volatile environment
    Annual Net Cash Flow objective reaffirmed

    • Segment revenue of $274m in Q2 2025, up +6% year-on-year, fueled by Geoscience (GEO) and Sensing & Monitoring (SMO)
    • Segment adjusted EBITDAs of $107m in Q2 2025 (+14% year-on-year) or 39% margin (c.+270 bps). Profitability increase mostly driven by: 1/ the end of vessel penalties at EDA in January 2025 and 2/ good progress on the restructuring plan at SMO
    • Net Cash Flow generation of $30m in Q2 2025
    • Bond maturity extended to October 2030 after end-March 2025 successful refinancing, $125m available RCF1
    • 2025 financial objectives reaffirmed

    Sophie Zurquiyah, Chair and CEO of Viridien: “Viridien delivered a solid performance in the second quarter of 2025. Despite a volatile environment, the Group demonstrated resilience, driven by its primary focus on offshore markets and on leading oil companies. Combined with ongoing internal performance improvements, this resulted in robust year-on-year growth in both segment revenue and margins. From a cash perspective, Viridien generated a solid $30 m in Net Cash Flow during the quarter, reinforcing our confidence in reaching our full-year target of $100 m. The combination of a healthy Geoscience backlog and expected licensing activity toward year-end supports our confidence in maintaining momentum on our deleveraging path.”

    (in millions of $)2 Q2 2025 Q2 2024 Change (%) H1 2025 H1 2024 Change (%)
    Segment figures            
    Revenue 274 258 +6% 575 532 +8%
    Adjusted EBITDAs 107 94 +14% 250 200 +25%
    IFRS figures            
    Revenue 234 317 -26% 492 566 -13%
    EBITDAs 68 150 -55% 167 230 -27%
    Operating Income 15 52 -72% 71 72 -1%
    Net Income 6 35 -83% -22 32 n.a.
    Net Cash Flow 30 -6 n.a. 10 24 -61%
    Net Debt 997 941 +6% 997 941 +6%

    KEY HIGHLIGHTS PER BUSINESS LINE3

    Data, Digital and Energy Transition (DDE)

    Segment revenue at $181 m in Q2 2025, up +3% year-on-year driven by Geoscience. New business opportunities are emerging in HPC, while low-carbon initiatives are slowing down due to delays in CCUS projects.

    Geoscience (GEO)

    • Revenue at $115 m (+10%)
    • Solid performance mostly driven by work performed in Latin America and Middle East
    • For the past few years, Viridien has seen growing demand for advanced, high-quality, high-end subsurface imaging, especially in the US Gulf, Middle East, North Africa, and South America

    Earth Data (EDA)

    • Revenue at $66 m (-8%), following a strong performance in the first quarter of 2025
    • New OBN projects started in Norway and the US Gulf

    Segment adjusted EBITDAs reached $101 m, up +6% year-on-year, with a margin increase of c.+160 basis points. This performance reflects improving margins in Earth Data, which now fully benefits from the end of the vessel capacity agreement. EDA Cash EBITDA breakeven over the period.

    Sensing and Monitoring (SMO)

    Segment revenue at $93 m in Q2 2025, a solid +14% increase year-on-year. Activity is mostly driven by the Land segment, with strong deliveries of nodal system in South America and cabled systems in the MENA region, in particular. The Marine segment remains subdued. In New Businesses, Infrastructure monitoring is showing double-digit growth, while our Marlin Offshore Logistics solution achieved encouraging initial commercial success, with a contract signed with ONGC.

    Segment adjusted EBITDAs stood at $13 m, more than double last year’s figure, reflecting both revenue growth and the gradual positive impact of ongoing restructuring actions. In margin terms, second-quarter EBITDA reached nearly 13.7%, representing a c.+620 bp improvement year-on-year.

    Segment adjusted Operating income at $7 m vs -$2m in Q2 2024.

    CONSOLIDATED IFRS FIGURES4

    Profit & Loss

    Consolidated IFRS revenue for the second quarter of 2025 came in at $234m, down -26% year-on-year. EBITDAs stood at $68m, down -55%.

    IFRS Net Income reaches $6m, vs $35m in the second quarter of 2024, after accounting for -$53 m of leases and D&A, -$27m net cost of financial debt, +$12m other financial income linked to the partial capitalization of refinancing operation costs and partly offset by forex impacts, and +$6m of deferred tax assets.

    (in millions of $) Q2 2025 Q2 2024 Change (%) H1 2025 H1 2024 Change (%)
    €/$ exchange rate  1.12 1.08     1.08 1.08   
    Revenue 234 317 -26% 492 566 -13%
    EBITDAs 68 150 -55% 167 230 -27%
    Operating income 15 52 -72% 71 72 -1%
    Equity from investment -1 0 n.a. -1 0 n.a.
    Net cost of financial debt -27 -25 +6% -52 -49 +6%
    Other financial income (loss) 12 -1 n.a. -34 -1 n.s.
    Income taxes 6 -8 n.a. -7 -6 +32%
    Net Income (loss) from continuing operations 5 19 -74% -24 16 n.a.
    Net Income (loss) from discontinued operations 1 16 -92% 2 16 -88%
    Consolidated Net Income (loss) 6 35 -83% -22 32 n.a.

    Cash Flow and Net debt

    Net Cash Flow of $10 m generated in the first half of 2025, including $30 m in the second quarter alone. A solid performance in light of the significant pressure on the Group’s working capital, caused by overdue receivables from Mexican National Oil Company PEMEX (c.$50 m as of June 30, 2025) and largely contributing to the negative -$46m change in working capital over the period.

    Also worth noting that Net Cash Flow in the first half of 2024 included a one-off positive inflow of $38 m, related to the settlement of a litigation with ONGC.

    (in millions of $) Q2 2025 Q2 2024 Change (%) H1 2025 H1 2024 Change (%)
    Segment EBITDAs 108 91 +19% 250 196 +28%
    Income Tax Paid -4 -9 -52% -8 -12 -31%
    Change in Working Capital & Provisions 1 -3 n.a. -46 -3 n.s.
    Other Cash Items -1 0 n.a. -1 0 n.a.
    Cash from Operating Activity 103 78 +32% 195 180 +8%
    Total Capex -58 -57 +1% -119 -115 +3%
    Acquisitions and Proceeds of Assets 1 0 n.a. 1 0 n.s.
    Cash from Investing Activity -56 -56 0% -118 -114 +3%
    Paid Cost of Debt -1 -45 -97% -40 -43 -8%
    Lease Repayment -16 -16 +5% -26 -27 -5%
    Cash from Financing Activity -18 -61 -71% -67 -71 -6%
    Discontinued Operations Acquisitions 0 33 -100% 0 30 -100%
    Net Cash Flow 30 -6 n.a. 10 24 -60%

    Bond maturity significantly extended to October 2030 following the successful refinancing at end-March 2025.
    Ample liquidity in place, including a $125m RCF5.

    (in millions of $) June 30, 2025 Dec. 31, 2024 Change (%) June 30, 2024 Change (%)
    Liquidity 262 392 -33% 430 -39%
    Cash 162 302 -46% 340 -52%
    Undrawn RCF 100 90 +11% 90 +11%
    Gross Debt 1,158 1,223 -5% 1,281 -10%
    Bonds 9876 1,049 -6% 1,126 -12%
    Other borrowings 31 31 -1% 32 -3%
    Accrued interests 25 18 +33% 20 +24%
    Lease liabilities 116 125 -7% 103 +12%
    Net Debt 997 921 +8% 941 +6%

    OUTLOOK

    The oil price environment has remained volatile in recent months but consistently above the $60/bbl threshold, generally considered an industry equilibrium level. In this context, Oil & Gas companies have maintained most of their exploration and development commitments, particularly in Viridien’s core segments.

    Assuming no major disruption to the current environment, Viridien reaffirms its confidence in generating around $100m in Net Cash Flow for 2025, supported by:

    • Geoscience growth, driven by industry-leading technology and a strong backlog;
    • Earth Data late sales, expected to benefit from upcoming lease rounds, combined with disciplined new multi-client engagements;
    • Sensing & Monitoring, fueled by broad land activity.

    ***

    Q2 2025 conference call details

    The press release and presentation will be made available on www.viridiengroup.com at 5:45 p.m. (CET).

    An English-language conference call is scheduled today at 6:00 p.m. (CET).

    Participants must register for the conference call by clicking here to receive a dial-in number and PIN code. Participants may also join the live webcast by clicking here.

    A replay of the conference call will be available starting the following day, for a period of 12 months, in audio format on the Company’s website www.viridiengroup.com.

    Status of the statutory auditors’ procedures

    The Board of Directors met on July 31, 2025, and closed the consolidated financial statements as of June 30, 2025. Limited review procedures were completed, and an unqualified opinion has been issued by the statutory auditors.

    Next financial information

    2025 third-quarter results: October 30, 2025 (after market close)

    About Viridien

    Viridien (www.viridiengroup.com) is an advanced technology, digital and Earth data company that pushes the boundaries of science for a more prosperous and sustainable future. With our ingenuity, drive and deep curiosity we discover new insights, innovations, and solutions that efficiently and responsibly resolve complex natural resources, digital, energy transition and infrastructure challenges. Viridien employs around 3,200 people worldwide and is listed as VIRI on the Euronext Paris SA (ISIN: FR001400PVN6).

    Disclaimer

    Certain information included in this press release is not historical data but forward-looking statements. These forward-looking statements are based on current beliefs and assumptions, including, but not limited to, assumptions about current and future business strategies and the environment in which Viridien operates, and involve known and unknown risks, uncertainties and other factors, which may cause actual results or performance, or the results or other events, to be materially different from those expressed or implied in such forward-looking statements. These risks and uncertainties include those discussed or identified in Chapter 2 “Risk Management and Internal Control” of the Universal Registration Document dated March 6, 2025, filed with the French Financial Markets Authority (AMF) under number D. 25-0075 and available on the Group’s website (www.viridiengroup.com) and on the AMF website (www.amffrance.org). These forward-looking statements and information are not guarantees of future performance. Forward-looking statements speak only as of the date of this press release. This press release does not contain or constitute an offer of securities or an invitation or inducement to invest in securities in France, the United States, or any other area.

    Investors contact

    VP Investor Relations and Corporate Finance
    Alexandre Leroy
    alexandre.leroy@viridiengroup.com
    +33 6 85 18 44 31

    APPENDICES

    Quarterly statements are unaudited and not subject to any review. Only IFRS condensed interim consolidated financial statements were subject to a review report by statutory auditors.

    Key Segment P&L figures

    (in millions of $) Q2 2025 Q2 2024 Change (%) H1 2025 H1 2024 Change (%)
    €/$ exchange rate  1.12 1.08     1.08 1.08   
    Segment Revenue 274 258 +6% 575 532 +8%
    DDE 181 177 +3% 396 362 +9%
    Geoscience 115 105 +10% 226 193 +17%
    Earth Data 66 72 -8% 170 169 +1%
    SMO 93 82 +14% 180 170 +6%
    Land 57 29 +99% 108 74 +47%
    Marine 21 42 -50% 46 75 -39%
    Other 15 11 +36% 26 21 +20%
    Segment EBITDAs 108 91 +19% 250 196 +28%
    Adjusted Segment EBITDAs 107 94 +14% 250 200 +25%
    DDE 101 96 +6% 238 199 +19%
    SMO 13 6 +108% 27 16 +63%
    Corporate and other -7 -8 -15% -15 -16 -8%
    Segment Operating Income 22 26 -16% 87 53 +63%
    Adjusted Segment Operating Income 21 29 -28% 86 57 +50%
    DDE 21 39 -47% 87 74 +17%
    SMO 7 -2 n.a. 15 0 n.s.
    Corporate and other -7 -8 -16% -16 -17 -6%
    EDA Cash EBITDA 0 10 -100% 39 44 -11%

    Other KPIs

    (in millions of $) H1 2025 H1 2024 Change (%)
    Geoscience Backlog 317 246 +29%
    Total Capex 119 115 +3%
    Earth Data Library Net Book Value7 508  440 +15%

    Definition of Alternative Performance Indicators (API)

    In its communications, Viridien includes Alternative Performance Indicators, the main ones being Segment Revenue, Segment EBITDAs, Adjusted Segment EBITDAs, and EDA Cash EBITDA. Their definitions are set out in the 2024 Universal Registration Document filed with the French Financial Markets Authority (AMF) and are reiterated below:

    • Segment revenue: Segment revenue is prepared in accordance with internal management reporting with Earth Data prefunding revenues recorded based upon percentage of completion.
    • Segment EBITDAs: Segment EBITDAs is defined as earnings before interest, tax, income from equity affiliates, depreciation, amortization net of amortization costs capitalized to Earth Data surveys, and cost of share-based compensation for employees and senior executives. The cost of share-based compensation includes the cost of stock options and allotments of performance shares. Segment EBITDAs is calculated based on internal management reporting, in which prefunding revenue from Earth Data surveys is recognized using the percentage of completion method.
    • Adjusted segment EBITDAs: Adjusted segment EBITDAs is Segment EBITDAs adjusted for non-recurring charges and gains.
    • EDA Cash EBITDA: EDA Cash EBITDA is defined as EDA (Earth Data) adjusted segment EBITDAs less investment in EDA surveys for the period, excluding inactivity compensation fees related to the vessel capacity agreement signed between Viridien and Shearwater. This indicator is used exclusively for the EDA activity.

    Reconciliation of API with the condensed interim consolidated financial statements

    The table below outlines the accounting adjustments made in accordance with IFRS 158 requirements. Over the period, these adjustments primarily relate to major survey projects conducted by Earth Data in the US Gulf and Norway.

      Q2 2025 H1 2025
    (in millions of $) Segment IFRS 15 adjustments IFRS Segment IFRS 15 adjustments IFRS
    Revenue 274 -40 234 575 -83 492
    EBITDAs 108 -40 68 250 -83 167
    Adjustments -1     0    
    Adjusted EBITDAs 107 -40 67 250 -83 167

    Interim Consolidated Statement of Operations

    (In millions of US$, except per share data) H1 2025 H1 2024
    Operating revenues 491.8 565.8
    Other income from ordinary activities 0.1 0.1
    Total income from ordinary activities 492.0 565.9
    Cost of operations (361.0) (424.1)
    Gross profit 131.0 141.8
    Research and development expenses – net (6.8) (9.6)
    Marketing and selling expenses (16.4) (19.0)
    General and administrative expenses (37.7) (38.0)
    Other revenues (expenses) – net 1.0 (3.6)
    Operating Income (loss) 71.2 71.6
    Cost of financial debt – gross (55.2) (55.1)
    Income from cash and cash equivalents 2.9 5.8
    Cost of financial debt – net (52.3) (49.3)
    Other financial income (loss) (34.4) (0.8)
    Income (loss) before income taxes and share of income (loss) from companies accounted for under the equity method (15.4) 21.5
    Income taxes (7.4) (5.6)
    Income (loss) before share of income (loss) from companies accounted for under the equity method (22.8) 15.9
    Net income (loss) from companies accounted for under the equity method (1.0) 0.0
    Net income (loss) from continuing operations (23.8) 15.9
    Net income (loss) from discontinued operations 1.9 16.1
    Consolidated net income (loss) (21.9) 32.0
    Attributable to:    
    Owners of Viridien SA (22.3) 31.6
    Non-controlling interests 0.4 0.4
    Net income (loss) per share9    
    Basic (3.12) 4.43
    Diluted (3.12) 4.41
    Net income (loss) from continuing operations per share8    
    Basic (3.38) 2.17
    Diluted (3.38) 2.16
    Net income (loss) from discontinued operations per share8    
    Basic 0.26 2.25
    Diluted 0.26 2.25

    Interim Consolidated Statement of Financial Position

    (In millions of US$) June 30, 2025 Dec. 31, 2024
    ASSETS    
    Cash and cash equivalents 161.6 301.7
    Trade accounts and notes receivable, net 330.7 339.9
    Inventories and work-in-progress, net 162.1 163.3
    Income tax assets 10.2 22.9
    Other current assets, net 78.8 74.0
    Assets held for sale, net 28.3 24.5
    Total current assets 771.7 926.2
    Deferred tax assets 47.2 43.6
    Other non-current assets, net 9.1 8.9
    Investments and other financial assets, net 24.7 25.7
    Investments in companies under the equity method 5.1 1.1
    Property, plant and equipment, net 205.3 220.6
    Intangible assets, net 589.3 535.4
    Goodwill, net 1,092.8 1,082.8
    Total non-current assets 1,973.5 1,918.1
    TOTAL ASSETS 2,745.2 2,844.3
    LIABILITIES AND EQUITY    
    Financial debt – current portion 63.1 56.9
    Trade accounts and notes payables 113.6 120.9
    Accrued payroll costs 82.5 84.5
    Income taxes payable 12.1 20.4
    Advance billings to customers 20.8 19.2
    Provisions — current portion 17.1 19.7
    Other current financial liabilities 0.0 0.5
    Other current liabilities 218.5 182.5
    Liabilities associated with non-current assets held for sale 2.3 2.4
    Total current liabilities 530.0 507.0
    Deferred tax liabilities 13.2 18.4
    Provisions – non-current portion 33.1 28.8
    Financial debt – non-current portion 1,095.3 1,165.6
    Other non-current financial liabilities 0.0 0.0
    Other non-current liabilities 1.9 1.7
    Total non-current liabilities 1,143.5 1,214.5
    Common stock: 11,201,879 shares authorized and 7,180,449 shares with a nominal value of €1.00 outstanding at June 30, 2025. 8.7 8.7
    Additional paid-in capital 118.7 118.7
    Retained earnings 1,014.7 1,036.5
    Other Reserves (0.9) 55.2
    Treasury shares (20.1) (20.1)
    Cumulative income and expense recognized directly in equity (1.7) (1.1)
    Cumulative translation adjustment (85.0) (113.3)
    Equity attributable to owners of Viridien S.A. 1,034.5 1,084.7
    Non-controlling interests 37.2 38.1
    Total equity 1,071.8 1,122.8
    TOTAL LIABILITIES AND EQUITY 2,745.2 2,844.3

    Interim Consolidated Statement of Cash Flows

    (In millions of US$)   H1 2025 H1 2024
    OPERATING ACTIVITIES      
    Consolidated net income (loss)   (21.9) 32.0
    Less: Net income (loss) from discontinued operations   (1.9) (16.1)
    Net income (loss) from continuing operations   (23.8) 15.9
    Depreciation, amortization and impairment   42.6 47.8
    Earth Data surveys impairment and amortization   59.0 116.3
    Depreciation and amortization capitalized in Earth Data surveys   (7.5) (7.0)
    Variance on provisions   (3.6) (0.3)
    Share-based compensation expenses   1.7 1.8
    Net (gain) loss on disposal of fixed and financial assets   (0.8) 0.1
    Share of (income) loss in companies recognized under equity method   1.0
    Other non-cash items   30.0 0.8
    Net cash-flow including net cost of financial debt and income tax   98.5 175.4
    Less: Cost of financial debt   52.3 49.3
    Less: Income tax expense (gain)   7.4 5.6
    Net cash-flow excluding net cost of financial debt and income tax   158.1 230.4
    Income tax paid   (8.3) (12.0)
    Net cash-flow before changes in working capital   149.8 218.4
    Changes in working capital   45.0 (38.2)
    – change in trade accounts and notes receivable   51.0 (17.2)
    – change in inventories and work-in-progress   16.8 11.0
    – change in other current assets   (6.7) 0.9
    – change in trade accounts and notes payable   (3.8) (12.5)
    – change in other current liabilities   (12.3) (20.3)
    Net cash-flow from operating activities   194.8 180.2
           
    INVESTING ACTIVITIES      
    Total capital expenditures (including variation of fixed assets suppliers, excluding Earth Data surveys)   (17.2) (17.8)
    Investment in Earth Data surveys, net cash   (101.6) (97.0)
    Proceeds from disposals of tangible and intangible assets   1.0 0.5
    Dividends received from investments in companies under the equity method   0.5
    Variation in other non-current financial assets   2.0 (3.3)
    Net cash-flow from investing activities   (115.7) (117.0)
    FINANCING ACTIVITIES      
    Repayment of long-term debt   (1,074.5) (0.4)
    Total issuance of long-term debt   945.7
    Call premium   (21.9)
    Refinancing transaction costs paid   (3.7)  –
    Lease repayments   (26.1) (27.1)
    Interests paid   (40.4) (43.2)
    Dividends paid and share capital reimbursements:      
    – to owners of Viridien   0
    – to non-controlling interests of integrated companies   (1.4) (3.8)
    Net cash-flow from financing activities   (222.4) (74.5)
           
    Effects of exchange rates on cash   3.7 (5.3)
    Net cash flows incurred by discontinued operations   (0.4) 29.6
    Net increase (decrease) in cash and cash equivalents   (140.1) 12.9
    Cash and cash equivalents at beginning of year   301.7 327.0
    Cash and cash equivalents at end of period   161.6 339.9

    1 $125m RCF of which $25m ancillary guarantee facility (used for $12 m) and $100m fully undrawn
    2 Quarterly statements are unaudited and not subject to any review. Only IFRS condensed interim consolidated financial statements were subject to a review report by statutory auditors
    3 Please refer to the “Definitions of Alternative Performance Indicators” in the appendices for explanations of the terms used in this section
    4 The reconciliation of alternative performance indicators to the condensed interim consolidated financial statements is provided in the appendices, along with their definitions
    5 $125m RCF of which $25m ancillary guarantee facility (used for $12 m) and $100m fully undrawn
    6 Including a $66m negative foreign exchange impact compared to December 31, 2024
    7 Post IFRS15 and 16

    8 IFRS 15 requires that Earth Data prefunding revenues be recognized only upon delivery of the final processed data, that is, when the performance obligation is fulfilled. As a result, revenue and margin recognition for ongoing surveys is deferred. Viridien’s segment reporting, however, continues to apply the percentage-of-completion method previously used before the adoption of IFRS 15, for recognizing Earth Data prefunding revenues and associated margins
    9 As a result of the July 31, 2024 reverse share split, the calculation of basic and diluted earnings per shares for June 2024 has been adjusted retrospectively. Number of ordinary shares outstanding has been adjusted to reflect the proportionate change in the number of shares

    Attachment

    The MIL Network

  • MIL-OSI: Euronext publishes Q2 2025 results

    Source: GlobeNewswire (MIL-OSI)

    Euronext publishes Q2 2025 results

    Euronext’s diversified business drives all-time record results, supported by organic growth, favourable market conditions and disciplined capital allocation.

    Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 31 July 2025 – Euronext, the leading European capital market infrastructure, today publishes its results for the second quarter of 2025.

    • Q2 2025 revenue and income was up +12.8% to €465.8 million:

    Non-volume-related revenue and income represented 58% of total revenue and income and covered 161% of underlying operating expenses, excluding D&A1:

    • Securities Services revenues grew to €86.2 million (+6.5%), driven by increasing assets under custody, higher settlement activity and double-digit growth in value-added services;
    • Capital Markets and Data Solutions revenue grew to €165.4 million (+12.0%), driven by the continued commercial expansion of Advanced Data Solutions and the strong performance of Euronext Corporate and Investor Solutions and Technology Services, supported by the acquisition of Admincontrol. Like-for-like at constant currencies, revenue grew by +6.5%;
    • Net treasury income grew to €20.0 million (+45.1%), demonstrating the benefits of the Euronext Clearing expansion, high volatility and the internalisation of net treasury income from LCH SA following the derivatives clearing migration in Q3 2024.

    Volume-related revenue was driven by high market volatility in the second quarter:

    • FICC2Markets revenue grew to €87.7 million (+20.1%), driven by another record performance in fixed income trading and clearing and in FX trading;
    • Equity Markets revenue grew to €106.2 million (+9.5%), reflecting a strong quarter in cash equity trading and clearing further boosted by high volatility in the first part of the quarter.
    • Underlying operating expenses excluding D&A were at €168.4 million (+7.9%), in line with Euronext’s 2025 underlying costs guidance. This reflects a step-up in growth investments and the impact of acquisitions, partially offset by a strong cost discipline. Euronext’s underlying operating expense guidance excluding D&A of €670 million excludes Admincontrol, acquired on 13 May 2025.
    • Adjusted EBITDA was €297.3 million (+15.8%) and adjusted EBITDA margin was 63.8% (+1.6pt).
    • Adjusted net income was €204.4 million (+23.8%) and adjusted EPS was €2.02 (+27.0%), supported by received dividends .
    • Reported net income was €183.8 million (+29.7%) and reported EPS was €1.81 (+32.1%).
    • Net debt to adjusted EBITDA3was at 1.8x at the end of June 2025, in line with Euronext’s target range. This ratio reflects the impact of the acquisition of Admincontrol on 13 May 2025 and the dividend payment in May 2025.

    Key figures for the second quarter of 2025:

    in €m, unless stated otherwise Q2 2025 Q2 2024 % var % var l-f-l
    Revenue and income 465.8 412.9 +12.8% +10.5%
    Underlying operational expenses exc. D&A                         (168.4) (156.1) +7.9% +3.9%
    Adjusted EBITDA 297.3 256.8 +15.8% +14.4%
    Underlying EBITDA margin 63.8% 62.2% +1.6pts +2.2pts
    Net income4                          183.8 141.7 +29.7%  
    Adjusted net income4                         204.4 165.2 +23.8%  
    Adjusted EPS (basic, in €) 2.02 1.59 +27.0%  
    Reported EPS (basic, in €) 1.81 1.37 +32.1%  
    • Progress with the delivery of ‘Innovate for Growth 2027’:
      • Euronext has strengthened its development in the Nordics and in the UK with the acquisition of Admincontrol on 13 May 2025. This transaction improves the share of subscription-based revenue and is in line with its ambition to scale up the SaaS offering.
      • Euronext is expanding its footprint in the Nordics and in the power business with the acquisition of Nasdaq Nordic’s power futures business. The final regulatory approval for the acquisition has been granted. Euronext and Nasdaq are now focusing on the upcoming migration of open interest from Nasdaq Clearing to Euronext Clearing in Q1 2026.
      • Euronext partnerships with Euroclear5 and Clearstream6 on tri-party collateral management support the broader expansion of its repo clearing services across Europe. In July 2025, Euronext launched the first phase of a multi-year strategy7 to deliver a fully integrated, pan-European clearing model.
      • On 31 July 2025, Euronext announced the submission of a voluntary share exchange offer to acquire all shares of HELLENIC EXCHANGES-ATHEX STOCK EXCHANGE S.A. (“ATHEX”), in exchange for newly issued Euronext shares, at a fixed conversion rate of 20.000 ATHEX ordinary shares for each new Euronext share8,9. Based on Euronext’s closing price of €142.7 as of 30 July 2025, the proposed Offer values ATHEX at €7.14 per share and the entire issued and to be issued ordinary share capital of ATHEX at approximately €412.8 million on a fully diluted basis. The Board of Directors of ATHEX is unanimously supportive of the Offer to ATHEX shareholders and entered into a cooperation agreement with Euronext.

    Stéphane Boujnah, Chief Executive Officer and Chairman of the Managing Board of Euronext, said:
    “In the second quarter of 2025, Euronext achieved all-time record revenue and income of €465.8 million, driven by organic growth and acquisitions. This is the fifth consecutive quarter of double-digit topline growth. The strong performance reflects the strength of Euronext’s diversified business model, capable of capturing favourable market conditions and of generating non-volume-related revenue growth.

    We have continued to invest in growth, while we maintained a strong cost discipline. Euronext reached an adjusted EBITDA close to €300 million in Q2 2025, marking a significant +15.8% increase compared to Q2 2024. In Q2 2025, we reached record adjusted EPS of €2.02 per share. Our reported EPS grew by +32.1% compared to Q2 2024, to €1.81 per share.

    We continue to foster the integration and competitiveness of European capital markets via strategic initiatives. With a strong footprint in Italian repo, a growing list of government bond coverage, and the majority of key clearing members already connected, Euronext is well positioned to become the clearing house of choice for European repo.

    Europe shows an unprecedented commitment to establish a Savings and Investments Union, and Euronext is a key player in Europe to accelerate the delivery of this ambition. Since the beginning of the year, Euronext has continued to deploy capital to expand across Europe. We have expanded our presence in the Nordics with the acquisition of Admincontrol and will further strengthen our position with the migration of Nasdaq Nordic’s power futures to Euronext Clearing in Q1 2026.

    The contemplated acquisition of ATHEX would expand our integrated model across Europe to deliver the Savings and Investments Union. We are strongly committed to boosting the development and attractivity of Greek markets internationally and generating efficiencies and competitiveness across the Group.”

    Q2 2025 business highlights

    In €m Q2 2025 Q2 2024 % var % var l-f-l
    Revenue and income 465.8 412.9 +12.8% +10.5%
    Securities Services 86.2 80.9 +6.5% +3.9%
    Capital Markets and Data Solutions                           165.4 147.7 +12.0% +6.5%
    FICC Markets 87.7 73.0 +20.1% +20.9%
    Equity Markets 106.2 97.0 +9.5% +9.5%
    Net treasury income 20.0 13.8 +45.1% +45.1%
    Other income 0.3 0.4 -30.4% -31.1%
    • Non-volume-related revenue
      • Securities Services
    In €m Q2 2025 Q2 2024 % var % var l-f-l
    Revenue 86.2 80.9 +6.5% +3.9%
    Custody & Settlement 77.5 70.0 +10.8% +7.8%
    Other Post Trade 8.6 10.9 -21.1% -21.1%

    Revenue from Custody and Settlement in Q2 2025 was at €77.5 million, +10.8% compared to Q2 2024. This strong performance was driven by growing Assets under Custody, dynamic settlement instructions and continued double-digit growth in services, supported by the acquisition of Acupay. At the end of the quarter, Assets under Custody amounted to €7.34 trillion, up +4.5% compared to end of Q2 2024. Over 36.9 million instructions were settled via Euronext Securities during the second quarter of 2025, up +15.0% compared to the second quarter of 2024.

    Other Post Trade revenue, which includes membership fees and other non-volume-related clearing fees, was €8.6 million in Q2 2025. The -21.1% decrease compared to Q2 2024 stems from the internalisation of the net treasury income related to Euronext derivatives flows in September 2024, which are now integrated in the net treasury income line.

    • Capital Markets and Data Solutions
    In €m Q2 2025 Q2 2024 % var % var l-f-l
    Revenue 165.4 147.7 +12.0% +6.5%
    Primary Markets 46.5 45.5 +2.3% +2.5%
    Advanced Data Solutions 65.2 60.6 +7.5% +4.6%
    Corporate and Investor Solutions and Technology Services                             53.7 41.5 +29.2% +13.5%

    Primary Markets revenue was €46.5 million in Q2 2025, an increase of +2.3% compared to Q2 2024. The second quarter recorded slower equity listing activity explained by a volatile environment. Euronext sustained its leading position for equity listing with 6 new listings.

    Advanced Data Solutions revenue was €65.2 million in Q2 2025, up +7.5% compared to Q2 2024. This dynamic performance reflects the contribution of GRSS, strong appetite from retail and growing monetisation of diversified datasets.

    Corporate and Investor Solutions and Technology Services revenue grew by +29.2% in Q2 2025 to €53.7 million. This strong performance reflects the contribution of Admincontrol for half a quarter and double-digit growth of investor solutions and colocation services.

    • Net treasury income

    Net treasury income was at €20.0 million, +45.1% compared to Q2 2024. This reflect the benefit from the Euronext Clearing expansion and the internalisation of treasury income from LCH SA following the completion of the derivatives clearing migration, as well as higher cash collateral posted to the CCP due to the elevated market volatility.

    • Volume-related revenue
      • FICC Markets
    In €m Q2 2025 Q2 2024 % var % var l-f-l
    Revenue 87.7 73.0 +20.1% +20.9%
    Fixed income trading & clearing 51.7 39.2 +31.9% +31.9%
    Commodities trading & clearing 26.7 26.0 +2.7% +3.1%
    FX trading 9.3 7.8 +18.9% +25.2%

    Fixed income trading and clearing revenue reached €51.7 million in Q2 2025, up +31.9% compared to Q2 2024, driven by record fixed income trading activity supported by favourable market conditions.

    Commodities10 trading and clearing revenue reached €26.7 million in Q2 2025, up +2.7% compared to Q2 2024, reflecting record intraday power trading volumes and softer agricultural commodity trading and clearing.

    FX trading revenue was up +18.9%, at €9.3 million in Q2 2025, reflecting record trading volumes in April 2025, which outbalanced the negative currency impact of the USD.

    • Equity Markets
    In €m Q2 2025 Q2 2024 % var % var l-f-l
    Revenue 106.2 97.0 +9.5% +9.5%
    Cash equity trading & clearing 93.4 80.4 +16.2% +16.2%
    Financial derivatives trading & clearing 12.8 16.6 -22.9% -22.9%

    Cash equity trading and clearing revenue11 was €93.4 million in Q2 2025, up +16.2% compared to Q2 2024 driven by exceptional market volatility. Euronext recorded average daily cash trading volumes of €13.4 billion, up +21.2% compared to Q2 2024. Euronext reached solid average revenue capture on cash trading at 0.52 bps for the second quarter of 2025, despite higher volumes and larger average order size compared to Q2 2024. Euronext market share on cash equity trading averaged 63.5% in Q2 2025.

    Financial derivatives trading and clearing revenue was €12.8 million in Q2 2025, -22.9% compared to Q2 2024. This mostly reflects lower volatility and the decrease of the average clearing fees. Following the clearing migration, certain clearing fees are now reported in the line Other Post Trade revenues, and as such not fully comparable with Q2 2024.

    Q2 2025 financial performance

    In €m, unless stated otherwise Q2 2025 Q2 2024 % var % var l-f-l
    Revenues and income 465.8 412.9 +12.8% +10.5%
    Underlying operating expenses excl. D&A                        (168.4) (156.1) +7.9% +3.9%
    Adjusted EBITDA 297.3 256.8 +15.8% +14.4%
    Adjusted EBITDA margin 63.8% 62.2% +1.6pts +2.2pts
    Operating expenses excl. D&A (171.8) (162.9) +5.5% +1.6%
    EBITDA 293.9 249.9 +17.6% +16.2%
    Depreciation & amortisation (48.2) (47.9) +0.5% +1.0%
    Total expenses (220.0) (210.9) +4.3% +1.2%
    Adjusted operating profit 274.7 234.8 +17.0% +15.7%
    Operating profit 245.8 202.0 +21.7%  
    Net financing income / (expense) (5.7) 3.5 N/A  
    Results from equity investments 24.5 1.2 N/A  
    Profit before income tax 264.5 206.7 +28.0%  
    Income tax expense (68.1) (55.7) +22.3%  
    Minority interests (12.6) (9.2) +36.3%  
    Net income 183.8 141.7 +29.7%  
    Adjusted net income 204.4 165.2 +23.8%  
    Adjusted EPS (basic, in €) 2.02 1.59 +27.0%  
    Reported EPS (basic, in €) 1.81 1.37 +32.1%  
    Adjusted EPS (diluted, in€) 2.01 1.59 +26.4%  
    Reported EPS (diluted, in€) 1.81 1.36 +33.1%  
    • Q2 2025 adjusted EBITDA

    Underlying operating expenses excluding D&A1 were at €168.4 million (+7.9%). The increase compared to Q2 2024 reflects investments in growth and the impact of acquisitions performed in 2025, partially offset by cost discipline.
    As a result of a double digit growth in revenue, adjusted EBITDA for the quarter reached €297.3 million, up +15.8% compared to Q2 2024. This represents an adjusted EBITDA margin of 63.8%, up +1.6pts vs. Q2 2024. On a like-for-like basis at constant currencies, adjusted EBITDA grew by +14.4% compared to Q2 2024.
    Q2 2025 non-underlying operating expenses excluding D&A amounted to €3.4 million, mostly related to the integration of recent acquisitions. As a consequence, reported EBITDA was at €293.9 million, up +17.6% compared to Q2 2024.

    • Q2 2025 net income, share of the parent company shareholders

    Depreciation and amortisation accounted for €48.2 million in Q2 2025, +0.5% more than Q2 2024. PPA related to acquired businesses accounted for €19.1 million. Adjusted operating profit was €274.7 million, up +17.0% compared to Q2 2024. Euronext reported a net financing expense of €5.7 million in Q2 2025, compared to €3.5 million net financing income in Q2 2024. The variation reflects decreasing interest rates, lower cash position after the redemption of the €500 million bond and the recognition of non-cash interest expense related to the convertible bonds.

    Income tax for Q2 2025 was €68.1 million. This translated into an effective tax rate of 25.7% for the quarter, compared to 27.0% in Q2 2024. The tax rate was positively impacted by the tax-exempt €24.5 million dividend received by Euroclear. Share of non-controlling interests amounted to €12.6 million, correlated with the strong performance of MTS and Nord Pool.

    As a result, the reported net income, share of the parent company shareholders, increased by +29.7%for Q2 2025 compared to Q2 2024, to €183.8 million. This represents a reported EPS of €1.81 basic and €1.81 diluted. Adjusted net income, share of the parent company shareholders, was up +23.8% to €204.4 million. Adjusted EPS (basic) was €2.02 and adjusted EPS (diluted) was €2.01. The increase in EPS reflects higher profit and a lower number of outstanding shares over the second quarter of 2025 compared to Q2 2024. The weighted number of shares used over the second quarter of 2025 was 101,374,346 for the basic calculation and 102,130,793 for the diluted calculation, compared to 103,653,544 and 103,986,292 respectively over the second quarter of 2024. The difference in share count is due to the share repurchase programme executed by Euronext and the consideration of the convertible bonds under IAS 33.

    In Q2 2025, Euronext reported a net cash flow from operating activities of €135.0 million, compared to €111.5 million in Q2 2024, reflecting higher profit before tax and higher income tax paid in Q2 2025. Excluding the impact of working capital from Euronext Clearing and Nord Pool CCP activities, net cash flow from operating activities accounted for 52.3% of EBITDA in Q2 2025.

    Q2 2025 corporate highlights since publication of the first quarter 2025 results on 14 May 2025

    • Euronext received regulatory approval for the acquisition of Nasdaq Nordic power futures

    On 4 June 2025, Euronext received regulatory approval for the extension of Euronext Clearing to power derivatives under Article 15 of EMIR. With this final approval, all regulatory approvals for the acquisition of Nasdaq Nordic’s power futures business have been granted. Euronext and Nasdaq continue to focus on the upcoming migration of open interest from Nasdaq Clearing to Euronext Clearing in Q1 202612.

    • Partnership with Clearstream on collateral management

    On 16 June 2025, Euronext and Clearstream announced the start of a new partnership13 to advance the continued development of Euronext Clearing’s collateral management services across repo and other asset classes.
    As part of this initiative, Clearstream will serve as a triparty agent (TPA) for Euronext Clearing, facilitating advanced collateral management capabilities. Clients will benefit from automated, flexible and operationally streamlined solutions that enhance margin and balance sheet optimisation. Clearstream will act as an independent third party, handling the collateral selection, valuation and substitution to ensure compliance with eligibility criteria while minimising operational complexities. In addition, Clearstream will manage settlement and custody services, provide robust regulatory reporting, and support liquidity and risk management objectives. The go-live of this enhanced service offering is scheduled for November 2025.

    • Euronext successfully launched its inaugural convertible bonds issuance

    On 22 May 2025, Euronext announced the success of its offering of senior unsecured bonds due 2032 convertible into new shares and/or exchangeable for existing shares of the Company (“OCEANEs”) (the “Bonds”), by way of a placement to qualified investors only, for a nominal amount of €425 million (the “Offering”)14. The Bonds were issued with a denomination of €100,000 each (the “Principal Amount”), and will be convertible and/or exchangeable into new and/or existing shares of Euronext (the “Shares”) and will pay a fixed coupon at a rate of 1.50% per annum, payable semi-annually in arrear on 30 May and 30 November of each year (or on the following business day if this date is not a business day), and for the first time on 30 November 2025. The initial conversion price of the Bonds is set at €191.1654. Unless previously converted, exchanged, redeemed or purchased and cancelled, the Bonds will be redeemed at par on 30 May 2032 (or on the following business day if such date is not a business day) (the “Maturity Date”).

    • Euronext successfully migrated Italian markets to a harmonised clearing framework

    On 30 June 2025, Euronext completed the migration of the Italian derivatives and cash equity markets to its Core Clearing System. Euronext is now clearing all its financial derivatives, commodities and cash equities markets through a single, streamlined, harmonised clearing gateway. This important milestones delivers to Euronext Clearing clients further material operational and risk management efficiencies, which optimise their total cost of trading on Euronext markets.

    Corporate highlights since 1 July 2025

    • Euronext launched the first phase of its strategic multi-year Repo expansion initiative15

    On 8 July 2025, Euronext announced the launch of its initiative to expand access, improve collateral usage and position Euronext as a leading Central Counterparty (CCP) for European repo markets. As a cornerstone of Euronext’s strategic plan announced in November 2024, the Repo initiative sets in motion Euronext’s vision to build a fully integrated, pan-European post-trade infrastructure. Euronext now offers repo clearing for Spanish, Portuguese and Irish government bonds, alongside its established Italian offering. For the first time, international firms can join the platform with seamless onboarding and scalable settlement operations.

    • Euronext to launch voluntary share exchange offer for all ATHEX shares

    On 31 July 2025, Euronext announced the submission of a voluntary share exchange offer to acquire all shares of HELLENIC EXCHANGES-ATHEX STOCK EXCHANGE S.A. (“ATHEX”), in exchange for newly issued Euronext shares, at a fixed conversion rate of 20.000 ATHEX ordinary shares for each new Euronext share16,17. Based on Euronext’s closing price of €142.7 as of 30 July 2025, the proposed Offer values ATHEX at €7.14 per share and the entire issued and to be issued ordinary share capital of ATHEX at approximately €412.8 million on a fully diluted basis. The Board of Directors of ATHEX is unanimously supportive of the Offer to ATHEX shareholders and entered into a cooperation agreement with Euronext.

    The combination between Euronext and ATHEX is in line with Euronext’s ambition to integrate European capital markets. The combined Group will foster harmonisation of European capital markets on a unified technology. Greek markets would benefit from increased visibility towards global investors as part of the leading single liquidity pool in Europe.

    Euronext expects the combination to deliver €12 million annual run-rate cash synergies by the end of 2028, with implementation costs related to these synergies expected at €25 million. The Offer is in line with Euronext’s investment criteria of ROCE > WACC in year 3 to 5 after the acquisition and is expected to be accretive for Euronext shareholders after delivery of synergies in year 1.

    The Offer is expected to be open for acceptance, subject to regulatory approvals, from Q4 2025. The transaction is expected to be completed by the end of 2025.

    Results Webcast

    A webcast will be held on Friday, 1 August 2025, at 09:00 CEST (Paris time) / 08:O0 BST (London time):

    For the live webcast go to: Webcast

    The webcast will be available for replay after the call at the webcast link and on the Euronext Investor Relations webpage.

    Contacts

    ANALYSTS & INVESTORS – ir@euronext.com

    Investor Relations        Aurélie Cohen                 

            Judith Stein        +33 6 15 23 91 97

    MEDIA – mediateam@euronext.com 

    Europe        Aurélie Cohen         +33 1 70 48 24 45 

            Andrea Monzani         +39 02 72 42 62 13 

    Belgium        Marianne Aalders         +32 26 20 15 01                 

    France, Corporate        Flavio Bornancin-Tomasella        +33 1 70 48 24 45                 

    Ireland        Catalina Augspach        +39 02 72 42 62 13                 

    Italy         Ester Russom         +39 02 72 42 67 56                 

    The Netherlands        Marianne Aalders         +31 20 721 41 33                 

    Norway         Cathrine Lorvik Segerlund        +47 41 69 59 10                 

    Portugal         Sandra Machado        +351 91 777 68 97                

    About Euronext 
    Euronext is the leading European capital market infrastructure, covering the entire capital markets value chain, from listing, trading, clearing, settlement and custody, to solutions for issuers and investors. Euronext runs MTS, one of Europe’s leading electronic fixed income trading markets, and Nord Pool, the European power market. Euronext also provides clearing and settlement services through Euronext Clearing and its Euronext Securities CSDs in Denmark, Italy, Norway and Portugal.
    As of June 2025, Euronext’s regulated exchanges in Belgium, France, Ireland, Italy, the Netherlands, Norway and Portugal host nearly 1,800 listed issuers with €6.3 trillion in market capitalisation, a strong blue-chip franchise and the largest global centre for debt and fund listings. With a diverse domestic and international client base, Euronext handles 25% of European lit equity trading. Its products include equities, FX, ETFs, bonds, derivatives, commodities and indices.
    For the latest news, go to euronext.com or follow us on X and LinkedIn.

    Disclaimer

    This press release is for information purposes only: it is not a recommendation to engage in investment activities and is provided “as is”, without representation or warranty of any kind. The figures in this document have not been audited or reviewed by our external auditor. While all reasonable care has been taken to ensure the accuracy of the content, Euronext does not guarantee its accuracy or completeness. Euronext will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided. No information set out or referred to in this publication may be regarded as creating any right or obligation. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by Euronext’s subsidiaries shall depend solely on the applicable rules of the market operator. All proprietary rights and interest in or connected with this publication shall vest in Euronext. This press release speaks only as of this date. Euronext refers to Euronext N.V. and its affiliates. Information regarding trademarks and intellectual property rights of Euronext is available at www.euronext.com/terms-use.

    © 2025, Euronext N.V. – All rights reserved. 

    The Euronext Group processes your personal data in order to provide you with information about Euronext (the “Purpose”). With regard to the processing of this personal data, Euronext will comply with its obligations under Regulation (EU) 2016/679 of the European Parliament and Council of 27 April 2016 (General Data Protection Regulation, “GDPR”), and any applicable national laws, rules and regulations implementing the GDPR, as provided in its privacy statement available at: www.euronext.com/privacy-policy. In accordance with the applicable legislation you have rights with regard to the processing of your personal data: for more information on your rights, please refer to: www.euronext.com/data_subjects_rights_request_information. To make a request regarding the processing of your data or to unsubscribe from this press release service, please use our data subject request form at connect2.euronext.com/form/data-subjects-rights-request or email our Data Protection Officer at dpo@euronext.com.

    Appendix

    The figures in this Appendix have not been audited or reviewed by our external auditor.

    Non-IFRS financial measures

    For comparative purposes, the company provides unaudited non-IFRS measures including:

    • Operational expenses excluding depreciation and amortisation, underlying operational expenses excluding depreciation and amortisation;
    • EBITDA, EBITDA margin, adjusted EBITDA, adjusted EBITDA margin.

    Non-IFRS measures are defined as follows:

    • Operational expenses excluding depreciation and amortisation as the total of salary and employee benefits, and other operational expenses;
    • Underlying operational expenses excluding depreciation and amortisation as the total of salary and employee benefits, and other operational expenses, excluding non-recurring costs;
    • Underlying revenue and income as the total of revenue and income, excluding non-recurring revenue and income;
    • Non-underlying items as items of revenue, income and expense that are material by their size and/or that are infrequent and unusual by their nature or incidence are not considered to be recurring in the normal course of business and are classified as non-underlying items on the face of the income statement within their relevant category in order to provide further understanding of the ongoing sustainable performance of the Group. These items can include:
      • integration or double run costs of significant projects, restructuring costs and costs related to acquisitions that change the perimeter of the Group;
      • one-off finance costs, gains or losses on sale of subsidiaries and impairments of investments:
      • amortisation and impairment of intangible assets which are recognised as a result of acquisitions and mostly comprising customer relationships, brand names and software that were identified during purchase price allocation (PPA);
      • tax related to non-underlying items.
    • Adjusted operating profit as the operating profit adjusted for any non-underlying revenue and income and non-underlying costs, including PPA of acquired businesses;
    • EBITDA as the operating profit before depreciation and amortisation;
    • Adjusted EBITDA as the adjusted operating profit before depreciation and amortisation adjusted for any non-underlying operational expenses excluding depreciation and amortisation;
    • EBITDA margin as EBITDA divided by total revenue and income;
    • Adjusted EBITDA margin as adjusted EBITDA, divided by total revenue and income;
    • Adjusted net income, as the net income, share of the parent company shareholders, adjusted for any non-underlying items and related tax impact.

    Non-IFRS financial measures are not meant to be considered in isolation or as a substitute for comparable IFRS measures and should be read only in conjunction with the consolidated financial statements.

    Consolidated income statement

      Q2 2025 Q2 2024
    In € million, unless stated otherwise Underlying Non-
    underlying
    Reported Underlying Non-
    underlying
    Reported
    Revenues 465.8 465.8 412.9 412.9
    Securities Services 86.2 86.2 80.9 80.9
    Custody and Settlement 77.5 77.5 70.0 70.0
    Other Post Trade 8.6 8.6 10.9 10.9
    Capital Markets and Data Solutions 165.4 165.4 147.7 147.7
    Primary Markets 46.5 46.5 45.5 45.5
    Advanced Data Solutions 65.2 65.2 60.6 60.6
    Corporate and Investor Solutions
    and Technology Services
    53.7 53.7 41.5 41.5
    FICC markets 87.7 87.7 73.0 73.0
    Fixed income trading and clearing 51.7 51.7 39.2 39.2
    Commodities trading and clearing 26.7 26.7 26.0 26.0
    FX trading 9.3 9.3 7.8 7.8
    Equity markets 106.2 106.2 97.0 97.0
    Cash equity trading and clearing 93.4 93.4 80.4 80.4
    Financial derivatives trading and clearing 12.8 12.8 16.6 16.6
    Net treasury income 20.0 20.0 13.8 13.8
    Other income 0.3 0.3 0.4 0.4
    Operating expenses excl. D&A (168.4) (3.4) (171.8) (156.1) (6.8) (162.9)
    Salaries and employee benefits (92.2) (1.1) (93.3) (79.9) (0.4) (80.2)
    Other operational expenses, of which (76.3) (2.2) (78.5) (76.2) (6.5) (82.7)
    System & Communication (26.5) (0.2) (26.7) (24.7) (1.1) (25.9)
    Professional services (17.7) (2.2) (19.9) (13.6) (4.4) (17.9)
    Clearing expense (0.2) (0.2) (9.9) (9.9)
    Accommodation (4.5) 0.1 (4.4) (4.1) (0.3) (4.4)
    Other operational expenses (27.3) (27.4) (23.9) (0.7) (24.6)
    EBITDA 297.3 (3.4) 293.9 256.8 (6.8) 249.9
    EBITDA margin 63.8%   63.1% 62.2%   60.5%
    Depreciation & amortisation (22.6) (25.6) (48.2) (21.9) (26.0) (47.9)
    Total expenses (191.0) (29.0) (220.0) (178.0) (32.8) (210.9)
    Operating profit 274.7 (29.0) 245.8 234.8 (32.8) 202.0
    Net financing income/(expense) (5.7) (5.7) 3.5 3.5
    Results from equity investment 24.5 24.5 0.1 1.2 1.2
    Profit before income tax 293.5 (29.0) 264.5 238.4 (31.7) 206.7
    Income tax expense (75.6) 7.5 (68.1) (64.0) 8.3 (55.7)
    Non-controlling interests (13.4) 0.8 (12.6) (9.2) (0.1) (9.2)
    Net income
    share of the parent company shareholders
    204.4 (20.6) 183.8 165.2 (23.4) 141.7
    EPS (basic, in €) 2.02   1.81 1.59   1.37
    EPS (diluted, in €) 2.01   1.81 1.59   1.36

    Adjusted EPS definition

     In € million, unless stated otherwise Q2 2025 Q2 2024
    Net income reported                183.8                 141.7
    EPS reported (in €) 1.81 1.37
    Adjustments for non-underlying items included in:    
    Operating expenses exc. D&A (3.4) (6.8)
    Depreciation and amortisation (25.6) (26.0)
    Results from equity investments                   –                  1.2
    Non-controlling interest 0.8 (0.1)
    Tax related to adjustments                       7.5                       8.3
    Adjusted net income                 204.4                  165.2
    Adjusted EPS (in €)                     2.02                     1.59

    Consolidated comprehensive income statement

    In € million Q2 2025 Q2 2024
    Profit for the period 196.4 151.0
         
    Other comprehensive income    
    Items that may be reclassified to profit or loss:    
    – Exchange differences on translation of foreign operations    (53.6) 15.2
    – Income tax impact on exchange differences on translation of foreign operations    7.4 (1.9)
    – Gains and losses on cash flow hedges    (2.2)
    – Change in value of debt investments at fair value through other comprehensive income    0.3
    – Income tax impact on change in value of debt investments at fair value through
    other comprehensive income
       –    (0.1)
         
    Items that will not be reclassified to profit or loss:    
    – Change in value of equity investments at fair value through other comprehensive income    46.1 6.5
    – Income tax impact on change in value of equity investments at fair value through
    other comprehensive income
    (0.4) (1.0)
    – Remeasurements of post-employment benefit obligations    1.9 1.9
    – Income tax impact on remeasurements of post-employment benefit obligations (0.2)
    Other comprehensive income for the period, net of tax (0.8) 20.8
    Total comprehensive income for the period 195.6 171.8
         
    Comprehensive income attributable to:    
    – Owners of the parent 184.0 162.5
    – Non-controlling interests 11.6 9.3

    Consolidated statement of financial position

    In € million 30 June 2025 31 March 2025
    Non-current assets    
    Property, plant and equipment 103.0 107.4
    Right-of-use assets 85.1 88.2
    Goodwill and other intangible assets18 6,586.7 6,096.5
    Deferred income tax assets 24.0 29.1
    Investments in associates and joint ventures 0.8 0.8
    Financial assets at fair value through OCI 403.1 357.0
    Other non-current assets 3.4 3.4
    Total non-current assets 7,206.2 6,682.4
         
    Current assets    
    Trade and other receivables 463.8 574.2
    Income tax receivable 32.2 17.5
    Derivative financial instruments 0.1 2.2
    CCP clearing business assets 348,903.3 341,647.6
    Other current financial assets 59.3 59.5
    Cash & cash equivalents 919.3 1,642.3
    Total current assets 350,378.1 343,943.3
    Total assets 357,584.2 350,625.7
         
    Equity    
    Shareholders’ equity 4,153.5 4,224.6
    Non-controlling interests 144.3 161.7
    Total equity 4,297.9 4,386.3
         
    Non-current liabilities    
    Borrowings 2,311.7 2,537.5
    Lease liabilities 69.8 71.7
    Other non-current financial liabilities 3.5 3.5
    Deferred income tax liabilities 488.4 495.1
    Post-employment benefits 21.2 23.0
    Contract liabilities 53.3 54.2
    Other provisions 7.1 7.0
    Total non-current liabilities 2,955.0 3,192.1
    Current liabilities    
    Borrowings 602.7 524.0
    Lease liabilities 22.2 21.9
    Other current financial liabilities1 103.5
    CCP clearing business liabilities 348,949.3 341,695.3
    Income tax payable 68.8 99.3
    Trade and other payables 422.5 526.5
    Contract liabilities 158.5 176.2
    Other provisions 3.7 4.1
    Total current liabilities      350,331.3 343,047.3
    Total equity and liabilities     357,584.2 350,625.7

    Consolidated statement of cash flows

    In € million Q2 2025 Q2 2024
    Profit before tax 264.5 206.7
    Adjustments for:    
    – Depreciation and amortisation 48.2 47.9
               – Share-based payments 5.6 2.9
    -Results from equity investments (24.5)
    -Gain on sale of associate (1.2)
    -Share of profit from associates and joint ventures (0.1)
               – Changes in working capital (43.8) (67.9)
    Cash flow from operating activities 250.0 188.4
    Income tax paid (115.1) (76.9)
    Net cash flows from operating activities 135.0 111.5
         
    Cash flow from investing activities    
    Business combinations, net of cash acquired                                     (400.4) (38.5)
    Proceeds from sale of associate                              0.9
    Purchase of current financial assets (0.4) (0.6)
    Redemption of current financial assets (0.2) 17.7
    Purchase of property, plant and equipment                                    (3.2)                               (5.0)
    Purchase of intangible assets (28.1) (15.8)
    Interest received                                     7.3 11.3
    Asset acquisitions (27.7)
    Proceeds from sale of property, plant, equipment and intangible assets (0.1)
    Dividends received from equity investments 24.5
    Dividends received from associates and joint ventures                                         – 0.1
    Net cash flow from investing activities (428.2) (30.0)
         
    Cash flow from financing activities    
    Proceeds from borrowings, net of transaction fees 846.2
    Repayment of borrowings, net of transaction fees (925.0)
    Interest paid (29.2) (28.2)
    Payment of lease liabilities (3.4) (4.2)
    Transactions in own shares 0.0 (10.0)
    Withholding tax paid at vesting of shares (1.9) (1.2)
    Dividends paid to the company’s shareholders (293.4) (257.3)
    Dividends paid to non-controlling interests (18.2) (18.9)
    Net cash flow from financing activities (424.9) (319.6)
         
    Total cash flow over the period (718.1) (238.1)
    Cash and cash equivalents – Beginning of period 1,642.3 1,609.6
    Non-cash exchange gains/(losses) on cash and cash equivalents (4.9) 4.6
    Cash and cash equivalents – End of period 919.3 1,376.0

    Business indicators for the second quarter of 2025

    • Securities Services
    Custody and Settlement Q2 2025 Q2 2024 % var
    Number of settlement instructions over the period 36,946,162 32,114,794 +15.0%
    Assets under Custody (in €bn), end of period 7,344 7,030 +4.5%
    • Capital Markets
    Primary Markets Q2 2025 Q2 2024 % var
    Number of issuers on Equities – Euronext 1,766 1,862 -5.0%
    Number of issuers on Equities – SMEs 1,371 1,469 -7.0%
    Number of listed Funds 2,179 2,347 -7.0%
    Number of listed ETFs 4,322 3,885 +11.0%
    Number of listed Bonds 57,367 58,147 -1.0%
    Capital raised on primary and secondary market (in €m)      
    Number of new equity listings 13 17  
    Money raised – New equity listings (including over-allotment) 155 3,403 -95.0%
    Money raised – Follow-ons on equities 4,457 2,362 +89.0%
    Money raised – Bonds 316,817 304,686 +4.0%
    • FICC Markets
    Fixed income trading and clearing Q2 2025 Q2 2024 % var
    Number of trading days 62 63
    Transaction value (in €m, single counted)      
    MTS      
    ADV MTS Cash 59,182 36,287 +63.0%
    TAADV MTS Repo 612,821 448,618 +37.0%
    Other fixed income      
    ADV fixed income 1,588 1,689 -6.0%
    Number of transactions and lots cleared (double counted)      
    Bonds – Wholesale (nominal value in €bn) 8,571 6,918 +23.9%
    Bonds – Retail (number of contracts) 3,313,182 3,658,240 -9.4%
    Commodities trading and clearing Q2 2025 Q2 2024 % var
    Number of trading days 91 91
    Power volume (in TWh) – ADV Day-ahead Power Market 2.53 2.53 0.0%
    Power volume (in TWh) – ADV Intraday Power Market          0.56 0.36 +58.0%
    Derivatives volume (in lots)      
    Number of trading days 62 63
    Commodity 6,746,377 7,898,126 -14.6%
    Futures 6,473,697 7,197,681 -10.1%
    Options 272,680 700,445 -61.1%
    FX trading Q2 2025 Q2 2024 % var
    Number of trading days 65 65
    FX volume (in $m, single counted)      
    Total Euronext FX 2,025,494 1,783,772 +13.6%
    ADV Euronext FX 31,161 27,443 +13.6%
    • Equity Markets
    Cash equity trading and clearing Q2 2025 Q2 2024 % var
    Number of trading days 62 63
    Number of transactions (buy and sell) (reported trades included)      
    Total Cash Market 186,375,884 152,354,170 +21.5%
    ADV Cash Market 3,006,063 2,434,193 +23.5%
    Transaction value (€ million, single counted)      
    Total Cash Market 831,391 696,882 +19.3%
    ADV Cash Market 13,410 11,062 +21.2%
    Shares (number of transactions and lots cleared – single counted) 75,751,603 55,211,959 +37.2%
    Financial derivatives trading and clearing Q2 2025 Q2 2024 % var
    Number of trading days 62 63
    Derivatives Volume (in lots) – Equity 30,293,449 35,317,815 -14.2%
    Index 10,684,578 13,753,365 -22.3%
    Futures 6,465,795 7,760,863 -16.7%
    Options 4,218,783 5,992,502 -29.6%
    Individual Equity 19,608,871 21,564,450 -9.1%
    Futures 526,418 2,782,606 -81.1%
    Options 19,082,453 18,781,844 +1.6%

    1 Definition in Appendix – adjusted for non-underlying operating expenses excluding D&A and non-underlying revenue and income.
    2   Fixed income, commodities and currencies
    3 Last twelve months adjusted EBITDA. Net debt to last twelve months reported EBITDA ratio was at 1.9x.
    4 Share of the parent company shareholders
    5https://www.euronext.com/en/about/media/euronext-press-releases/euronext-announces-collaboration-euroclear-enhance-euronext
    6https://www.euronext.com/en/about/media/euronext-press-releases/euronext-and-clearstream-launch-partnership-further-strengthen
    7https://www.euronext.com/en/about/media/euronext-press-releases/euronext-launches-first-phase-its-strategic-multi-year-repo
    8https://www.euronext.com/en/about/media/euronext-press-releases/euronext-launch-voluntary-share-exchange-offer-for-all-athex-0
    9 Offer is subject to customary and regulatory approvals.
    10 Including revenue from power trading and clearing
    11 Including equities, ETFs, warrants and certificates
    12www.euronext.com/en/news/euronext-nasdaq-clearing-agreement-power-derivatives-transfer-set-for-march-2026.
    13 www.euronext.com/en/about/media/euronext-press-releases/euronext-and-clearstream-launch-partnership-further-strengthen
    14www.euronext.com/en/investor-relations/financial-information/news/euronext-announces-success-its-offering-bonds-due
    15 www.euronext.com/en/about/media/euronext-press-releases/euronext-launches-first-phase-its-strategic-multi-year-repo
    16 https://www.euronext.com/en/about/media/euronext-press-releases/euronext-launch-voluntary-share-exchange-offer-for-all-athex-0
    17 Offer is subject to customary and regulatory approvals.

    18 The Nasdaq Nordic transaction qualifies as an ‘asset acquisition’. The full purchase price, consisting of a fixed amount of US$35.0 million and a contingent consideration amount estimated at US$115.0 million, is allocated to customer relationships as an intangible asset. The Group has chosen to apply the liability approach that follows IFRIC 1 principles for recognition of the contingent consideration liability, whereby subsequent changes in the liability are adjusted against the carrying amount of the related asset.

    Attachment

    The MIL Network

  • MIL-OSI: Coface SA: Description of the 2025-2026 Share Buyback Program

    Source: GlobeNewswire (MIL-OSI)

    Description of the 2025-2026 Share Buyback Program

    1. INTRODUCTION

    It is reminded that the Shareholders’ Combined General Meeting of COFACE SA (the Company) held on of May 16, 2024, had previously authorised the Board of Directors, in its fourth (4th) resolution, to carry out transactions on COFACE SA’s shares under the framework of the 2024-2025 Share Buyback Program. The main features and description of the said program are published on the Company’s website and on the 2024 Universal Registration Document.

    The Company, listed on Euronext Paris – Compartment A -, wishes to continue to have a Share Buyback Program (the Program), pursuant to applicable regulation (See “Legal Framework” below).

    To this end, the Shareholders’ Combined General Meeting of May 14, 2025 issued a new authorisation to the Board of Directors, with the power to sub delegate in accordance with legislative and regulatory provisions, thirteen (13th) resolution, to implement a new Share Buyback Program on the Company’s shares (Code ISIN FR0010667147). This Program shall replace the existing one established by the Shareholders’ Combined General Meeting of May 16, 2024.

    1. MAIN CHARACTERISTICS OF THE 2025-2026 SHARE BUYBACK PROGRAM

    2.1 Date of Shareholders’ General Meeting authorising the Program

    The 2025-2026 Program was authorised by the Shareholders’ Combined General Meeting of May 14, 2025, in its thirteen (13th) resolution.

    The Board of Directors of July 31, 2025, authorised COFACE SA, with the power to sub delegate to the CEO, pursuant to the delegation given by the Shareholder’s Combined General Meeting of May 14, 2025 in its thirteen (13th) resolution, to trade on the Company’s share through the “2025-2026 Share Buyback Program”, whose main features are described below.

    2.2 Allotment by objective of shares held as of June 30, 2025

    COFACE SA held, as of June 30, 2025, 0.57% of its share capital or 852,060 common shares. At that date, the breakdown by objective of the number of shares held was as follows:

    Objectives Number of own shares held
    a) ensure liquidity and boost the market for the Company’s stock through an investment service provider acting independently within the context of a liquidity contract in compliance with the Charter of Ethics recognised by the French Financial Markets Authority 92,102
    b) allot shares to employees of the Company and in particular within the context:
    (1) of profit sharing;
    (2) any stock option plan of the Company, pursuant to the provisions of Articles L.225-177 et seq. of the French Commercial Code;
    (3) any savings plan in compliance with Articles L.3331-1 et seq. of the French Labour Code;
    (4) any allocation of bonus shares pursuant to the provisions of Articles L.225-197-1 et seq. of the French Commercial Code;
    as well as performing all hedging operations relating thereto, under the conditions provided for by the market authorities and at the times to be determined by the Board of Directors or the person acting upon its delegation
     

    0
    0

    0

    755,958

    e) cancel all or part of the stock thus purchased 0
    TOTAL 852,060

    2.3 Objectives of the 2025-2026 Share Buyback Program

    Purchases and sales of the Company’s shares may be made, by decision of the Board, to:

    Authorised objectives
    a) ensure liquidity and boost the market for the Company’s stock through an investment service provider acting independently within the context of a liquidity agreement, in compliance with the market practice accepted by the Autorité des marchés financiers on 2 July 2018;
    b) allocate shares to the corporate officers and employees of the Company and of other Group entities, in particular within the context of:
    (i) employee profit sharing;
    (ii) any stock option plan of the Company, pursuant to Article L.225-177 et seq. of the French Commercial Code;
    (iii) any savings plan in compliance with Article L.3331-1 et seq. of the French Labour Code;
    (iv) any allocation of bonus shares pursuant to the provisions of Article L.225‑197-1 et seq. of the French Commercial Code;
    as well as performing all hedging operations relating to these operations, under the conditions provided for by the market authorities, and at the times to be determined by the Board of Directors or the person acting by delegation thereof
    c) transfer the Company’s shares upon exercise of the rights attached to securities entitling their bearers, directly or indirectly, through reimbursement, conversion, exchange, presentation of a warrant or in any other manner, to the allocation of the Company’s shares pursuant to current regulations; additionally, perform all hedge operations relating to these transactions, under the conditions provided for by the market authorities and at the times to be determined by the Board of Directors or the person acting by delegation of the Board of Directors
    d) keep the Company’s shares and subsequently remit them as payment or trade within the context of any external growth operations
    e) cancel all or part of the stock purchased
    f) implement any market practice that may be authorised by the French Financial Markets Authority and, more generally, perform all operations in compliance with applicable regulations in particular with Regulation (EU) No 596/2014 of the European Parliament and of the Council of April 16, 2014 on market abuse (market abuse regulation)

    2.4 Maximum percentage of the share capital, maximum number of shares, maximum purchase price and characteristics of the shares that COFACE SA intends to buyback

    2.4.1 Characteristics of the shares that COFACE SA intends to buyback

    Common shares of the Company traded on Euronext Paris:

    STOCK MARKET PROFILE
    Trading Euronext Paris (compartment A), eligible for
    deferred settlement service (SRD)
    ISIN code FR0010667147
    Reuters code COFA.PA
    Bloomberg code COFA FP
    Stock market indexes SBF 120, CAC All Shares, CAC All-Tradable,
    CAC Financials, CAC Mid & Small, CAC Mid 60, Next 150

    2.4.2 Maximum percentage of the share capital

    The Board of Directors can authorise, with the power to sub-delegate under the legal and regulatory conditions, in compliance with the provisions of Articles L.22-10-62 et seq and  L.225-210 et seq. of the French Commercial Code, the purchase of –in one or more instances and at the times to be determined by it – a number of shares of the Company not to exceed:
    (i)    10% the total number of shares composing the share capital, at any time whatsoever; or,
    (ii)    5% of the total number of shares subsequently composing the share capital if it concerns shares acquired by the Company in view of keeping them and transferring them as payment or exchange under a merger, spin-off or contribution operation.

    These percentages apply to a number of shares adjusted, where appropriate, according to the operations that could affect the share capital subsequent to the Shareholders’ Meeting of 16 May 2024.

    2.4.3 Maximum number of shares

    COFACE SA is committed, by law, not to exceed the holding limit of 10% of its capital, such 10% limit being, for information purposes, 15,017,979 shares as at June 30, 2025.

    2.4.4 Maximum purchase price

    According to the thirteen (13th) resolution proposed and accepted by the Shareholder’s Combined General Meeting of May 14, 2025, the maximum purchase price per unit may not exceed €30, excluding costs.

    The Board of Directors may nevertheless, for operations involving the Company’s capital, in particular a modification of the par value of the share, a capital increase by incorporation of reserves following the creation and allocation of bonus shares, a stock split or reverse stock split, adjust the aforementioned maximum purchase price in order to take into account the impact of these operations on the value of the Company’s stock.

    2.4.5 Other information

    The acquisition, disposal or transfer of these shares may be completed and paid for by all methods authorised by the current regulations, on a regulated market, multilateral trading system, a systematic internaliser, or over the counter, in particular through the acquisition or disposal of blocks of shares, using options or other derivative financial instruments, or warrants or, more generally, securities entitling their bearers to shares of the Company, at the times that the Board of Directors will determine.

    The Board of Directors shall have all powers, with the power to sub delegate in compliance with legislative and regulatory conditions, in order to, in accordance with applicable legislative and regulatory provisions, proceed with the permitted reallocation of repurchased shares in view of one of the objectives of the programme, to one or more of its other objectives, or even their disposal, on or off the market.

    2.5 Term of the 2025-2026 Share Buyback Program

    According to thirteen (13th) resolution proposed and accepted by the Shareholders’ Combined General Meeting of May 14, 2025, this Program will have a maximum period of eighteen (18) months from the date of said Combined General Meeting and will therefore continue no later than November 13, 2026 (including) or until the date of its renewal by a Shareholders’ General Meeting, the one occurring first.

    This authorisation concludes the one granted by the fourth (4th) resolution that was adopted by the Shareholders’ Combined Meeting of May 16, 2024.

    1. LEGAL FRAMEWORK

    Legal Framework

    The legal framework used for this document shall be that in force on June 30, 2025.
    It shall be noted that regulation may evolve during time and its updates shall be taken into consideration.

    1. Regulation (EU) No 596/2014 of the European Parliament and of the Council of April 16, 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC;
    2. Commission Delegated Regulation (EU) 2016/1052 of March 8, 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the conditions applicable to buy-back programs and stabilisation measures;
    3. Article L.225-206 and following of the French Commercial Code (and updates);
    4. General Regulation of the French Market Authority: Article L.221-1 and seq. and Article L.241-1 and seq.;
    5. AMF Policy Documents.

    Historical figures

    The main features of the Share Buyback Programs have been published on the website of the Company (http://www.coface.com/Investors) and are also described in the Universal Registration Documents.

    Share Buyback Program General Assembly authorising the Program Decision to implement the Program by the Board of Directors Transactions framework
    Liquidity Agreement LTIP Cancellation of shares
    2020 – 2021 May 14, 2020 (Res. 5) July 29, 2020 Yes No Yes1
    2021 – 2022 May 12, 2021 (Res. 17) July 28, 2021 Yes No No
    2022 – 2023 May 17, 2022 (Res. 8) July 28, 2022 Yes Yes2 No
    2023 – 2024 May 16, 2023 (Res. 4) August 10, 2023 Yes Yes3 No
    2024 – 2025 May 16, 2024 (Res. 4) August 5, 2024 Yes No No
    2025 -2026 May 14, 2025 (Res. 13) July 31, 2025 Yes Yes No

    (1)   Own shares transactions Agreement, signed with Kepler Cheuvreux, from October 27, 2020 to January 29, 2021, to buy Coface’s shares for their cancellation. For more information, the reader should refer to the Universal Registration Document published in 2021 on the 2020 financial statements.
    (2)   Own shares transactions Agreement, signed with BNP Paribas Exane, from September 13, 2022 to November 15, 2022, to buy Coface’s shares for their allocation under the LTIP. For more information, the reader should refer to the Universal Registration Document published in 2023 on the 2022 financial statements.
    (3)   Own shares transactions Agreement, signed with Kepler Cheuvreux, from September 11, 2023 to September 29, 2023, to buy Coface’s shares for their allocation under the LTIP. For more information, the reader should refer to the Universal Registration Document published in 2024 on the 2023 financial statements.

    Regulated documents posted by COFACE SA have been secured and authenticated with the blockchain technology by Wiztrust. You can check the authenticity on the website www.wiztrust.com.

    Attachment

    The MIL Network

  • MIL-OSI: Families Are Hitting the Road for Summer Travel: How to Maximize Every Travel Dollar

    Source: GlobeNewswire (MIL-OSI)

    WILMINGTON, Del. and DETROIT, July 31, 2025 (GLOBE NEWSWIRE) — With summer in full swing, families are hitting the road for vacations, choosing cars over planes for everything from camping weekends to family reunions. Car travel remains the top choice, but rising prices have prompted more travelers to stretch every dollar, especially when traveling with kids, grandparents or even a pet or two.

    “Planning ahead is key,” said Joe Saul-Sehy, personal finance expert and host of “The Stacking Benjamins Podcast.” “Set a budget that includes everything, not just gas and hotels, but food, entertainment and the unexpected. That’s where families often get caught off guard.”

    A Media Snippet accompanying this announcement is available by clicking on this link.

    One way travelers are maximizing their money is by using rewards programs that allow them to earn on everyday spending. A new option is the GM Rewards program and GM Rewards Mastercard from Barclays which enables cardmembers to earn and redeem points across GM brands. Points can be applied toward new vehicles, exclusive experiences, accessories, services, and digital features like most OnStar plans and Super Cruise.

    “You’re already spending on things like groceries, gas and travel,” Saul-Sehy said. “A card like this helps turn that spending into something that can actually reduce future costs and can make a real difference.”

    Cardmembers can earn up to 10x points on GM purchases – that’s 7x points for every $1 spent on eligible purchases plus up to 3x points for being a GM Rewards Member.

    GM enhances loyalty program and unveils new GM Rewards™ Mastercard® from Barclays.

    There is no cap on earnings, and new cardmembers can earn 30,000 bonus points after meeting initial spending requirements. For more information, visit experience.gm.com.

    The MIL Network

  • MIL-OSI: Equasens: H1 revenue at 30 June 2025: €116.0m

    Source: GlobeNewswire (MIL-OSI)

    Villers-lès-Nancy (France), 31 July 2025 – 6:00 PM (CET)

    PRESS RELEASE

    H1 revenue at 30 June 2025: €116.0m
    +7.4% on a reported basis and +6.4% like-for-like

    H1 2025 Group revenue (€m) 2024
    Reported basis
    2025
    Reported basis
    Change /
    Reported basis
    Of which external growth Like-for-like change
    (organic growth)
    Q1 53.3 57.0 3.7 6.9% 0.5 3.2 5.9%
    Q2 54.7 58.9 4.3 7.8% 0.5 3.8 6.9%
    Total 108.0 116.0 8.0 7.4% 1.1 6.9 6.4%
    H1 2025 revenue / Division (€m) 2024
    Reported basis
    2025
    Reported basis
    Change /
    Reported basis
    Of which external growth Like-for-like change
    (organic growth
    Pharmagest 82,1 85,9 3,9 4,7%   3,9 4,7%
    Axigate Link 15,4 16,5 1,0 6,7%   1,0 6,7%
    e-Connect 5,5 7,5 2,0 36,6%   2,0 36,6%
    Médical Solutions 3,9 5,1 1,1 29,1% 1,1 0,1 2,2%
    Fintech 1,1 1,0 -0,1 -7,6%   -0,1 -7,6%
    Total 108,0 116,0 8,0 7,4% 1,1 6,9 6,4%

    As of 30 June 2025, Equasens Group (Euronext Paris™ – Compartment B – FR 0012882389 -EQS), a leading provider of digital solutions for healthcare professionals, reported revenue of €116.0m, up 7.4% from H1 2024 on a reported basis and 6.4% like-for-like.

    Revenue from CALIMED SAS, acquired by the Medical Solutions Division in December 2024, was restated to reflect changes in the scope of consolidation (€1.1m).

    H1 2025 highlights by type of business

    In order to facilitate the analysis of performance, a new breakdown of the Group’s activities is proposed: “maintenance and subscriptions” includes all recurring revenues, and “software and services” mainly includes license sales and revenues from training, consulting, and intermediation.

    • Configuration and hardware sales (+9.9%) remain a major growth driver for the Group, particularly for the Pharmagest (+6.1%) and e-Connect (+125.9%) Divisions
    • Maintenance and subscriptions (+5.5%) grow steadily, benefiting from customer loyalty and the success of SaaS offerings, particularly in the Axigate Link Division (+5.6%). Calimed (Medical Solutions Division) contributed growth of 2.0% to this segment.
    • Software solutions and services (+6.4%) continue to perform very well, driven by license sales, particularly those linked to the Pharmagest Division’s latest product launches (+4.6%) and by new deployments by the Axigate Link Division (+8.9%).
    H1 2025 revenue / Activity (€m) 2024**
    Reported basis
    2025
    Reported basis
    Change / Reported basis
    Configurations and hardware 42.9 47.1 4.2 9.9%
    Maintenance and subscriptions 48.7 51.4 2.7 5.5%
    Software and services 16.4 17.4 1.1 6.4%
    Total 108.0 116.0 8.0 7.4%

    * Maintenance and subscriptions: recurring revenues including SaaS
    ** 2024 reported basis: reconstituted data

    H1 2025 highlights by Division
            
    The PHARMAGEST Division recorded H1 revenue of €85.9m (+4.7%).  This performance confirms the positive momentum that began in Q1 2025, driven by innovation and improved customer satisfaction.

    • In France, all business activities grew (+3.4% to €74.0m), driven by:
      • Equipment renewal needs and new equipment offerings, the “electronic labels” business was particularly buoyant in the second quarter.
      • The launch, in early 2025, of differentiating software solutions focused on pharmacy automation, productivity and safety. The market response to these new solutions has been very positive, with over 800 id.genius and 160 id.secure box sold.
      • Electronic invoice management solutions for pharmacies (Digipharmacie), which confirmed its market leadership by adding more than 900 new customers.
      • Only the professional training sector (Atoopharm) is experiencing a slowdown in response to changes in the regulatory environment, and in particular a one-year extension of the training cycle.
    • In Italy, sales grew evenly across both wholesale and pharmacy activities (+16.5% to €7.7m). This positive sales momentum remained strong, with the opening of more than 150 new pharmacies in the first half.
    • In Germany, sales were up (+11.2% to €3.0m) in both the medication adherence and pharmacy management segments, thanks in particular to the success of id.express payment terminals.
    • In Belgium, the return to growth has been confirmed (+6.4% to €1.2m).

    This Division accounts for 74.1% of total revenue.

    The AXIGATE LINK division reported H1 2025 revenue of €16.5m (+6.7%).

    • The Nursing Home sector (+4.5% to €8.4m) has benefited from the ESMS NUMERIQUE public funding in France, resulting in a strong business performance. Titanlink has been deployed at 164 sites since January 2025 in France (789 in total) and 16 in Belgium (58 sites in total).
    • The Homecare sector (+13.9% to €3.9m) has continued to perform well, driven by the signing of new contracts and the success of offers designed for Regional Resource Centres (CRT) and Family Caregiver Support Services (PFR). Expansion into the Home Care Services market has met with a very positive response.
    • The Hospital sector (+16.6% to €2.1m) has been particularly successful, with the signature of contracts for four hospital networks, confirming the growing reputation of the Axigate Hospilink solution in this market.

    This Division accounts for 14.2% of total revenue.

    The E-CONNECT division reported H1 2025 revenue of €7.5m (+36.6%).

    • Building on the momentum of Q1, the Division continued to roll out its Mobility solutions at a rapid pace, notably eS-KAP+, a new solution launched in Q1 2025 that has been very well received by more than 20 key software publishers in this market.
    • Since March 2025, the project to equip smartphones with a digital solution of the French health insurance card (Apps Vitale) has been gradually rolled out in accordance with the regional timetable established by the French national health insurance system.

    This Division accounts for 6.5% of total revenue.

    The MEDICAL SOLUTIONS Division had €5.1m in revenue, up 29.1% on a reported basis and 2.2% like-for-like.

    • The integration of Calimed (acquired at the end of 2024) has been the main driver of this growth as its SaaS offering for surgeons and doctors continues to attract new customers thanks to its high added value for these professions.
    • The Division’s long-standing solutions are benefiting from the very positive response to new offerings like the LOQUii voice-based AI companion and add-on services like online backup, attesting to the loyalty of the customer base and the strength of the recurring model in an intensely competitive environment.

    The Division accounts for 4.4% of total revenue.

    The FINTECH Division had H1 revenue of €1.0m (-7.6%).

    • Efforts are continuing to clean up the customer portfolio to limit risk exposure and improve its quality.
    • Sales remained buoyant in a difficult economic environment.

    The Division accounts for 0.9% of total revenue.

    Material subsequent events after 30 June 2025 Acquisition of the DIS and ResUrgences businesses – Strategic reinforcement of the AXIGATE LINK Division

    On July 1st, 2025, the Group finalized the acquisition of two businesses specialising in solutions for the public healthcare sector: Novaprove (publisher of ResUrgences software) and the business assets of DIS. This strategic acquisition, which adds more than 300 customers from the public healthcare sector and generates annual revenue of around €5m, significantly strengthens the position of the Axigate Link Division in the hospital and medical-social software market.
    ResUrgences, a cloud platform specialising in the management of hospital emergency services, used by eight university hospitals and 75 other establishments, and the DIS range representing a comprehensive suite of digital solutions used by 215 sites (125 healthcare establishments and 90 nursing homes), further enhance the Division’s existing offering. The integration of these new functional modules (Electronic Patient Records, invoicing, accounting, inventory management, and HR) into the Hospilink, Titanlink and Domilink ranges will create a comprehensive ecosystem to support the digital transformation of public and private institutions, in line with the Group’s ambition to become the leading technology partner for the French healthcare system.

    H2 2025 outlook:

    Encouraged by the positive commercial momentum experienced across all of its divisions in H1 2025, Equasens Group looks ahead to the second half with confidence for which it is expecting continuing growth.
    At the same time, Equasens Group remains attentive to the decisions of public authorities regarding the level of financial compensation granted by health insurance for the purchase of generic and biosimilar medicines. These decisions could have an impact on pharmacy economics and the pharmacy network.
    The investment and structural efforts made since 2024 are starting to show results, with the successful rollout of new software solutions for all healthcare professionals. These measures will be maintained for the remainder of FY 2025.
    The integration of DIS and ResUrgences businesses, effective as of 1 July 2025, will start contributing to the performance of the Axigate Link Division in Q3 and will create promising technical and commercial synergies.
    With a solid financial structure, the Group remains attentive to opportunities for external growth, both in France and in Europe that will strengthen its position as a leader in digital healthcare solutions.

    Financial calendar:

    • H1 2025 results: 26 September 2025
    • Presentation of H1 2025 results to analysts (SFAF): 29 September 2025 – Paris
    • Q3 2025 revenue: 5 November 2025
    • FY 2025 revenue: 5 February 2026

    About Equasens Group

    Founded over 35 years ago, Equasens Group, a leader in digital healthcare solutions, today employs over 1.300 people across Europe.
    Equasens Group’s specialised business applications facilitate the day-to-day work of healthcare professionals and their teams, working in private practice, collaborative medical structures or healthcare establishments. The Group also provides comprehensive support to healthcare professionals in the transformation of their profession by developing electronic equipment, digital solutions and healthcare robotics, as well as data hosting, financing and training adapted to their specific needs.
    And reflecting the spirit of its tagline “Technology for a More Human Experience”, the Group is a leading provider of interoperability solutions that improve coordination between healthcare professionals, their communications and data exchange resulting in better patient care and a more efficient and secure healthcare system.

    Listed on Euronext Paris™ – Compartment B

    Indexes: MSCI GLOBAL SMALL CAP – GAÏA Index 2020 – CAC®SMALL and CAC®All-Tradable
    Included in the Euronext Tech Leaders segment and the European Rising Tech label

    Eligible for the Deferred Settlement Service (“Service à Réglement Différé” – SRD) and equity savings accounts invested in small and mid caps (PEA-PME).
    ISIN: FR 0012882389 – Ticker Code: EQS

    Get all the news about Equasens Group www.equasens.com and on LinkedIn

    CONTACTS

    EQUASENS Group
    Analyst and Investor Relations:
    Chief Administrative and Financial Officer: Frédérique Schmidt
    Tel: +33 (0)3 83 15 90 67 – frederique.schmidt@equasens.com

    Financial communications agency:
    FIN’EXTENSO – Isabelle Aprile

    Tel.: +33 (0)6 17 38 61 78 – i.aprile@finextenso.fr

    Forward-looking statements
    This press release contains forward-looking statements that are not guarantees of future performance and are based on current opinions, forecasts and assumptions, including, but not limited to, assumptions about Equasens’ current and future strategy and the environment in which Equasens operates. These involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements, or industry results or other events, to materially differ from those expressed in or implied by such forward-looking statements. These risks and uncertainties include those detailed in Chapter 3 “Risk factors” of the Universal Registration Document filed with the French financial market authority (Autorité des Marchés Financiers or AMF) on April 29, 2025 under number D.25-0334. These forward-looking statements are valid only as of the date of this press release.

    Attachment

    The MIL Network

  • MIL-OSI: Applied Releases Commercial Lines Premium Rate Index Findings for Q2 2025

    Source: GlobeNewswire (MIL-OSI)

    Toronto, ON, July 31, 2025 (GLOBE NEWSWIRE) — Applied Systems® today announced the second quarter 2025 results of the Applied Commercial Index™, the Canadian insurance industry’s premium rate index. Overall, the magnitude of rate increases was down across all lines relative to average premium renewals in the same quarter last year with 3.63% in Q2 2025 down from 5.83% in Q2 2024. All lines of business saw decreases compared to the same quarter last year.
    Quarter over quarter, Q2 2025 results showed average renewal rate change decreased across many lines of the most commonly placed Commercial Lines categories, including Real Estate Property, Business and Professional Services, and Construction. Hospitality Services and Retail Services experienced an increase in average renewal rate change.
    Significant findings include:

    • Business and Professional Services: Q2 2025 premium renewal rate change average was 3.00%, down from the Q1 2025 average of 3.99%.
    • Construction, Erection, and Installation Services: Premium renewal rate change average was 3.56% for the quarter, down from the Q1 2025 average of 3.85%.
    • Hospitality Services: Q2 2025 premium renewal rate change average was 4.53%, up from the Q1 2025 average of 3.08%.
    • Real Estate Property: Premium renewal rate change average was 3.38% for the quarter, down from the Q1 2025 average of 3.58%.
    • Retail Services: Premium renewal rate change averaged 4.62%, up from the Q1 2025 average of 4.57%.

    “This quarter’s average premium renewal rate change continues to decrease across the most commonly placed commercial lines of business, except Hospitality Services which saw a spike,” said Steve Whitelaw, SVP and general manager, Canada, Applied Systems. “As we make our way into the second of the year, the Applied Commercial Index will shine light on how current macro trends such as US tariffs and others will affect rates.”
    Access the complete quarterly report here.                                                            

    # # #

    Applied Commercial Index is a trademark of Applied Systems, Inc. All data is fully anonymized when aggregating and analyzing the Applied Commercial Index.

    About Applied Systems
    Applied Systems is the leading global provider of cloud-based software that powers the business of insurance. Recognized as a pioneer in insurance automation and the innovation leader, Applied is the world’s largest provider of agency and brokerage management systems, serving customers throughout the United States, Canada, the Republic of Ireland, and the United Kingdom. By automating the insurance lifecycle, Applied’s people and products enable millions of people around the world to safeguard and protect what matters most.

    The MIL Network

  • MIL-OSI: Austin Proptech Startup Rent with Clara Announces Launch of “Trust Layer” for the Rental Market

    Source: GlobeNewswire (MIL-OSI)

    Austin, Texas, July 31, 2025 (GLOBE NEWSWIRE) — Rent with Clara, a Proptech platform developed by Clara Technologies, announced today a major rebrand and product repositioning aimed at combating rental fraud through a new infrastructure model it calls the “Trust Layer for the Rental Economy.” The company, accessible at https://www.rentwithclara.com, is introducing the Clara Rental Passport—a renter-controlled “Trust Layer” that combats fraud and accelerates secure, compliant rental applications for both renters and landlords.

    Rent with Clara – Tenant Screening Software

    Founded by real estate expert and tech entrepreneur Taylor Wilson, the platform combines rigorous verification technology with a mission-driven approach rooted in the founder’s own experience as a renter, landlord, and agent. Wilson’s firsthand exposure to the “inequities and inefficiencies” of the rental process inspired the creation of a platform that serves all sides of the transaction fairly—while delivering enterprise-grade fraud prevention for independent landlords and brokers alike.

    “We’re not trying to be the next listing site or property manager-in-a-box,” said Wilson. “This is about infrastructure. Just like Stripe did for payments and Plaid for banking data, Clara is building trust for rentals, fast, secure, and legally compliant.” – Taylor Wilson

    From Renter Frustration to Founder’s Vision

    The idea was born out of Wilson’s frustration navigating rental applications from all sides, first as a renter, then as a listing manager, and finally as an independent landlord. That trifecta gave her unique visibility into how broken the process was: from fraud-prone documents to invisible bias, and a complete lack of standardized, renter-controlled data.

    What emerged is the Clara Rental Passport: a reusable, renter-controlled profile that securely stores verified identity, income, rental history, and more. With one click, applicants can share it with any participating landlord. Meanwhile, landlords receive fully verified reports, delivered in minutes, without the risk of forged pay stubs or liability from non-compliant screening processes.

    An Anti-Fraud Platform Backed by FinTech DNA

    Under the hood, Clara leans on a powerful tech stack:

    • Argyle: real-time income and employment verification directly from payroll systems
    • Veriff: identity validation and secure data transfer
    • TransUnion: standardized credit and criminal background data

    “Fake pay stubs are a billion-dollar problem, and they’re shockingly easy to make,” Wilson said. “With Clara, landlords never have to look at a PDF again.” 

    – Taylor Wilson

    Clara’s compliance-first design is also built for scale, with compliance and transparency baked into every screening flow.

    Business Model Designed for Network Effects

    Unlike most screening platforms, Clara is free for landlords and agents. Renters pay a one-time $49 fee, which can be reused across multiple applications. That go-to-market strategy removes adoption friction and builds a virtuous network: the more landlords accept Clara, the more valuable the passport becomes.

    The company is currently bootstrapped, but Wilson confirmed that Clara Technologies is in early discussions with strategic investors as it ramps platform adoption across Texas and beyond.

    A look inside the application as a Landlord

    About Rent with Clara

    Rent with Clara is a PropTech platform that brings trust, speed, and security to the rental process through fraud-proof tenant screening and renter-controlled data. Built by Clara Technologies in Austin, TX, the platform is designed to serve landlords, agents, and renters with verified information they can rely on—without the friction of outdated paperwork or opaque decision-making. 

    Press inquiries

    Rent with Clara
    https://rentwithclara.com
    Gelo Amonelo
    gelo@rentwithclara.com
    Austin, Texas USA

    The MIL Network

  • MIL-OSI: SCOR announces the availability of its 2025 Interim Financial Report

    Source: GlobeNewswire (MIL-OSI)

    Press release
    July 31, 2025 – N° 12

    SCOR announces the availability of its 2025 Interim Financial Report

    SCOR (“SCOR” or the “Company”) announces the availability and the filing with the French Autorité des marchés financiers of its Interim Financial Report for the period ended June 30, 2025.

    The 2025 Interim Financial Report is available in the “Regulated Information” section of the Company’s website at www.scor.com.

    Hard copies of the 2025 Interim Financial Report are also available at SCOR’s headquarters, located at the following address:

    SCOR SE
    5, avenue Kléber
    75795 Paris Cedex 16
    France

    *

    *         *

    SCOR, a leading global reinsurer

    As a leading global reinsurer, SCOR offers its clients a diversified and innovative range of reinsurance and insurance solutions and services to control and manage risk. Applying “The Art & Science of Risk,” SCOR uses its industry-recognized expertise and cutting-edge financial solutions to serve its clients and contribute to the welfare and resilience of society.

    The Group generated premiums of EUR 20.1 billion in 2024 and serves clients in more than 150 countries from its 37 offices worldwide.

    For more information, visit: www.scor.com

    Media Relations
    Alexandre Garcia
    media@scor.com

    Investor Relations
    Thomas Fossard
    InvestorRelations@scor.com

    Follow us on LinkedIn

     

    All content published by the SCOR group since January 1, 2024, is certified with Wiztrust. You can check the authenticity of this content at wiztrust.com.

    General

    Figures presented throughout the 2025 Interim Financial Report may not add up precisely to the totals in the tables and text. Percentages and percent changes are calculated on complete figures (including decimals); therefore, the 2025 Interim Financial Report might contain immaterial differences in sums and percentages due to rounding. Unless otherwise specified, the sources for the business ranking and market positions are internal.

    The 2025 Interim Financial Report does not constitute an offer to sell or exchange, or a solicitation of an offer to buy SCOR securities in any jurisdiction.

    Forward-looking statements

    The 2025 Interim Financial Report includes forward-looking statements, assumptions, and information about SCOR’s financial condition, results, business, strategy, plans and objectives, including in relation to SCOR’s current or future projects.

    These statements may be identified by the use of the future tense or conditional mode, or terms such as “estimate”, “believe”, “anticipate”, “aim”, “expect”, “have the objective”, “intend to”, “plan”, “result in”, “should”, and other similar expressions.

    It should be noted that the achievement of these objectives, forward-looking statements, assumptions and information is dependent on circumstances and facts that may or may not arise in the future.

    No guarantee can be given regarding the achievement of these forward-looking statements, assumptions and information. These forward-looking statements, assumptions and information are not guarantees of future performance. Forward-looking statements, assumptions and information (including on objectives) may be impacted by known or unknown risks, identified or unidentified uncertainties and other factors that may significantly impact the future results, performance and accomplishments planned or expected by SCOR.

    In particular, it should be noted that the full impact of the economic, financial and geopolitical risks on SCOR’s business and results cannot be precisely assessed.

    Accordingly, all assessments, assumptions, and figures presented in the 2025 Interim Financial Report should be considered as estimates based on evolving analyses, and encompass a wide range of theoretical hypotheses, which are highly evolutive.

    Information regarding risks and uncertainties that may affect SCOR’s business is set forth in the 2024 Universal Registration Document filed on March 20, 2025, under number n°D.25-0124 with the French Autorité des marchés financiers (AMF) available on SCOR’s website www.scor.com and on the AMF’s website www.amf-france.org.

    In addition, such forward-looking statements, assumptions and information are not “profit forecasts” within the meaning of Article 1 of Commission Delegated Regulation (EU) 2019/980.

    SCOR does not undertake and has no obligation or intention to complete, update, revise or change these forward-looking statements, assumptions and information, whether as a result of new information, future events or otherwise.

    Financial information

    The Group’s financial information contained in the 2025 Interim Financial Report is prepared on the basis of IFRS and interpretations issued and approved by the European Union.

    Unless otherwise specified, prior-year balance sheet, income statement items and ratios have not been reclassified.

    The calculation of financial ratios (such as return on invested assets, regular income yield, return on equity and combined ratio) is detailed in the Appendices of the presentation related to the financial results for the second quarter and first half of 2025 which is available on SCOR’s website www.scor.com.

    The financial results for the first half of 2025 included in the 2025 Interim Financial Report have been subject to a limited review by SCOR’s statutory auditors. Unless otherwise specified, all figures are presented in Euros.

    Any financial data or figures for a period subsequent to June 30, 2025 are not to be construed as a forecast of the expected financials for these periods.

    Attachment

    The MIL Network

  • MIL-OSI: RCI Banque: ‘’2025 First Half Business Report is now available’’

    Source: GlobeNewswire (MIL-OSI)

    July 31st, 2025

    RCI Banque: ‘’2025 First Half Business Report is now available’’

    The RCI Banque group ‘’2025 First Half Business Report’’ is now available on the Mobilize Financial Services website www.mobilize-fs.com

    Attachment

    The MIL Network

  • MIL-OSI: Introducing Rippling Travel: For Faster Bookings, Smarter Spending, and Better Travel

    Source: GlobeNewswire (MIL-OSI)

    SAN FRANCISCO, July 31, 2025 (GLOBE NEWSWIRE) — Rippling, a leading business software company, today announced the launch of Rippling Travel, allowing companies to save more time and money on business travel. Rippling Travel unifies expense management, corporate cards, bill pay, payroll, and travel booking all within a single, integrated system – making it faster, easier, and cheaper than ever to book and manage corporate travel.

    “At Rippling, our focus has always been to free people to work on hard problems by automating away repetitive admin work so they can focus on strategic work,” said Matt Epstein, General Manager, Rippling Spend.

    That’s why we launched Rippling Travel. It makes it insanely easy for employees to book flights, hotels, and cars without having to worry about what is (and isn’t) in-policy. And for companies to automatically control every penny their employees spend on business travel, from in-flight seat upgrades to reimbursements on the road.

    Corporate travel has historically been a headache. For employees, it takes time and causes stress. For employers, it requires endless administrative tasks and back-and-forths on approvals. In fact, in a recent Rippling survey, 80% of companies said business travel is critical to revenue generation – but 93% still using legacy travel platforms report budget overruns and administrative inefficiencies.

    Rippling Travel solves these issues, providing an alternative to outdated software and disparate systems with a single system for unified travel and expense management that offers:

    • Seamless and cost conscious booking: Rippling Travel makes it quick and easy for employees to book and manage their travel. We partnered with Duffel to offer options from Expedia Group, Priceline, Booking.com, and direct airline integrations – all from within one intuitive platform.
    • Hyper-custom policies: Rippling Travel allows you to build hyper-custom policies around flights, hotels, and car rentals in just a few clicks. Rippling Travel’s deep integration with other business systems means policies automatically adapt to internal organizational changes (such as promotions or procedural updates).
    • Comprehensive reporting and analytics: Integrated into the Spend suite, Rippling Travel empowers employers with real-time, comprehensive data and analytics reports on all travel and spend related matters across the business.

    Ready to consolidate all spend management with Rippling – including Travel? Learn more and sign up for a demo today.

    About Rippling
    Rippling gives businesses one place to run HR, IT, and Spend – globally. It brings together all of the workforce systems that are normally scattered across a company, like payroll, expenses, benefits, and computers. For the first time ever, you can manage and automate every part of the employee lifecycle in a single system. Based in San Francisco, CA, Rippling has raised $1.8B from the world’s top investors – including Kleiner Perkins, Founders Fund, Sequoia, and Bedrock.

    The MIL Network

  • MIL-OSI: Sleep Lean: Why SleepLean Is the Nighttime Fat Burner Everyone’s Talking About in 2025 (INVESTIGATIVE REPORT)

    Source: GlobeNewswire (MIL-OSI)

    New York City, NY, July 31, 2025 (GLOBE NEWSWIRE) —

    As the connection between quality sleep and body composition gains wider recognition, a new supplement is capturing attention for its unique nighttime approach: Sleep Lean. Both early users and wellness enthusiasts are praising it as a promising step forward in aligning sleep patterns with body balance goals, all while preserving restful sleep.

    In recent years, wellness has expanded beyond daytime routines and fitness tracking to include what occurs during nighttime hours. This growing awareness has sparked interest in nighttime supplements like Sleep Lean, which provide support during one of the body’s most important regenerative phases: sleep.

    Traditionally, weight management products have centered around daytime activity, focusing on boosting energy, controlling diet, or adjusting caloric intake. However, emerging research into circadian rhythms and hormonal cycles has made one thing clear: sleep significantly influences how the body performs throughout the day.

    This is where Sleep Lean stands out. It isn’t a fast-acting stimulant or a harsh sleep aid. Instead, it works in harmony with the body’s natural rhythm, supporting rest, regulation, and renewal without interference.

    According to current wellness trends, demand for nighttime supplements has grown significantly over the last 18 months, particularly among midlife wellness consumers. As sleep becomes more widely acknowledged as a key pillar of health, products like Sleep Lean are moving from the margins to the mainstream of long-term body balance strategies.

    Why Sleep Lean Is Gaining Momentum in 2025

    As the global wellness landscape continues to expand, a meaningful shift is taking place. People are beginning to recognize sleep not just as a way to recharge energy, but as a crucial period for internal regulation and balance. Leading this movement is Sleep Lean, a new supplement making waves among those seeking a more natural and gentle approach to overall wellness.

    In contrast to traditional methods that emphasize energy-boosting products or strict daytime routines, Sleep Lean supplement offers a unique solution by working in sync with the body’s nighttime processes. Its growing popularity isn’t the result of flashy marketing.

    Instead, it’s being fueled by genuine user experiences, active wellness communities, and shared reports of better sleep paired with noticeable improvements in body rhythm.

    Experts in the wellness field are calling this emerging mindset the “rest revolution” — a pivot from pushing harder to supporting smarter. Sleep Lean supplement aligns perfectly with this concept by targeting the body’s natural metabolic recovery processes that occur during sleep.

    As awareness continues to rise both in the United States and internationally, Sleep Lean is standing out not as a passing trend but as a symbol of shifting wellness values. In a space often saturated with stimulating products, this supplement is helping people rediscover one of the most effective yet underappreciated health tools available: quality sleep.

    >>Visit the Official Website To Get More Information

    The Science Behind Sleep and Metabolism

    Recent scientific findings continue to highlight the strong connection between sleep and metabolic function. Despite this, most wellness strategies have historically focused on what happens during the day. That’s where Sleep Lean stands out in 2025, by addressing the often-overlooked role of nighttime in supporting internal balance and overall well-being.

    Sleep is far from a passive state. It marks a shift in how the body operates, triggering changes in hormone activity, cellular repair, and energy regulation. For example, growth hormone peaks during deep sleep, helping with tissue regeneration and nutrient allocation.

    Meanwhile, cortisol—associated with stress response and fat storage—tends to recalibrate overnight, especially in those who sleep well.

    Disrupted or poor-quality sleep interferes with these processes, contributing to imbalances in energy, appetite control, and weight fluctuations. Sleep Lean supplement is designed to support the body’s natural rhythms, encouraging more restorative rest while creating a calm internal environment for recovery and regulation.

    By focusing on nighttime as a window for wellness, Sleep Lean taps into a growing base of evidence showing that sleep is not just recovery—it’s a vital phase for realigning metabolic health. This approach appeals to people looking for solutions that work with their body, rather than quick fixes that mask deeper imbalances.

    How Sleep Lean Supports the Body Without Harsh Stimulants

    Sleep Lean is gaining attention for its unique focus on aiding the body’s natural processes during rest. While many wellness products are geared toward daytime activity, this supplement is specifically formulated to enhance restorative metabolism, the quiet balancing work that happens while we sleep.

    Instead of relying on strong stimulants or ingredients that may lead to energy crashes, Sleep Lean takes a more gentle and supportive approach. Its carefully selected components help promote easier sleep onset while also encouraging healthy nutrient processing and storage during the night.

    This combination of restful sleep support and metabolic assistance is becoming increasingly popular among those seeking effective, non-invasive options. Early users have reported better sleep quality alongside subtle yet consistent improvements in body composition.

    Experts in the wellness space point out that sleep is still one of the most underappreciated aspects of metabolic health. With the introduction of Sleep Lean, this important connection is finally receiving the attention it deserves.

    >>For more information, including pricing and availability, visit the official Sleep Lean website.

    What Makes Sleep Lean’s Ingredients Stand Out

    The growing popularity of Sleep Lean supplement can be traced back to its thoughtfully selected ingredients, each chosen to support restful sleep and nighttime metabolic function without overwhelming the body.

    At the heart of the formula are natural adaptogens, which help the body stay balanced during periods of stress. Rather than inducing drowsiness, these ingredients encourage a smooth transition into rest, creating the right conditions for the body to carry out its nightly repair and regulation work.

    Sleep Lean also includes specific amino acid compounds linked to neurotransmitter activity. These compounds play a subtle but important role in helping regulate the sleep-wake cycle, allowing users to move into deeper, more restorative sleep phases. During these stages, the body is better equipped to manage energy use and nutrient processing.

    Adding to this blend is a botanical complex rich in antioxidants. Known for their calming and cell-supporting properties, these botanicals contribute to the body’s overnight recovery and renewal efforts.

    Instead of forcing sleep, Sleep Lean works in harmony with the body’s natural rhythm. This gentle and holistic approach is a major reason why it is resonating with individuals seeking non-disruptive support for both rest and metabolic health.

    What Sets Sleep Lean Apart from Daytime Weight Loss Supplements?

    According to the official website, most wellness supplements focus on boosting energy, increasing thermogenesis, or controlling appetite during the day. Sleep Lean, however, takes a different approach by providing support while the user is resting, aligning with the body’s natural recovery phase at night.

    Daytime products typically aim to stimulate the body, offering quick bursts of energy or increased alertness that may aid motivation but can disrupt rest if consumed too late. Sleep Lean avoids these issues completely. It contains no ingredients that cause jitters, no sudden energy crashes, and no interference with the body’s natural cortisol rhythm.

    Instead, Sleep Lean is formulated to assist the body’s natural processes after dark: resetting, repairing, and restoring balance. Research indicates that during sleep, the body undertakes complex metabolic functions such as nutrient processing and cellular maintenance. Sleep Lean supports these activities rather than working against them.

    This fundamental difference makes Sleep Lean a popular choice for those seeking sustainable wellness support without sacrificing sleep quality. It does not compete with energy levels but instead complements the body’s circadian rhythm. In an age of constant overstimulation, a supplement that focuses on nighttime recovery offers a welcome and increasingly popular alternative.

    >>Visit the official website to learn more.

    Who Is Using Sleep Lean in 2025?

    In 2025, wellness communities are experiencing a subtle but important change. People are increasingly recognizing rest not as idle downtime but as a vital part of maintaining overall body balance. This perspective is evident in the growing number of individuals choosing Sleep Lean pills.

    The range of users is broad. Busy professionals incorporate it into their nightly routines to encourage deeper, more restorative sleep and to support balance. Those going through midlife transitions, when sleep and metabolism often become more unpredictable, find value in the supplement’s gentle assistance.

    Even younger wellness seekers, who previously paid little attention to nighttime supplementation, are now embracing Sleep Lean as a key element of a comprehensive self-care regimen.

    Discussions on social media and wellness podcasts frequently highlight the “rest and reset” philosophy. Instead of seeking rapid results, many users prefer approaches that feel manageable over the long term. Sleep Lean fits well within this mindset, serving as a quiet, consistent support that works behind the scenes.

    What brings this diverse group together is a common priority: steady progress without sacrifice. In a market crowded with products promising quick fixes, Sleep Lean supplement appeals to those who want lasting improvements aligned with the body’s natural rhythms.

    Is Sleep Lean Safe for Nighttime Use?

    In 2025, safety continues to be a major concern for consumers, particularly when it comes to supplements intended for use before sleep. Sleep Lean has attracted attention not only for its distinctive approach but also for its responsible formulation designed specifically for nighttime support.

    The product is created without ingredients known to interfere with restful sleep, such as strong stimulants, synthetic sedatives, or addictive substances. Instead, it relies on naturally sourced compounds that help regulate the body’s circadian rhythms, promote nervous system balance, and gently support metabolic processes.

    Each ingredient is chosen for its suitability during evening hours. Rather than causing sudden changes in the body, the formula aims to facilitate a gradual and smooth transition into deeper sleep. Users frequently report experiencing calmness without feeling groggy upon waking, which is uncommon in this category of supplements.

    Moreover, the Sleep Lean formula avoids artificial colors, common allergens, and unnecessary fillers. This careful composition makes it a suitable choice for many wellness-minded individuals who want a safe and high-quality nighttime supplement.

    As the demand for sleep-centered metabolic support increases, Sleep Lean stands out as a thoughtful and balanced option that values harmony with the body’s natural rhythms over aggressive intervention.

    Where to Buy Authentic Sleep Lean in 2025

    As Sleep Lean’s popularity grows, many people are asking where to purchase it safely. The most reliable source for genuine Sleep Lean remains the official website, which offers a secure way to ensure the product’s authenticity, proper storage, and access to full customer support.

    Buying directly from the official website guarantees that customers receive the original formula along with the latest information, accurate usage instructions, and any available promotions. Because unauthorized sellers and counterfeit versions have appeared on some third-party marketplaces, wellness experts advise verifying the source before making a purchase.

    Safety is another important reason to choose official channels. Supplements designed for use during rest often include temperature-sensitive ingredients and require precise dosing, making quality control essential. This level of care is not always guaranteed when buying from unverified sellers.

    For those planning to incorporate Sleep Lean into their wellness routine, the brand also provides package options aimed at supporting consistent use over several weeks. This is especially beneficial for individuals seeking sustained support for body balance.

    What Wellness Experts Are Saying About Sleep Lean

    As the focus on restorative wellness grows, health professionals and holistic practitioners are paying close attention to products like Sleep Lean that prioritize working with the body’s natural rhythms rather than forcing change. Although daytime supplements remain important, the wellness community is increasingly acknowledging that rest itself plays an active and essential role in overall balance.

    Experts tracking the industry view Sleep Lean’s rising popularity as part of a larger trend. More consumers are selecting supplements based not only on their ingredients but also on how and when these ingredients support bodily functions. By targeting the nighttime hours, Sleep Lean provides an innovative alternative to products that emphasize daytime energy use.

    Many nutrition specialists have noted that Sleep Lean’s formulation aligns well with current knowledge about safe and gentle nighttime support. The fact that it does not contain synthetic sedatives or potent stimulants is often highlighted as a significant advantage.

    Overall, Sleep Lean is being seen not merely as a supplement but as an effective tool within a broader approach to enhancing metabolic health through quality rest.

    Final Thoughts: The Place of Sleep Lean in the 2025 Wellness Landscape

    Each year, thousands of supplements enter the wellness market, yet only a select few succeed in changing how people view body balance. In 2025, Sleep Lean is becoming one of those standout products—not because it makes flashy claims, but because it aligns perfectly with the evolving ways consumers approach wellness.

    Rather than trying to override the body’s natural systems or work against biology, Sleep Lean formula complements the body’s inherent design for recovery—quietly and gently supporting this process during rest.

    Its growing popularity reflects a broader shift in mindset. More people are adopting long-term strategies, seeking solutions that easily fit into their daily lives instead of products that require drastic lifestyle changes. Sleep Lean offers a simple integration: one capsule, a consistent routine, and a commitment to peaceful nights and balanced days.

    As awareness continues to build, Sleep Lean’s role in wellness becomes clearer. It focuses not on rushing results but on fostering smarter, sustainable habits. In a world filled with constant stimulation, this calm and supportive approach could be what truly sets it apart.

    For the most reliable and up-to-date information about the product, including pricing and availability, always refer to the official Sleep Lean website.

    Disclaimer: The information provided in this article about Sleep Lean is for informational purposes only and is not intended as medical advice. Results may vary from person to person. Before starting any new supplement, including Sleep Lean, it is recommended to consult with a healthcare professional, especially if you have existing medical conditions, are pregnant, nursing, or taking medications. This product is not designed to diagnose, treat, cure, or prevent any disease. The statements made regarding Sleep Lean have not been evaluated by the Food and Drug Administration (FDA). Always follow the manufacturer’s guidelines and instructions when using this supplement.

    Brand website: https://sleeplean.net/

    Project name: Sleep Lean

    Address: 285 Northeast Ave, Tallmadge, OH 44278, United States

    Postal code: 44278

    Contact:

    Email: support@sleeplean.net

    Attachment

    The MIL Network

  • MIL-OSI: Presentation Reveals Details on Potential Starlink “Super-IPO” Announcement Predicted August 13

    Source: GlobeNewswire (MIL-OSI)

    Baltimore, MD, July 31, 2025 (GLOBE NEWSWIRE) — A released presentation suggests Elon Musk’s Starlink could be preparing for what some are calling a “Super-IPO” with an announcement expected as soon as August 13, 2025.

    In the presentation, tech entrepreneur James Altucher outlines what he describes as “a trillion-dollar technological revolution” that he believes “could have a far bigger impact on the world than any other technology [Elon Musk] has created before.”

    Three “Smoking Guns” Point to A Potential Announcement

    According to the presentation, Altucher highlights three pieces of evidence that Starlink is preparing for a public announcement:

    • Elon Musk Statement:
      In a previous public comment, Musk confirmed plans to take Starlink public when its cash flow became predictable. Altucher notes that the company has “officially crossed that milestone”
    • Financial Motivation:
      “What Musk really needs is another publicly traded company that would allow him to unlock some of his wealth and take the pressure off Tesla,” the presentation states, citing Barron’s coverage
    • Corporate Spinoff:
      Bloomberg reported that “SpaceX is discussing an initial public offering for its fast-growing Starlink satellite business as soon as late 2024… in a bid to capitalize on robust demand for communications via space”

    Altucher argues these moves combined with “a major industry conference scheduled for August 13, 2025” make the date a likely venue for what he calls a “historic announcement”

    The Technology Behind the Headlines

    The presentation describes Starlink as a radical reinvention of internet access, delivering “fast, reliable, unlimited internet through the air… directly to your device.” .Altucher claims the technology “could cripple the trillion-dollar telecom industry over time” while connecting “billions of previously un-connected people” to the web.

    Why This Matters

    “Fifty years from now, people may remember it as one of the greatest innovations of the 21st century,” Altucher says in the presentation. “An innovation which could be bigger than Tesla or anything else Elon has done before.”

    About James Altucher

    James Altucher is a tech entrepreneur, venture capitalist, and Wall Street Journal bestselling author. He has been recognized as “one of the best venture capitalists, angel investors, and tech entrepreneurs in the world.” Altucher has built a career spotting transformative technology trends early and has been featured in publications such as CNBC. He is the founder of Altucher’s Investment Network and host of The James Altucher Show podcast, which has been downloaded more than 40 million times.

    The MIL Network

  • MIL-OSI: Immunefi Adds Onchain Monitoring to Protect $180B+ in Digital assets as 2025 Crypto Hacks Top $3.1B

    Source: GlobeNewswire (MIL-OSI)

    Immunefi’s Magnus platform becomes first unified system to monitor smart contracts, social engineering, and reputational threats in real-time, bringing together Fuzzland and Failsafe to catch smart contract exploits, social engineering attacks, and brand threats in real-time.

    AUSTIN, Texas – July 31, – With crypto hacks surpassing $3.1 billion in 2025 and access-control flaws still the industry’s biggest security gap, Immunefi – the leading onchain security platform protecting $180 billion in user funds – is launching onchain monitoring capabilities across protocols like Arbitrum, zkSync, and Curve Finance via its unified platform, Magnus.

    Immunefi now integrates with Fuzzland and FailSafe to bring smart contract monitoring and alerts into their Magnus platform. 

    The launch comes as the industry faces an evolution in attack vectors that shows a significant shift from code-based exploits to operational security failures, with social engineering and compromised keys becoming the dominant threat vectors.

    Take Arbitrum, which now secures over $3.4 billion in stablecoins including PayPal’s PYUSD, or zkSync, which has quickly become the second-largest network for tokenized real-world assets behind Ethereum, with $2.4 billion in value. These aren’t just DeFi platforms anymore, they’re becoming financial infrastructure. And with that shift, real-time threat detection and brand protection are no longer nice-to-haves, they’re essential.

    Magnus unifies monitoring to detect and neutralize these threats in minutes instead of hours. Trusted by leading networks like Ethereum, BNB, and Arbitrum, it gives teams the response speed today’s onchain economy demands.

    At the core of the Magnus is Codexa, the most comprehensive dataset of blockchain vulnerabilities in the industry by orders of magnitude. Codexa powers Magnus, leveling up its security models and ensures Magnus continuously evolves alongside emerging threats, giving protocols intelligence fast enough to intervene before funds disappear. With Codexa, Immunefi moves beyond static monitoring tools toward adaptive, AI-native security infrastructure.

    Although crypto hackers can drain millions in seconds, security teams currently waste precious hours jumping between disconnected tools trying to piece together threats and respond to potential security incidents. Magnus’s onchain monitoring enables teams to receive unified alerts through their preferred channels (Slack, PagerDuty, etc.) and access all threat details in one consolidated view so they can act on threats immediately rather than spending time on manual correlation.

    “When every second counts during an active exploit, having all your security intelligence in one place is the difference between a close call and a catastrophe,” said Mitchell Amador, CEO and Founder of Immunefi. “Unlike platforms that lock you into proprietary tools, Magnus lets you leverage best-in-class monitoring providers while maintaining unified operations.”

    The integration brings together complementary monitoring capabilities across the broadest range of blockchains in the industry. Fuzzland contributes both monitoring alerts and 24/7 automated penetration testing findings via API, scanning thousands of transactions per second and having already prevented over 110 attacks and rescued $33.4 million in assets. FailSafe brings continuous security signal coverage across leading chains, with advanced tools for regulatory-focused use cases such as stablecoin compliance under MiCA and DORA.

    Together, these partners are integrating their monitoring capabilities directly into the Magnus platform, beginning with support for Ethereum, BNB Smart Chain, Arbitrum, Polygon, Base, and Avalanche. Additional chains will be added over time.

    Magnus has already attracted adoption from major protocols, including Babylon Labs and Lombard Finance, which together secure $8 billion in Bitcoin DeFi assets. By unifying partner monitoring within a single interface, Magnus enables these institutions to maintain proactive, transparent security operations that meet the expectations of regulators and institutional counterparties.

    Magnus’s monitoring capabilities alert teams to unusual patterns, behaviors, and incidents in real-time to enable rapid response to potential threats. When threats are detected, teams receive immediate notifications with full context that reduces the time from detection to action.

    “Security fragmentation has been the Achilles’ heel ” of protocols trying to scale to institutional standards,” said Aneirin, cofounder of FailSafe. “With Magnus, we unify cross-chain monitoring, threat detection, and policy enforcement into a single command center, giving security teams real-time visibility and compliance-grade coverage that used to require a patchwork of tools.”

    The monitoring integration is available immediately in beta release for Magnus early access partners.

    -ends-

    For more information please contact:
    immunefi@clpr.agency

    About ImmunefiImmunefi is the leading onchain security platform, working with groundbreaking protocols such as Ethereum Foundation, Chainlink, Optimism, Arbitrum, and many more. The company’s latest product, Magnus, bridges the gap between security solutions by creating a unified platform for security operations. The platform’s growing community of over 60,000 security researchers protects $180B in user funds and has prevented over $25B in hacks across 500+ protocols. Learn more at immunefi.com

    The MIL Network

  • MIL-OSI: Viridien: 2025 Interim Financial Report available

    Source: GlobeNewswire (MIL-OSI)

    Viridien

    Société Anonyme with a share capital of €7,180,449
    Registered office: 27 avenue Carnot, 91300 Massy
    No.: 969 202 241 – RCS Evry

    2025 Interim Financial Report available

    Paris, France – July 31, 2025

    Viridien announced that its interim financial report as at June 30, 2025 was filed today with the Autorité des Marchés Financiers (AMF).

    This document is available on the Company’s website: https://www.viridiengroup.com/ under the Investors section (both in “Regulated information” and “Results and Publications”).

    About Viridien:

    Viridien (www.viridiengroup.com) is an advanced technology, digital and Earth data company that pushes the boundaries of science for a more prosperous and sustainable future. With our ingenuity, drive and deep curiosity we discover new insights, innovations, and solutions that efficiently and responsibly resolve complex natural resource, digital, energy transition and infrastructure challenges. Viridien employs around 3,400 people worldwide and is listed as VIRI on the Euronext Paris SA (ISIN: FR001400PVN6).

    Contact: Legal Department, 27 avenue Carnot, 91300 Massy

    Attachment

    The MIL Network

  • MIL-OSI: The Pink Salt Trick Recipe for Fast Weight Loss Trend in 2025: Why Trimology Is the Science-Backed Alternative

    Source: GlobeNewswire (MIL-OSI)

    New York City, NY, July 31, 2025 (GLOBE NEWSWIRE) —

    Pink Salt Trick Recipe Explained: Why It’s Trending for Weight Loss

    A viral wellness trend called the “Pink Salt Trick” has swept social media—particularly TikTok, Instagram, and wellness blogs. The hype: a morning ritual mixing Himalayan pink salt, water, lemon and honey claims to boost metabolism, reduce bloating, and even accelerate fat loss. But credible medical sources now label it a pseudoscientific fad with no proven weight‑loss benefits—and potential risks for high blood pressure sufferers.

    Enter Trimology, a science‑backed supplement brand positioned as a safer, evidence‑based alternative. Rather than quick fixes or social media stunts, Trimology takes its inspiration from a traditional Ugandan weight‑maintenance ritual: women consuming bitter green bananas rich in resistant starch (RS2), which naturally support gut microbiome health and metabolic resilience. Trimology translates that ritual into a modern capsule form by delivering concentrated RS2 plus supporting pre‑ and probiotics. 

    While the Pink Salt Trick rides on viral popularity, Trimology is introduced as a metabolic reset system—one that doesn’t promise overnight miracles, but rather aims for sustainable internal recalibration through gut‑brain‑fat signaling pathways. Want to Learn More About Trimology? Click Here

    Why Trimology Is the Safer, Science‑Backed Alternative

    Enter Trimology — a next‑generation, gut‑first weight‑loss supplement designed to offer credible, long‑term benefit rather than a viral illusion. Unlike the Pink Salt Trick, which hinges on vague mineral magic and untested methods, Trimology is rooted in microbiome science and targeted metabolic support.

    • Biological foundation: Trimology blends resistant starch (RS2), chicory inulin, and a signature probiotic triad (including Clostridium butyricum, Akkermansia muciniphila, Bifidobacterium infantis) to feed fat‑regulating gut bacteria and restore healthy metabolic signals.
    • Ancient inspiration: Derived from research into a traditional Ugandan practice—women consuming bitter green bananas rich in RS2 stayed lean well into older age—Trimology replicates the benefits in a clean capsule instead of a literal banana ritual.
    • Transparent formulation: Ingredients and microbial strains are fully disclosed, sourced at pharmaceutical quality, and backed by peer‑reviewed research—not buried in proprietary blends.
    • User‑friendly delivery: One capsule taken daily with breakfast. No meal‑timing restrictions, no yo‑yo dieting, no fasting requirements—just simple consistency. That ease of use appeals especially to women juggling busy schedules.
    • Safety and clarity: Trimology does not rely on caffeine, stimulants, hormone disruptors, or laxatives. It’s not sold as a cure, but a metabolic reset—respecting the body’s natural systems with traceable ingredients and no outrageous promises.

    While the Pink Salt Trick offers instant visual appeal and anecdotal enthusiasm, Trimology emphasizes measured improvement, restoring the gut‑brain‑fat axis, promoting satiety, and supporting energy through internal recalibration—not by shocking the system or inflating expectations. Unlock the Full Story Behind Trimology– Learn More Now

    Why the Internet Believed Deep‑Fake Celebrities Promoted the Pink Salt Trick

    The Pink Salt Trick’s rapid rise is strongly tied to deep‑fake endorsements and manipulated celebrity faces. Reports indicate that creators used AI‑generated clips mimicking well‑known public figures “trying” or “endorsing” the trend. Sensational headlines and algorithm‑driven reach amplified the illusion of legitimacy.

    The strategy tapped into users’ trust in celebrities, piggy‑backing on FOMO (fear of missing out) by suggesting these are insider weight‑loss secrets. Social platforms prioritized visually compelling before‑after testimonials and simplified recipes—despite medical experts warning the trend is unsupported or potentially unsafe.

    In essence, trust was manufactured—the product had no clinical trials, no published data—but looked persuasive because of faux celebrity endorsement and viral momentum. In contrast, Trimology emphasizes transparency, open ingredient sourcing, and no misleading influencer claims.

    Why the Pink Salt Trick Doesn’t Work — and Might Be Harmful

    At first glance, the Pink Salt Trick Recipe seems harmless. After all, pink Himalayan salt is often marketed as a “natural” source of minerals like magnesium, calcium, and potassium. But when used improperly—or in excess—it becomes not only ineffective, but potentially dangerous.

    Here’s why:

    • Too much sodium: One teaspoon of pink Himalayan salt contains about 2,300 mg of sodium—the maximum daily limit recommended by most health authorities. Those doing the trick multiple times a day (as some videos suggest) could be ingesting well over the safe threshold, increasing risk of high blood pressure, fluid retention, and cardiovascular strain.
    • No real metabolic effect: Despite its reputation, there is no clinical evidence that pink salt boosts metabolism, burns fat, or suppresses appetite in any meaningful way. The minor effects people feel—such as increased fullness or reduced cravings—are likely due to hydration or placebo, not salt-specific properties.
    • Dehydration and electrolyte imbalance: In some versions of the trick, users consume large quantities of saltwater without adjusting their hydration elsewhere. This can disrupt the body’s sodium-potassium balance, especially dangerous for people with kidney conditions, hypertension, or existing heart issues.
    • No support for gut health: While pink salt may contain trace minerals, it offers no prebiotic or probiotic benefit, meaning it does nothing to support the gut microbiome—which scientists now agree plays a crucial role in regulating metabolism, insulin sensitivity, and weight stability.
    • Not FDA-regulated: Most of the Pink Salt Trick kits sold online are unregulated and vary widely in quality. Some are sourced from poorly tested suppliers and may contain microplastics or industrial contaminants.

    In contrast, Trimology was developed to avoid all of these pitfalls. Its probiotic strains and resistant starches are carefully dosed for metabolic safety, backed by lab data, and formulated in cGMP-certified facilities. There’s no sodium loading, no electrolyte disruption, and no gimmicky biohacks.

    Trimology’s gut-first approach helps re-establish satiety signaling, healthy blood sugar control, and long-term fat regulation—all while nurturing the digestive ecosystem, not irritating it. Its gradual, cumulative effects are exactly what the body needs—not a one-time shock that confuses internal systems and creates dependency.

    Perhaps most importantly, Trimology doesn’t promise miracles. It encourages consistency, not urgency, which is critical in breaking the cycle of fad-based dieting that trends like the Pink Salt Trick perpetuate. Trimology provides a more intelligent, research-backed solution

    How Trimology Supports Weight Loss

    Trimology supports weight loss by targeting foundational metabolic pathways—not by temporary suppression or dehydration. Its key strategy: nourish beneficial gut bacteria with RS2 and inulin to optimize butyrate production. Butyrate enhances insulin sensitivity, reduces systemic inflammation, and reinforces the gut lining—helping the body regulate blood sugar and fat storage more effectively.

    The included probiotic strains further support natural hunger regulation: Akkermansia is linked with improved satiety hormone function and better insulin response; Clostridium butyricum promotes sustained butyrate output; and Bifidobacterium infantis may help stabilize mood, reduce food cravings, and normalize ghrelin/leptin balance.

    Users are advised to take a single capsule each morning with water or coffee—no complex fasting windows, no food tracking. Over time (usually 2–4 weeks), users report sharper energy, fewer cravings, less bloating, and gradual weight reduction—consistent with internal metabolic reset before visible change.

    Trimology positions weight loss not as an immediate outcome, but as a secondary benefit of restoring internal harmony and resilience—ideally paired with healthy eating and movement, but not dependent on them.

    Key Ingredients of Trimology

    Trimology’s formula stands on five core active components:

    • Pharmaceutical‐grade RS2 (resistant starch): sourced from green banana or potato starch; resists digestion until it reaches the colon, where specific bacteria ferment it, producing butyrate—a short-chain fatty acid central to metabolic regulation.
    • Chicory root (inulin): a soluble fiber and prebiotic that nourishes a diverse gut microbiome, amplifying butyrate production and improving digestion and glucose response.
    • Clostridium butyricum: a robust butyrate-producer that helps lower inflammation, stabilize gut environment, and support fat-burning pathways.
    • Akkermansia muciniphila: known to improve gut barrier integrity, increase satiety hormone responses, and enhance insulin sensitivity—like a natural appetite regulator.
    • Bifidobacterium infantis: associated with reduced cravings, hormone regulation, better digestion, and mood balance—all supportive of sustainable weight.

    These ingredients were chosen not for hype, but for measurable roles in reactivating the gut‑brain‑fat axis. Together, they form what Trimology refers to as the “Signal Reset Triad”—a synergy that supports calm inflammatory processes, improved satiety, and metabolic resilience.

     Visit Trimology Official Website To Know More About ……..

    What Makes Trimology Different From Other Weight Loss Supplements

    Trimology diverges from traditional fat burners or appetite suppressants in several key ways:

    1. No stimulants or synthetic hormones: unlike energizing fat‑burners loaded with caffeine or hormone‑mimicking compounds, Trimology works through microbiome support—not chemical triggers.
    2. Transparent labeling: ingredients are clearly identified, including specific probiotic strains and prebiotic sources. No proprietary blends or ambiguous fillers—each component was selected based on clinical research.
    3. Simplicity and compatibility: single capsule daily, compatible with most lifestyles and diet plans. No food tracking, no cycles, no loading phases. Reviewers consistently praise its integration ease and non‑aggressive positioning.
    4. Sustainable orientation: Trimology encourages long‑term use to rebuild metabolic signaling—not short bursts of weight loss that fade when the supplement ends.
    5. Gut‑focused rather than symptom focused: Rather than treating appetite or bloating as surface issues, Trimology treats them as symptoms of disrupted gut‑brain communication, aiming for root‑cause recalibration.

    Why Women Over 30 Are More Likely to Fall for These Weight Loss Trends

    Women over 30—especially in their late 30s and 40s—often encounter metabolic shifts as hormonal cycles evolve and gut microbiome diversity diminishes. Age-related declines in resistant starch intake, poorer insulin sensitivity, and changing satiety hormone patterns can make weight less responsive to diet and exercise alone.

    Traditional diet programs often backfire for this demographic, causing fatigue, rebound weight gain, or hormonal disruption. Many women report frustration after trying numerous programs with limited long-term results. This vulnerability makes them more susceptible to quick-fix trends like the Pink Salt Trick—offering false hope with minimal effort and social proof.

    Trimology acknowledges these real challenges. Unlike superficial hacks, it works by targeting age‑sensitive systems: gut‑brain communication, butyrate deficit recovery, and hormone stability. Its gentle, supportive approach aligns with women’s busy lives and biological realities: a daily capsule versus restrictive detoxes or influencer‑pushed gimmicks.

    By addressing the invisible drivers of metabolic slowdown—not just calories or fat—Trimology offers a credible alternative for those most affected by modern metabolic.

    Is This Product Backed by Science?

    Yes—while Trimology is a supplement, its formula is built on published scientific research into resistant starch, gut microbiota, and metabolic signaling.

    • RS2 has been shown in multiple studies to increase butyrate production, reduce inflammation, and support healthy glycemic response.
    • Akkermansia muciniphila has clinical data linking it to improved insulin sensitivity and satiety hormone levels.
    • Clostridium butyricum is documented for its resilience and butyrate‑producing capacity.
    • Bifidobacterium infantis has been associated with reduced appetite and improved digestion.

    Although Trimology capsules themselves haven’t undergone large‑scale clinical trials, each ingredient is supported by peer‑reviewed research. Independent reviewers and affiliate health blogs repeatedly cite these scientific underpinnings in endorsement articles.

    Furthermore, Trimology emphasizes ingredient sourcing transparency, avoids false claims or miracle marketing, and communicates realistic expectations—traits aligned with science‑based consumer trust.

    Where To Get Trimology?

    Trimology is available exclusively through its official website. This direct‑to‑consumer model helps ensure authenticity, clarity in pricing and subscription options, and avoids counterfeit distribution common in third‑party marketplaces.

    In contrast to viral “Pink Salt Trick” videos with undisclosed affiliate links, Trimology’s official site provides detailed ingredient listings, FAQ sections, customer support contacts, and opt‑out cancellation policies at no hidden fees.

    Users should purchase only via the official domain to avoid scams or unauthorized resellers. Many reviewers also recommend starting with the introductory offer (typically 30‑day supply) before committing to longer subscriptions.

    Final Thoughts: Why This Trend Matters More Than It Seems

    On the surface, the Pink Salt Trick appears harmless: a pinch of salt, a glass of water, maybe lemon and honey. But beneath the glossy viral veneer lies the risk of misinformation, procedural mimicry, and potential health issues for those with hypertension or kidney conditions.

    This trend exemplifies what happens when social media bypasses scientific validation—when AI‑generated celebrity testimonials and simplified ritual hacks displace rigorous evidence and expert guidance. It’s a warning sign: even well‑meaning health culture can propagate dangerous fads fast.

    Trimology represents the opposite trajectory. It doesn’t promise instant transformation but offers a model of sustainable metabolic realignment rooted in gut science, real‑food traditions, and transparent sourcing. It shifts the narrative from external fixes to internal recalibration.

    In a cultural moment flooded with wellness trends, the difference between viral popularity and scientific credibility matters. The Pink Salt Trick may vanish as its lack of efficacy becomes clearer; Trimology, by contrast, seeks longer‑term trust through measurable ingredients and consumer empowerment.

    For consumers—especially women over 30—it’s a reminder to prioritize evidence over endorsement, gut‑health over gimmicks, and sustainable support over superficial trend chasing.

    Media Contact:
    Brand website: https://trimologyweight.com/
    Project name: Trimology
    Email: support@trimologyweight.com
    Phone: +1 (302) 467-2939

    Attachment

    The MIL Network

  • MIL-OSI: The Pink Salt Trick Recipe for Fast Weight Loss Trend in 2025: Why Trimology Is the Science-Backed Alternative

    Source: GlobeNewswire (MIL-OSI)

    New York City, NY, July 31, 2025 (GLOBE NEWSWIRE) —

    Pink Salt Trick Recipe Explained: Why It’s Trending for Weight Loss

    A viral wellness trend called the “Pink Salt Trick” has swept social media—particularly TikTok, Instagram, and wellness blogs. The hype: a morning ritual mixing Himalayan pink salt, water, lemon and honey claims to boost metabolism, reduce bloating, and even accelerate fat loss. But credible medical sources now label it a pseudoscientific fad with no proven weight‑loss benefits—and potential risks for high blood pressure sufferers.

    Enter Trimology, a science‑backed supplement brand positioned as a safer, evidence‑based alternative. Rather than quick fixes or social media stunts, Trimology takes its inspiration from a traditional Ugandan weight‑maintenance ritual: women consuming bitter green bananas rich in resistant starch (RS2), which naturally support gut microbiome health and metabolic resilience. Trimology translates that ritual into a modern capsule form by delivering concentrated RS2 plus supporting pre‑ and probiotics. 

    While the Pink Salt Trick rides on viral popularity, Trimology is introduced as a metabolic reset system—one that doesn’t promise overnight miracles, but rather aims for sustainable internal recalibration through gut‑brain‑fat signaling pathways. Want to Learn More About Trimology? Click Here

    Why Trimology Is the Safer, Science‑Backed Alternative

    Enter Trimology — a next‑generation, gut‑first weight‑loss supplement designed to offer credible, long‑term benefit rather than a viral illusion. Unlike the Pink Salt Trick, which hinges on vague mineral magic and untested methods, Trimology is rooted in microbiome science and targeted metabolic support.

    • Biological foundation: Trimology blends resistant starch (RS2), chicory inulin, and a signature probiotic triad (including Clostridium butyricum, Akkermansia muciniphila, Bifidobacterium infantis) to feed fat‑regulating gut bacteria and restore healthy metabolic signals.
    • Ancient inspiration: Derived from research into a traditional Ugandan practice—women consuming bitter green bananas rich in RS2 stayed lean well into older age—Trimology replicates the benefits in a clean capsule instead of a literal banana ritual.
    • Transparent formulation: Ingredients and microbial strains are fully disclosed, sourced at pharmaceutical quality, and backed by peer‑reviewed research—not buried in proprietary blends.
    • User‑friendly delivery: One capsule taken daily with breakfast. No meal‑timing restrictions, no yo‑yo dieting, no fasting requirements—just simple consistency. That ease of use appeals especially to women juggling busy schedules.
    • Safety and clarity: Trimology does not rely on caffeine, stimulants, hormone disruptors, or laxatives. It’s not sold as a cure, but a metabolic reset—respecting the body’s natural systems with traceable ingredients and no outrageous promises.

    While the Pink Salt Trick offers instant visual appeal and anecdotal enthusiasm, Trimology emphasizes measured improvement, restoring the gut‑brain‑fat axis, promoting satiety, and supporting energy through internal recalibration—not by shocking the system or inflating expectations. Unlock the Full Story Behind Trimology– Learn More Now

    Why the Internet Believed Deep‑Fake Celebrities Promoted the Pink Salt Trick

    The Pink Salt Trick’s rapid rise is strongly tied to deep‑fake endorsements and manipulated celebrity faces. Reports indicate that creators used AI‑generated clips mimicking well‑known public figures “trying” or “endorsing” the trend. Sensational headlines and algorithm‑driven reach amplified the illusion of legitimacy.

    The strategy tapped into users’ trust in celebrities, piggy‑backing on FOMO (fear of missing out) by suggesting these are insider weight‑loss secrets. Social platforms prioritized visually compelling before‑after testimonials and simplified recipes—despite medical experts warning the trend is unsupported or potentially unsafe.

    In essence, trust was manufactured—the product had no clinical trials, no published data—but looked persuasive because of faux celebrity endorsement and viral momentum. In contrast, Trimology emphasizes transparency, open ingredient sourcing, and no misleading influencer claims.

    Why the Pink Salt Trick Doesn’t Work — and Might Be Harmful

    At first glance, the Pink Salt Trick Recipe seems harmless. After all, pink Himalayan salt is often marketed as a “natural” source of minerals like magnesium, calcium, and potassium. But when used improperly—or in excess—it becomes not only ineffective, but potentially dangerous.

    Here’s why:

    • Too much sodium: One teaspoon of pink Himalayan salt contains about 2,300 mg of sodium—the maximum daily limit recommended by most health authorities. Those doing the trick multiple times a day (as some videos suggest) could be ingesting well over the safe threshold, increasing risk of high blood pressure, fluid retention, and cardiovascular strain.
    • No real metabolic effect: Despite its reputation, there is no clinical evidence that pink salt boosts metabolism, burns fat, or suppresses appetite in any meaningful way. The minor effects people feel—such as increased fullness or reduced cravings—are likely due to hydration or placebo, not salt-specific properties.
    • Dehydration and electrolyte imbalance: In some versions of the trick, users consume large quantities of saltwater without adjusting their hydration elsewhere. This can disrupt the body’s sodium-potassium balance, especially dangerous for people with kidney conditions, hypertension, or existing heart issues.
    • No support for gut health: While pink salt may contain trace minerals, it offers no prebiotic or probiotic benefit, meaning it does nothing to support the gut microbiome—which scientists now agree plays a crucial role in regulating metabolism, insulin sensitivity, and weight stability.
    • Not FDA-regulated: Most of the Pink Salt Trick kits sold online are unregulated and vary widely in quality. Some are sourced from poorly tested suppliers and may contain microplastics or industrial contaminants.

    In contrast, Trimology was developed to avoid all of these pitfalls. Its probiotic strains and resistant starches are carefully dosed for metabolic safety, backed by lab data, and formulated in cGMP-certified facilities. There’s no sodium loading, no electrolyte disruption, and no gimmicky biohacks.

    Trimology’s gut-first approach helps re-establish satiety signaling, healthy blood sugar control, and long-term fat regulation—all while nurturing the digestive ecosystem, not irritating it. Its gradual, cumulative effects are exactly what the body needs—not a one-time shock that confuses internal systems and creates dependency.

    Perhaps most importantly, Trimology doesn’t promise miracles. It encourages consistency, not urgency, which is critical in breaking the cycle of fad-based dieting that trends like the Pink Salt Trick perpetuate. Trimology provides a more intelligent, research-backed solution

    How Trimology Supports Weight Loss

    Trimology supports weight loss by targeting foundational metabolic pathways—not by temporary suppression or dehydration. Its key strategy: nourish beneficial gut bacteria with RS2 and inulin to optimize butyrate production. Butyrate enhances insulin sensitivity, reduces systemic inflammation, and reinforces the gut lining—helping the body regulate blood sugar and fat storage more effectively.

    The included probiotic strains further support natural hunger regulation: Akkermansia is linked with improved satiety hormone function and better insulin response; Clostridium butyricum promotes sustained butyrate output; and Bifidobacterium infantis may help stabilize mood, reduce food cravings, and normalize ghrelin/leptin balance.

    Users are advised to take a single capsule each morning with water or coffee—no complex fasting windows, no food tracking. Over time (usually 2–4 weeks), users report sharper energy, fewer cravings, less bloating, and gradual weight reduction—consistent with internal metabolic reset before visible change.

    Trimology positions weight loss not as an immediate outcome, but as a secondary benefit of restoring internal harmony and resilience—ideally paired with healthy eating and movement, but not dependent on them.

    Key Ingredients of Trimology

    Trimology’s formula stands on five core active components:

    • Pharmaceutical‐grade RS2 (resistant starch): sourced from green banana or potato starch; resists digestion until it reaches the colon, where specific bacteria ferment it, producing butyrate—a short-chain fatty acid central to metabolic regulation.
    • Chicory root (inulin): a soluble fiber and prebiotic that nourishes a diverse gut microbiome, amplifying butyrate production and improving digestion and glucose response.
    • Clostridium butyricum: a robust butyrate-producer that helps lower inflammation, stabilize gut environment, and support fat-burning pathways.
    • Akkermansia muciniphila: known to improve gut barrier integrity, increase satiety hormone responses, and enhance insulin sensitivity—like a natural appetite regulator.
    • Bifidobacterium infantis: associated with reduced cravings, hormone regulation, better digestion, and mood balance—all supportive of sustainable weight.

    These ingredients were chosen not for hype, but for measurable roles in reactivating the gut‑brain‑fat axis. Together, they form what Trimology refers to as the “Signal Reset Triad”—a synergy that supports calm inflammatory processes, improved satiety, and metabolic resilience.

     Visit Trimology Official Website To Know More About ……..

    What Makes Trimology Different From Other Weight Loss Supplements

    Trimology diverges from traditional fat burners or appetite suppressants in several key ways:

    1. No stimulants or synthetic hormones: unlike energizing fat‑burners loaded with caffeine or hormone‑mimicking compounds, Trimology works through microbiome support—not chemical triggers.
    2. Transparent labeling: ingredients are clearly identified, including specific probiotic strains and prebiotic sources. No proprietary blends or ambiguous fillers—each component was selected based on clinical research.
    3. Simplicity and compatibility: single capsule daily, compatible with most lifestyles and diet plans. No food tracking, no cycles, no loading phases. Reviewers consistently praise its integration ease and non‑aggressive positioning.
    4. Sustainable orientation: Trimology encourages long‑term use to rebuild metabolic signaling—not short bursts of weight loss that fade when the supplement ends.
    5. Gut‑focused rather than symptom focused: Rather than treating appetite or bloating as surface issues, Trimology treats them as symptoms of disrupted gut‑brain communication, aiming for root‑cause recalibration.

    Why Women Over 30 Are More Likely to Fall for These Weight Loss Trends

    Women over 30—especially in their late 30s and 40s—often encounter metabolic shifts as hormonal cycles evolve and gut microbiome diversity diminishes. Age-related declines in resistant starch intake, poorer insulin sensitivity, and changing satiety hormone patterns can make weight less responsive to diet and exercise alone.

    Traditional diet programs often backfire for this demographic, causing fatigue, rebound weight gain, or hormonal disruption. Many women report frustration after trying numerous programs with limited long-term results. This vulnerability makes them more susceptible to quick-fix trends like the Pink Salt Trick—offering false hope with minimal effort and social proof.

    Trimology acknowledges these real challenges. Unlike superficial hacks, it works by targeting age‑sensitive systems: gut‑brain communication, butyrate deficit recovery, and hormone stability. Its gentle, supportive approach aligns with women’s busy lives and biological realities: a daily capsule versus restrictive detoxes or influencer‑pushed gimmicks.

    By addressing the invisible drivers of metabolic slowdown—not just calories or fat—Trimology offers a credible alternative for those most affected by modern metabolic.

    Is This Product Backed by Science?

    Yes—while Trimology is a supplement, its formula is built on published scientific research into resistant starch, gut microbiota, and metabolic signaling.

    • RS2 has been shown in multiple studies to increase butyrate production, reduce inflammation, and support healthy glycemic response.
    • Akkermansia muciniphila has clinical data linking it to improved insulin sensitivity and satiety hormone levels.
    • Clostridium butyricum is documented for its resilience and butyrate‑producing capacity.
    • Bifidobacterium infantis has been associated with reduced appetite and improved digestion.

    Although Trimology capsules themselves haven’t undergone large‑scale clinical trials, each ingredient is supported by peer‑reviewed research. Independent reviewers and affiliate health blogs repeatedly cite these scientific underpinnings in endorsement articles.

    Furthermore, Trimology emphasizes ingredient sourcing transparency, avoids false claims or miracle marketing, and communicates realistic expectations—traits aligned with science‑based consumer trust.

    Where To Get Trimology?

    Trimology is available exclusively through its official website. This direct‑to‑consumer model helps ensure authenticity, clarity in pricing and subscription options, and avoids counterfeit distribution common in third‑party marketplaces.

    In contrast to viral “Pink Salt Trick” videos with undisclosed affiliate links, Trimology’s official site provides detailed ingredient listings, FAQ sections, customer support contacts, and opt‑out cancellation policies at no hidden fees.

    Users should purchase only via the official domain to avoid scams or unauthorized resellers. Many reviewers also recommend starting with the introductory offer (typically 30‑day supply) before committing to longer subscriptions.

    Final Thoughts: Why This Trend Matters More Than It Seems

    On the surface, the Pink Salt Trick appears harmless: a pinch of salt, a glass of water, maybe lemon and honey. But beneath the glossy viral veneer lies the risk of misinformation, procedural mimicry, and potential health issues for those with hypertension or kidney conditions.

    This trend exemplifies what happens when social media bypasses scientific validation—when AI‑generated celebrity testimonials and simplified ritual hacks displace rigorous evidence and expert guidance. It’s a warning sign: even well‑meaning health culture can propagate dangerous fads fast.

    Trimology represents the opposite trajectory. It doesn’t promise instant transformation but offers a model of sustainable metabolic realignment rooted in gut science, real‑food traditions, and transparent sourcing. It shifts the narrative from external fixes to internal recalibration.

    In a cultural moment flooded with wellness trends, the difference between viral popularity and scientific credibility matters. The Pink Salt Trick may vanish as its lack of efficacy becomes clearer; Trimology, by contrast, seeks longer‑term trust through measurable ingredients and consumer empowerment.

    For consumers—especially women over 30—it’s a reminder to prioritize evidence over endorsement, gut‑health over gimmicks, and sustainable support over superficial trend chasing.

    Media Contact:
    Brand website: https://trimologyweight.com/
    Project name: Trimology
    Email: support@trimologyweight.com
    Phone: +1 (302) 467-2939

    Attachment

    The MIL Network

  • MIL-OSI: NDT Global Announces Strategic Addition of Entegra®

    Source: GlobeNewswire (MIL-OSI)

    QUÉBEC CITY, July 31, 2025 (GLOBE NEWSWIRE) — NDT Global, a leading provider of advanced diagnostic inspection and integrity solutions for the energy sector, is proud to announce the acquisition of Entegra, a premium technology company specializing in Ultra-High-Resolution Magnetic Flux Leakage (UHR MFL) in-line inspection services.

    This strategic union brings together two market-leading technology providers significantly enhancing NDT Global’s service portfolio, strengthening its growing position in the gas pipeline market, and reinforcing its continued commitment to delivering the best data driven insights and high-performance integrity solutions. Together, NDT Global and Entegra are affirming their stance in redefining the future of pipeline integrity. By harnessing the power of technology, the complimentary services will act as an enabler for safer, more cost-effective pipeline operations, empowering customers with the insights needed to make smarter, faster decisions for their assets.

    The combination of NDT ILI, Dynamic Risk, and now Entegra brings together highly complementary technology platforms in ultrasonic testing (UT), Acoustic Resonance (ART), UHR MFL, and data management solutions, creating a unique set of solutions for pipeline operators seeking best-in-class data-driven inspection, diagnostic, and integrity services across a diverse asset base.

    “This is a pivotal moment for NDT Global,” said Martin Thériault, CEO and Chairman of NDT Global. “Entegra’s entrepreneurial spirit, technical leadership and excellence, and deep market knowledge make them an ideal fit for our joint vision going forward. The company will work on accelerating the development of next-generation inspection technologies and, in return, deliver an even greater value to customers through enhanced service offerings and global reach.”

    Paul Cooper, President of NDT Global, highlights “The addition of Entegra’s market-leading capabilities to our portfolio allows us to offer a broader, more integrated suite of solutions to our clients. It also helps us to better serve the growing needs of the gas pipeline sector, where Entegra has built a strong reputation for innovation and reliability. All in all, the merged entities will accelerate our joint growth journey based on technology and innovation. It’s a bold step forward in our mission to deepen partnerships and lead the industry with innovation that protects what matters most.”

    “I can’t thank Amberjack Capital enough for their direction and support the past 10 years, and I’m really excited about what we’re going to achieve in the next phase of our growth story as we bring together the two best brands in in-line-inspection” said Mark Olson, Chairman and CEO, Entegra. “Our purpose, our ‘Why’ if you will, is to make better every pipeline with which we interact, and this deal accelerates that quest by several years.”

    The combined entity will benefit from expanded international reach and the ability to deliver joint UT and MFL scopes, axial and now circumferential, to valued clients. This move also supports NDT Global’s and Entegra’s long-term vision of becoming the most trusted partner in pipeline integrity management.

    The transaction was made possible through the continued support of Novacap, the majority shareholder of NDT Global, alongside La Caisse (formerly CDPQ), and NDT Global as well as Entegra founders and executives. Before today’s announcement, Entegra was owned by Amberjack Capital Partners as well as a group of co-founders led by Mark Olson, who played a pivotal role in building the company’s reputation for innovation and excellence in the MFL space. As part of the transaction, the NDT Global and Entegra founders and key management will remain shareholders of the combined company.

    “We are thrilled to unite two leading innovators in the ILI industry, combining world-class technology platforms and talented teams. This partnership enhances NDT’s ability to serve customers and uphold the integrity of critical infrastructure globally. We are proud to continue our partnership with Martin, Paul and the NDT team, and we warmly welcome Mark and the entire Entegra family as we work together to build a stronger, more impactful business together” added David Lewin, Lead Senior Partner Novacap.

    “NDT Global has distinguished itself through its ability to innovate and develop state-of-the-art solutions, becoming a global reference in the integrity and inspection services industry,” adds Kim Thomassin, Executive Vice-President and Head of Québec at La Caisse. “With this investment, La Caisse is strengthening NDT Global’s ambitious growth strategy through both equity and debt financing — building on our recent support to unlock the company’s full potential.”

    Jason Turowsky, Managing Partner of Amberjack Capital Partners, said “Amberjack is proud to have supported Entegra’s exceptional growth, driven by its talented team and commitment to innovation. We are confident the combination with NDT Global will propel further advancements in pipeline integrity solutions, benefiting clients globally. We congratulate Mark and the Entegra team and look forward to their continued success.”

    McCarthy Tétrault LLP and Willkie Farr & Gallagher LLP acted as legal advisors to NDT Global, while Jefferies LLC acted as exclusive financial advisor to NDT Global.

    Sidley Austin LLP acted as legal advisor to Entegra, while Baird acted as its exclusive financial advisor.

    ABOUT NDT GLOBAL

    NDT Global is the leading provider of in-line diagnostic solutions, integrity management and subsea robotics solutions, offering advanced data insights and services that ensure the safety and longevity of energy-sector infrastructure assets. Recognized as the forerunner in ultrasonic inspection innovations—including Pulse Echo, Pitch-and-Catch, Phased Array, and Acoustic Resonance (ART Scan) technologies — the company continues to push technological advancement and the introduction of revolutionary new inspection technologies, including gas pipelines, to ensure the safety of its customers’ critical assets. NDT Global employs approximately 880 people. Learn more at www.ndt-global.com.

    ABOUT ENTEGRA

    Recognized as the industry-leading, trusted supplier of in-line inspection services for corrosion, 3rd party damage, pipe grade classification, hard spot assessment, and for assessing the effectiveness of cathodic protection systems for oil and gas pipelines, Entegra provides the most thorough, clear, and nuanced knowledge about the condition of pipelines inspected. The Company offers ultra-high resolution axial MFL, circumferential MFL, Caliper, low-field, GPS mapping, and cathodic protection current mapping services for critical energy infrastructure. Learn more at www.entegrasolutions.com.

    ABOUT NOVACAP

    Novacap is a leading North American private equity investor and one of Canada’s most experienced private equity firms. Founded in 1981 to partner with visionary entrepreneurs, Novacap focuses on middle market and lower-middle market companies in four core sectors: Technologies, Digital Infrastructure, Industries and Financial Services. Novacap combines deep sector specific expertise and strategic and operational excellence to partner with entrepreneurs and management teams. Since its inception, the firm has made primary and add-on investments in more than 250 companies. With over C$11 billion in assets under management and a presence across offices in Montreal, Toronto, and New York, Novacap accelerates value creation through strategic growth initiatives and a strong focus on execution. For more information, please visit: https://novacapcorp.com.

    ABOUT LA CAISSE

    At La Caisse, formerly CDPQ, we have invested for 60 years with a dual mandate: generate optimal long-term returns for our 48 depositors, who represent over 6 million Quebecers, and contribute to Québec’s economic development.

    As a global investment group, we are active in the major financial markets, private equity, infrastructure, real estate and private credit. As at December 31, 2024, La Caisse’s net assets totaled CAD 473 billion. For more information, visit lacaisse.com or consult our LinkedIn or Instagram pages.

    La Caisse is a registered trademark of Caisse de dépôt et placement du Québec that is protected in Canada and other jurisdictions and licensed for use by its subsidiaries.

    ABOUT AMBERJACK CAPITAL PARTNERS

    Amberjack Capital is a private equity firm that invests in and partners with entrepreneurs and business owners to build market leaders serving the industrial, infrastructure and environmental services end markets. Often the first institutional investor in founder-led companies, Amberjack has a particular focus on supporting high performing companies undertaking strategic or transformative initiatives. Headquartered in Houston, TX, the firm has raised $2.1 billion of committed capital since its inception in 2006 and has invested in over 50 companies.

    For more information:

    Tracey Murray
    Director, Marketing
    NDT Global
    Tel.: (403) 819-9351
    tmurray@ndt-global.com

    The MIL Network

  • MIL-OSI: LYNO Launches Early Bird Presale Phase with 16 Million Tokens at $0.050

    Source: GlobeNewswire (MIL-OSI)

    ROAD TOWN, British Virgin Islands, July 31, 2025 (GLOBE NEWSWIRE) — LYNO, a decentralized cross-chain arbitrage protocol powered by artificial intelligence (AI), has officially launched the Early Bird phase of its token presale. This initial phase is offering 16 million $LYNO tokens at the price of $0.050 per token. Once this allocation is sold out, the next phase will see the token price increase to $0.055. This announcement marks the beginning of LYNO’s public sale process as it aims to distribute 28% of its total token supply through a seven-phase community presale.

    This milestone represents a significant step forward in LYNO’s roadmap as it prepares for its official platform deployment. The project’s token sale structure is designed to progressively increase the token price at each stage, incentivizing early participation and distributing value to early supporters.

    Purpose-Built Arbitrage Protocol for DeFi

    LYNO is engineered to automate cross-chain arbitrage opportunities across fragmented decentralized finance (DeFi) markets. Its infrastructure enables users to benefit from price inefficiencies across different blockchain networks, executing profitable trades without requiring any manual intervention. The platform supports over 15 EVM-compatible chains, maximizing market coverage and arbitrage scope.

    The protocol operates on a four-layer architectural model: DataAIExecution, and Settlement. This layered system allows LYNO to constantly monitor real-time price feeds, apply machine learning algorithms to identify profitable opportunities, and execute trades using smart contracts and flash loans. This approach aims to deliver high-speed execution and accuracy, setting the stage for a more efficient decentralized trading environment.

    Integration with Leading Blockchain Bridges

    LYNO’s design includes compatibility with several of the leading cross-chain messaging and liquidity bridges. This includes integration with LayerZeroAxelarWormhole, and others, which ensures seamless capital movement across networks. By using these bridges, LYNO can minimize slippage, reduce latency, and increase transaction success rates in arbitrage operations. These integrations are essential for real-time cross-chain trading, enabling LYNO to maintain its operational speed and accuracy across diverse DeFi markets.

    Utility and Tokenomics

    The $LYNO token is central to the protocol’s operation. It will serve multiple functions within the LYNO ecosystem, including:

    • Governance participation: Token holders can vote on protocol upgrades, fee structures, and future proposals.
    • Staking: Users can stake tokens to receive a share of the protocol’s profits.
    • Tool access: Holders can unlock AI-based real-time analytics and arbitrage monitoring tools.

    LYNO has implemented a multi-layered tokenomic model designed to align user incentives with the long-term success of the platform. Key features include:

    • Buyback and burn mechanisms to support price stability and reduce circulating supply.
    • Liquidity mining incentives for early liquidity providers.
    • Revenue sharing model distributing up to 60% of platform fees to stakers and participants.

    These mechanisms are intended to increase transparency, support decentralization, and maintain consistent user engagement. The project has been audited by Cyberscope, further enhancing its credibility and focus on smart contract security.

    How to Participate in the Presale

    Investors who wish to take part in the Early Bird presale can do so by connecting their wallets—such as MetaMask, Trust Wallet, or any WalletConnect-compatible wallet—to the LYNO presale platform at https://lyno.ai/#presale. The supported payment options for purchasing $LYNO tokens include ETHUSDC, and USDT. Tokens purchased during the presale will be claimable after the conclusion of all presale phases.

    This Early Bird phase is time-sensitive and available on a first-come, first-served basis. After the initial 16 million tokens are sold, the token price will increase from $0.050 to $0.055 in the next stage. This price progression will continue through the subsequent rounds, designed to reward early contributors before the token listing on exchanges.

    Building a Transparent and Automated DeFi Future

    LYNO is part of a new wave of DeFi protocols aiming to reduce inefficiencies and human error in the arbitrage trading process. By leveraging artificial intelligence, cross-chain compatibility, and fully automated systems, LYNO introduces an alternative to manual DeFi trading strategies.

    With increasing fragmentation in liquidity across blockchains and growing interest in interoperable DeFi solutions, LYNO’s protocol arrives at a time when seamless arbitrage execution is becoming increasingly important. The LYNO platform aims to help users unlock value from market inefficiencies while offering governance and income opportunities via staking and community engagement.

    About LYNO

    LYNO is an AI-powered, decentralized cross-chain arbitrage protocol built to automate real-time profitable trades across multiple EVM-compatible chains. The protocol is designed to optimize DeFi trading by offering speed, transparency, and efficiency while leveraging powerful AI technologies and smart contract automation. LYNO’s infrastructure is compatible with top bridge solutions, making it a versatile and forward-looking solution for decentralized arbitrage.

    For More Information, Please Visit:

    Contact:
    LYNO AI
    Email: contact@lyno.ai

    Disclaimer: This content is provided by LYNO. The statements, views, and opinions expressed in this content are solely those of the content provider and do not necessarily reflect the views of this media platform or its publisher. We do not endorse, verify, or guarantee the accuracy, completeness, or reliability of any information presented. We do not guarantee any claims, statements, or promises made in this article. This content is for informational purposes only and should not be considered financial, investment, or trading advice.Investing in crypto and mining-related opportunities involves significant risks, including the potential loss of capital. It is possible to lose all your capital. These products may not be suitable for everyone, and you should ensure that you understand the risks involved. Seek independent advice if necessary. Speculate only with funds that you can afford to lose. Readers are strongly encouraged to conduct their own research and consult with a qualified financial advisor before making any investment decisions. However, due to the inherently speculative nature of the blockchain sector—including cryptocurrency, NFTs, and mining—complete accuracy cannot always be guaranteed.Neither the media platform nor the publisher shall be held responsible for any fraudulent activities, misrepresentations, or financial losses arising from the content of this press release. In the event of any legal claims or charges against this article, we accept no liability or responsibility.Globenewswire does not endorse any content on this page.

    Legal Disclaimer: This media platform provides the content of this article on an “as-is” basis, without any warranties or representations of any kind, express or implied. We assume no responsibility for any inaccuracies, errors, or omissions. We do not assume any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information presented herein. Any concerns, complaints, or copyright issues related to this article should be directed to the content provider mentioned above.

    Photos accompanying this announcement are available at

    https://www.globenewswire.com/NewsRoom/AttachmentNg/7f1c0f27-b1f5-4966-b736-ef6709c13738

    https://www.globenewswire.com/NewsRoom/AttachmentNg/88ca5dde-10a7-4491-b8c2-fd5abf715a3a

    The MIL Network

  • MIL-OSI: The AR Alliance Welcomes Magic Leap, Tekscend Photomask, and UC San Diego as New Members

    Source: GlobeNewswire (MIL-OSI)

    PISCATAWAY, N.J., July 31, 2025 (GLOBE NEWSWIRE) — The AR Alliance a program of the ISTO federation that is dedicated to advancing open and interoperable augmented reality (AR) ecosystem standards, proudly announces the addition of four influential members: Magic Leap, Tekscend Photomask, and University of California San Diego.

    These new members reflect the global diversity and strength of the AR hardware development ecosystem, bringing expertise across foundational research, advanced optics, semiconductor tooling, and spatial computing platforms. Their participation reinforces the Alliance’s collaborative mission to accelerate innovation, support open standards, and unify the AR industry through concrete action and shared success.

    The AR Alliance provides a supportive and neutral environment for organizations of all sizes to take an active role in advancing and strengthening the augmented reality hardware development ecosystem.  Diverse organizations across the expanding, global AR ecosystem work together through The AR Alliance to speed innovation and breakthrough technologies and processes for building AR wearables and devices that create meaningful and positive experiences for users.

    “We are building AR together” said Dr. Bharath Rajagopalan, Chair of The AR Alliance and Director of Strategic Marketing, STMicroelectronics. “The promise of AR and its potential market are so vast that there is ample room for all our member companies, and stakeholders, to succeed together. The AR Alliance is the place where concrete work takes place to harmonize approaches for advancing, unifying, and growing the global AR supply chain as well as accelerating innovation.  We are pleased to welcome these new members to the AR Alliance and to join us in this important work and bring their deep technology experience, manufacturing capabilities, product leadership and research to help enable the AR market.”

    Magic Leap is a leader in transparent optics technology and scalable optics manufacturing for Augmented Reality (AR) experiences. They build proprietary manufacturing equipment and processes to produce highly precise eyepieces, with their flagship AR product, Magic Leap 2, featuring patented optics and a lightweight design.

    UC San Diego has been named the No. 8 university worldwide in powering global innovation, according to Clarivate’s latest report. The university ranked third among U.S. public institutions, reflecting its deep impact on industry and society through cutting-edge research and breakthrough patents.

    The unique collaboration between UC San Diego’s Swartz Center for Computational Neuroscience and the Arthur C. Clarke Center for Human Imagination has given rise to an interdisciplinary team of neuroscientists, computer scientists and artists working together to pose problems in new ways and advance scientific methods and knowledge with full STEAM ahead.  Their combined methods leverage recent advances in lightweight biometric sensors, virtual reality, eye tracking, EEG, as well as state of the art immersive Virtual Reality.  Their lab (located at the Supercomputer Center for Neuroscience, UCSD) has a wide variety of neuroscientists.  The lab is also renowned for the use of the MoBI lab, a research space dedicated to virtual reality experiments.

    Tekscend Photomask Corp is the world’s premier provider of photomasks for semiconductors, and a group company of TOPPAN Holdings Inc. Tekscend Photomask was previously known as Toppan Photomask. Headquartered in Tokyo, Tekscend Photomask leverages its worldwide customer service network and eight manufacturing facilities in key geographic locations to offer the worlds most advanced lithography technology.  Tekscend Photomask is also expanding into nanoimprint molds and other nano-fabricated products.

    About The AR Alliance

    The AR Alliance Founding Board Members comprise STMicroelectronics, META, Essilor Luxottica, Corning, Dispelix, Optofidelity, MICROOLED, Google, and Qualcomm.

    Organizations of every size and in any sector of the ecosystem are respected, heard, and supported in The AR Alliance’s non-competitive, collaborative environment. Flexible membership levels remove barriers to access enabling companies of varying stages of maturity and resources to engage.

    To learn more about membership in The AR Alliance, please visit www.thearalliance.org.

    Media Contact:
    Brianna Rich
    Program Manager
    brianna.rich@isto.org

    The MIL Network

  • MIL-OSI: Erayak Power Solution Group. Announces $7 Million Registered Direct Offering

    Source: GlobeNewswire (MIL-OSI)

    Wenzhou, China, July 31, 2025 (GLOBE NEWSWIRE) — Erayak Power Solution Group Inc. (NASDAQ: RAYA) (“Erayak” or the “Company”), a leading manufacturer, designer, and exporter of high-quality products in the power supply industry, today announced that it has entered into a securities purchase agreement with certain institutional investors for the purchase and sale of an aggregate of 107,692,307 shares of the Company’s Class A ordinary shares, par value $0.0001 per share (the “Shares”) (or pre-funded warrants in lieu thereof) at a purchase price of $0.065 per share in a registered direct offering. The purchase price for the pre-funded warrants is identical to the purchase price for Shares, less the exercise price of $0.0001 per share.

    The aggregate gross proceeds to the Company of this offering are expected to be approximately $7 million. The transaction is expected to close on or about August 1, 2025, subject to the satisfaction of customary closing conditions.

    Craft Capital Management is acting as the sole placement agent for the offering. 

    The registered direct offering is being made pursuant to a shelf registration statement on Form F-3 (File No. 333-278347) previously filed by the Company and declared effective by the U.S. Securities and Exchange Commission (“SEC”) on May 16, 2024.

    The offering is being made only by means of a prospectus supplement and accompanying prospectus. The prospectus supplement describing the terms of the public offering will be filed with the SEC prior to the closing and will form a part of the effective registration statement, available on the SEC’s website located at http://www.sec.gov.

    Copies of the prospectus supplement and accompanying prospectus relating to the offering may be obtained from Craft Capital Management, 377 Oak St., Lower Concourse, Garden City, NY 11530, Attention: Syndicate Dept.; email: info@craftcm.com

    This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.

    About Erayak Power Solution Group Inc.

    Erayak specializes in the manufacturing, research and development, and wholesale and retail of power solution products. Erayak’s product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery and smart chargers, and custom-designed products. Our products are used principally in agricultural and industrial vehicles, recreational vehicles, electrical appliances, and outdoor living products. Our goal is to be the premier power solutions brand and a solution for mobile life and outdoor living. For more information, visit www.erayakpower.com.

    Safe Harbor Statement

    This press release contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur.

    Investor Relations Contact:

    Erayak Power Solution Group Inc.
    No. 528, 4th Avenue
    Binhai Industrial Park
    Wenzhou, Zhejiang Province
    People’s Republic of China 325025

    Email: investor@erayakpower.com

    The MIL Network